Method and apparatus for coupling soft tissue to a bone

Information

  • Patent Grant
  • 11446019
  • Patent Number
    11,446,019
  • Date Filed
    Wednesday, May 1, 2019
    5 years ago
  • Date Issued
    Tuesday, September 20, 2022
    2 years ago
Abstract
A method and apparatus for surgically repairing a tear in soft tissue is disclosed. A plurality of collapsible tubes are positioned about the suture. The collapsible tubes are pushed through soft tissue and orthopedic mesh on opposite sides of a tear in soft tissue. When tension is applied to the suture, the tubes are compressed to fix the suture to the soft tissue and draw the soft tissue portions together.
Description
FIELD

The present disclosure relates to method of coupling soft tissue to a bone and, more particularly, to a method of implanting an ACL within a femoral tunnel.


BACKGROUND

The statements in this section merely provide background information related to the present disclosure and may not constitute prior art.


It is commonplace in arthroscopic procedures to employ sutures and anchors to secure soft tissues to bone. Despite their widespread use, several improvements in the use of sutures and suture anchors may be made. For example, the procedure of tying knots may be very time consuming, thereby increasing the cost of the procedure and limiting the capacity of the surgeon. Furthermore, the strength of the repair may be limited by the strength of the knot. This latter drawback may be of particular significance if the knot is tied improperly as the strength of the knot in such situations may be significantly lower than the tensile strength of the suture material.


To improve on these uses, suture having a single preformed loop have been provided. FIG. 1 represents a prior art suture construction. As shown, one end of the suture is passed through a passage defined in the suture itself. The application of tension to the ends of the suture pulls a portion of the suture through the passage, causing a loop formed in the suture to close. Relaxation of the system, however may allow a portion of the suture to translate back through the passage, thus relieving the desired tension.


It is an object of the present teachings to provide an alternative device for anchoring sutures to bone and soft tissue. The device, which is relatively simple in design and structure, is highly effective for its intended purpose.


SUMMARY

To overcome the aforementioned deficiencies, a method for configuring a braided tubular suture and a suture configuration are disclosed. The method includes passing a first end of the suture through a first aperture into a passage defined by the suture and out a second aperture defined by the suture so as to place the first end outside of the passage. A second end of the suture is passed through the second aperture into the passage and out the first aperture so as to place the second end outside of the passage.


A method of surgically implanting a suture construction in a femoral tunnel is disclosed. A suture construction is formed by passing the suture through a bore defined by a locking member. A first end of the suture is passed through a first aperture within the suture into a passage defined by the suture and out a second aperture defined by the suture so as to place the first end outside of the passage and define a first loop. A second end of the suture is then passed through the second aperture into the passage and out the first aperture so as to place the second end outside of the passage, and define a second loop. The first and second ends and the first and second loops are then passed through the femoral tunnel. Soft tissue is then passed through the first and second loops. Tension is applied onto the first and second ends to constrict the first and second loops to pull the soft tissue into the tunnel.


In another embodiment, a method of surgically implanting a suture is disclosed. The suture is passed through a bore defined by a first fastener. A suture construction is formed by passing the suture through a bore defined by a locking member. A first end of the suture is passed through a first aperture within the suture into a passage defined by the suture and out a second aperture defined by the suture so as to place the first end outside of the passage and define a first loop. A second end of the suture is then passed through the second aperture into the passage and out the first aperture so as to place the second end outside of the passage, and define a second loop. A second fastener is coupled to at least one of the first and second loops. After the fastener is coupled to the patient, tension is applied onto the first and second ends to constrict at least one of the first and second loops.


In another embodiment a method of surgically implanting a soft tissue replacement for attaching two bone members is disclosed. A first and second tunnel is formed in first and second bones. A locking member having a first profile which allows insertion of the locking member through the tunnel and a second profile which allows engagement with the positive locking surface upon rotation of the locking member is provided. The suture construction described above is coupled to the locking member. The first and second ends and the first and second loops of the construction and the locking member are threaded through the first and second tunnels. Soft tissue is threaded through the first and second loops so as to engage bearing surfaces on the first and second loops. The locking member is then engaged.


Further areas of applicability will become apparent from the description provided herein. It should be understood that the description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.





DRAWINGS

The drawings described herein are for illustration purposes only and are not intended to limit the scope of the present disclosure in any way.



FIG. 1 represents a prior art suture configuration;



FIGS. 2A and 2B represent suture constructions according to the teachings;



FIG. 3 represents the formation of the suture configuration shown in FIG. 4A;



FIGS. 4A and 4B represent alternate suture configurations;



FIGS. 5-7 represent further alternate suture configurations;



FIG. 8 represents the suture construction according to FIG. 5 coupled to a bone engaging fastener;



FIGS. 9-11B represent the coupling of the suture construction according to FIG. 5 to a bone screw;



FIGS. 12A-12E represent the coupling of a soft tissue to an ACL replacement in a femoral/humeral reconstruction;



FIGS. 13A-13D represent a close-up view of the suture shown in FIGS. 1-11C;



FIGS. 14-16 represent fixed length textile anchors;



FIGS. 17-21 represent adjustable length textile anchors according to the teachings herein;



FIGS. 22-24 represent alternate adjustable length textile anchors;



FIGS. 25-27 represent alternate suture configurations;



FIG. 28 represents the preparation of the tibia and femur to accept the anchors disclosed in FIGS. 14-24;



FIGS. 29A and 29B represent the coupling of an ACL replacement in a femoral/tibial reconstruction using the textile anchor of FIG. 18;



FIGS. 30A and 30B represent the coupling of an ACL replacement in a femoral/tibial reconstruction using the textile anchor of FIG. 17;



FIGS. 31A and 31B represent the coupling of an ACL replacement in the femoral/tibial reconstruction using the textile anchor of FIG. 15;



FIGS. 32A and 32B represent the coupling of an ACL replacement in a femoral/humeral reconstruction using the textile anchor of FIG. 16;



FIG. 33 represents a suture construction having a plurality of collapsible tubes;



FIGS. 34A-34C represent a tool used to surgically implant the suture construction shown in FIG. 33;



FIGS. 35A-35C show the suture construction of FIG. 33 coupled to an orthopedic mesh;



FIGS. 36A-36C represent the use of an orthopedic mesh to repair a soft tissue tear;



FIGS. 37A-39D represent various methodologies of coupling the suture constructions of FIG. 33 to soft tissue; and



FIGS. 40-45 represent an alternate suture construction.





DETAILED DESCRIPTION

The following description is merely exemplary in nature and is not intended to limit the present disclosure, application, or uses. It should be understood that throughout the drawings, corresponding reference numerals indicate like or corresponding parts and features.



FIG. 2A represents a suture construction 20 according to the present teachings. Shown is a suture 22 having a first end 24 and a second end 26. The suture 22 is formed of a braided body 28 that defines a longitudinally formed hollow passage 30 therein. First and second apertures 32 and 34 are defined in the braided body 28 at first and second locations of the longitudinally formed passage 30.


Briefly referring to FIG. 3, a first end 24 of the suture 22 is passed through the first aperture 32 and through longitudinal passage 30 formed by a passage portion and out the second aperture 34. The second end 26 is passed through the second aperture 34, through the passage 30 and out the first aperture 32. This forms two loops 46 and 46′. As seen in FIG. 2B, the relationship of the first and second apertures 32 and 34 with respect to the first and second ends 24 and 26 can be modified so as to allow a bow-tie suture construction 36. As described below, the longitudinal and parallel placement of first and second suture portions 38 and 40 of the suture 22 within the longitudinal passage 30 resists the reverse relative movement of the first and second portions 38 and 40 of the suture once it is tightened.


The first and second apertures are formed during the braiding process as loose portions between pairs of fibers defining the suture. As further described below, the first and second ends 24 and 26 can be passed through the longitudinal passage 30 multiple times. It is envisioned that either a single or multiple apertures can be formed at the ends of the longitudinally formed passage.


As best seen in FIGS. 4A and 4B, a portion of the braided body 28 of the suture defining the longitudinal passage 30 can be braided so as to have a diameter larger than the diameter of the first and second ends 24 and 26. Additionally shown are first through fourth apertures 32, 34, 42, and 44. These apertures can be formed in the braiding process or can be formed during the construction process. In this regard, the apertures 32, 34, 42, and 44 are defined between adjacent fibers in the braided body 28. As shown in FIG. 4B, and described below, it is envisioned the sutures can be passed through other biomedically compatible structures.



FIGS. 5-7 represent alternate constructions wherein a plurality of loops are formed by passing the first and second ends 24 and 26 through the longitudinal passage 30 multiple times. The first and second ends 24 and 26 can be passed through multiple or single apertures defined at the ends of the longitudinal passage 30. The tensioning of the ends 24 and 26 cause relative translation of the sides of the suture with respect to each other.


Upon applying tension to the first and second ends 24 and 26 of the suture 22, the size of the loops 46a-d is reduced to a desired size or load. At this point, additional tension causes the body of the suture defining the longitudinal passage 30 to constrict about the parallel portions of the suture within the longitudinal passage 30. This constriction reduces the diameter of the longitudinal passage 30, thus forming a mechanical interface between the exterior surfaces of the first and second parallel portions as well as the interior surface of the longitudinal passage 30.


As seen in FIGS. 8-11, the suture construction can be coupled to various biocompatible hardware. In regard, the suture construction 20 can be coupled to an aperture 52 of the bone engaging fastener 54. Additionally, it is envisioned that soft tissue or bone engaging members 56 can be fastened to one or two loops 46. After fixing the bone engaging fastener 54, the members 56 can be used to repair, for instance, a meniscal tear. The first and second ends 24, 26 are then pulled, setting the tension on the loops 46, thus pulling the meniscus into place. Additionally, upon application of tension, the longitudinal passage 30 is constricted, thus preventing the relaxation of the tension caused by relative movement of the first and second parallel portions 38, 40, within the longitudinal passage 30.


As seen in FIGS. 9-11B, the loops 46 can be used to fasten the suture construction 20 to multiple types of prosthetic devices. As described further below, the suture 22 can further be used to repair and couple soft tissues in an anatomically desired position. Further, retraction of the first and second ends allows a physician to adjust the tension on the loops between the prosthetic devices.



FIG. 11B represents the coupling of the suture construction according to FIG. 2B with a bone fastening member. Coupled to a pair of loops 46 and 46′ is tissue fastening members 56. The application of tension to either the first or second end 24 or 26 will tighten the loops 46 or 46′ separately.



FIGS. 12A-12E represent potential uses of the suture constructions 20 in FIGS. 2A-7 in an ACL repair. As can be seen in FIG. 12A, the longitudinal passage portion 30 of suture construction 20 can be first coupled to a fixation member 60. The member 60 an have a first profile which allows insertion of the member 60 through the tunnel and a second profile which allows engagement with a positive locking surface upon rotation. The longitudinal passage portion 30 of the suture construction 20, member 60, loops 46 and ends 24, 26 can then be passed through a femoral and tibial tunnel 62. The fixation member 60 is positioned or coupled to the femur. At this point, a natural or artificial ACL 64 can be passed through a loop or loops 46 formed in the suture construction 20. Tensioning of the first and second ends 24 and 26 applies tension to the loops 46, thus pulling the ACL 64 into the tunnel. In this regard, the first and second ends are pulled through the femoral and tibial tunnel, thus constricting the loops 46 about the ACL 64 (see FIG. 12B).


As shown, the suture construction 20 allows for the application of force along an axis 61 defining the femoral tunnel. Specifically, the orientation of the suture construction 20 and, more specifically, the orientation of the longitudinal passage portion 30, the loops 46, and ends 24, 26 allow for tension to be applied to the construction 20 without applying non-seating forces to the fixation member 60. As an example, should the loops 24, 26 be positioned at the member 60, application of forces to the ends 24, 26 may reduce the seating force applied by the member 60 onto the bone.


As best seen in FIG. 12C, the body portion 28 and parallel portions 38, 40 of the suture construction 20 remain disposed within to the fixation member 60. Further tension of the first ends draws the ACL 64 up through the tibial component into the femoral component. In this way, suture ends can be used to apply appropriate tension onto the ACL 64 component. The ACL 64 would be fixed to the tibial component using a plug or screw as is known. The suture construction has loops 46 and 46′ with a first length which allows rotation of the fixation member 60. Application of tension onto the ends 24, 26 of the sutures pulls the fixation member 60 into position and the loops 46 and 46′ into a second length. In this position, rotation of the locking member in inhibited.


After feeding the ACL 64 through the loops 46, tensioning of the ends allows engagement of the ACL with bearing surfaces defined on the loops. The tensioning pulls the ACL 64 through a femoral and tibial tunnel. The ACL 64 could be further coupled to the femur using a transverse pin or plug. As shown in FIG. 12E, once the ACL is fastened to the tibia, further tensioning can be applied to the first and second ends 24, 26 placing a desired predetermined load on the ACL. This tension can be measured using a force gauge. This load is maintained by the suture configuration. It is equally envisioned that the fixation member 60 can be placed on the tibial component 66 and the ACL pulled into the tunnel through the femur. Further, it is envisioned that bone cement or biological materials may be inserted into the tunnel 62.



FIGS. 13A-13D represent a close-up of a portion of the suture 20. As can be seen, the portion of the suture defining the longitudinal passage 30 has a diameter d1 which is larger than the diameter d2 of the ends 24 and 26. The first aperture 32 is formed between a pair of fiber members. As can be seen, the apertures 32, 34 can be formed between two adjacent fiber pairs 68, 70. Further, various shapes can be braided onto a surface of the longitudinal passage 30.


The sutures are typically braided of from 8 to 16 fibers. These fibers are made of nylon or other biocompatible material. It is envisioned that the suture 22 can be formed of multiple type of biocompatible fibers having multiple coefficients of friction or size. Further, the braiding can be accomplished so that different portions of the exterior surface of the suture can have different coefficients of friction or mechanical properties. The placement of a carrier fiber having a particular surface property can be modified along the length of the suture so as to place it at varying locations within the braided constructions.



FIGS. 14-16 represent collapsible anchors 70, 72, 74 according to the present teachings. The anchors are deformable from a first cross section to a second engaging cross section. The anchors 70, 72, 74 are biocompatible materials for example polymer or a knit or woven textile such as a braided nylon material. Disposed within a collapsible tube 76 is a closed loop of suture material 78 which may form a portion of the collapsible tube 76. Optionally, this collapsible tube 76 can be slidable with respect to the closed loop of suture material 78. The collapsible tube 76 is further collapsible to form a fabric mass 110 (see for example FIG. 29B).


The suture material 78 can be passed through a pair of openings 83 in the collapsible tube 76 a single time to form a single soft tissue bearing surface 80. Additionally, (see FIG. 15), the closed loop of the suture material 78 can be looped over itself and passed through the collapsible flexible tube 76 to form a pair of soft tissue bearing surface portions 82. In each of the embodiments shown, the collapsible tube 76 defines at least one tube bearing surface.



FIG. 16 represents a closed loop of suture 78 passed through an aperture 77 defined in a body 79 of the collapsible tube 76. In this regard, the suture 78 is passed through a first open end 95 of the tube 78 and through the aperture 77 leaving a portion 81 of the collapsible tube 76 which can be used to assist in the insertion of a graft to a patient (see FIG. 32A).



FIGS. 17-19 represent adjustable sized loops of suture material 78 disposed within the collapsible tube 76 so as to form a suture anchor assembly 84, 86, 88. FIG. 17 shows the suture material 78 passed several times through the collapsible tube 76. By applying tension to the ends 90 and 92 of the suture material 78, the loops of the suture material constrict. If placed adjacent to a bearing surface (not shown), the end 94 and 96 of the collapsible tube 76 are brought together, thus collapsing the tube to form a collapsed material or fabric mass 110. It is envisioned a portion of the suture material 78 can be passed through the collapsible tube 76 to help maintain the position of the suture with respect to the collapsible tube 76.



FIGS. 18 and 19 show the loops of the suture construction of FIG. 4a within a collapsible tube 76. The tubular portion of the construction of FIG. 4a can be disposed either within or outside of the collapsible tube 76. As with the embodiment shown in FIGS. 14-16, translation of the tube 76 with respect to the suture material 78 can cause the ends 94 of the tube 76 to be brought together to compress the loops into a fabric mass 110.



FIGS. 20 and 21 show the loops of FIGS. 2B, 4A or 5 disposed within the collapsible tube 76. Shown are the ends and loops disposed at least partially through a portion 100 of the tube 76. Tensioning of the ends 24, 26 causes the portions 100 of the tube 76 to collapse to form a mass 110, while leaving other portions 85 uncollapsed. The outer uncollapsed portion 85 can function as a bearing surface to assist in the collapse of portion 100 when portion 100 is subjected to compressive loads.



FIG. 21 shows an embodiment where suture loops are passed through the sidewalls of the collapsible tube 76. Optionally, the loops 46 and 47 as well as the ends 24 and 26 can be passed through together. This construction can be used in situations where a large collapsed mass 110 is needed.



FIG. 22 shows the loop of FIG. 2B having a pair of collapsible tubes 76. The collapsible tubes 76 are disposed about the loops 46 and 46′ and will collapse upon application of tension to the ends of the suture construction in a manner which places compressive loads onto the ends of the tube 76. It is envisioned that these collapsible tubes 76 can be collapsed simultaneously or staggered in time as needed by a treating physician. It is also envisioned that the loop construction can be used to pull adjacent portions of a patient's anatomy together.



FIG. 23 depicts the loop construction shown in FIG. 2A having its loops disposed through a pair of co-joined crossed collapsible tubes 76. If placed adjacent to a bearing surface, the ends of the co-joined tubes come together, thus increasing in cross-section. This forms the fabric mass 110. This construction can be used in situations where a large collapsed mass is needed.



FIG. 24 shows the complex suture construction which embodies a pair of suture constructions of FIG. 2A coupled together using a collapsible tube 76. The ends of the suture 22 can be passed though a pair of passages 30 and 30′ formed in the suture material 22. Portions of the suture 22 are looped through each other to form a pair of locked loops 112. This construction can be used to provide a static seat for a graft bearing surface.



FIGS. 25-27 represent alternate suture constructions where the ends of the sutures 22 are fed multiple times through holes 105 defined within longitudinal passage 30 of the suture to form adjustable loops 46. In situations where relaxation of a tightened construction is to be minimized, the ends can be passed in and out of the passage 30 several times. In this regard, the first and second ends are positioned so as to be parallel and adjacent to each other in the passage 30.



FIGS. 26 and 27 represent constructions where the first and second ends 24 and 26 a passed through the same passage 30, but do not overlap and are not adjacent. This construction may be useful for joining pairs of members. This construction would be useful to bind pairs of appendages such as fingers.



FIG. 28 represents the formation of a femoral tunnel shown as a tunnel 62 having a varying diameter. Disposed within either the femoral or tibial tunnel 62 are a first portion 102 having a first diameter and a second portion 104 having a second diameter larger than the first diameter. Defined on an exterior surface of either the tibia or femur is a bearing surface 103, which is configured to interface with the fabric mass 110 of compressed textile material to prevent the relative motion of the fabric mass 110, and thus the suture construction with respect to the bone. This bearing surface can be machined or natural.



FIGS. 29A and 29B represent potential uses of the suture construction 86 in FIG. 18 in an ACL repair. As can be seen in FIG. 29A, the longitudinal passage portion 30 of suture construction 86 can be first coupled to a collapsible tube 76. The tube 76 can have a first profile which allows insertion of the tube 76 through the tunnel 62 and a second cross-sectional profile which allows engagement with a positive locking surface 103 upon collapse of the collapsible tube 76 into the fabric mass 110. The longitudinal passage portion 30 of the suture construction 84, tube 76, loops 46 and ends 24, 26 can then be pulled through a femoral and tibial tunnel 62. The tube 76 is positioned or coupled to the femur. At this point, a natural or artificial ACL 64 can be passed through a loop or loops 46 formed in the suture construction 20 or can be supported by the passage portion 30. Tensioning of the first and second ends 24 and 26 applies tension to the loops 46 and 47 thus pulling the ACL 64 into the tunnel. In this regard, the first and second ends are pulled through the femoral and tibial tunnel 62, thus constricting the loops 46 about the ACL 64.


After feeding the ACL 64 through the loops 46, tensioning of the ends allows engagement of the ACL with bearing surfaces defined on the loops. The tensioning pulls the ACL 64 through a femoral and tibial tunnel and collapses the tube 76 to form a locking fabric mass 110 outside the bone or tunnel 62. The ACL 64 could be further coupled to the femur or tibia using a transverse pin or plug. As shown in FIG. 29B, once the ACL is fastened to the tibia, further tensioning can be applied to the first and second ends 24, 26 placing a desired predetermined load on the ACL. As described above, this tension can be measured using a force gauge. This load is maintained by the suture configuration. It is equally envisioned that the fixation member 60 can be placed on the tibial component 66 and the ACL pulled into the tunnel through the femur. Further, it is envisioned that bone cement or biological materials may be inserted into the tunnel 62. The longitudinal passage 30 resists relaxation or reverse movement of the suture.


As best seen in FIG. 29B, the body portion 28 and parallel portions 38, 40 of the suture construction 86 remain disposed within the femoral tunnel 62. Further tension of the first ends draws the ACL 64 up through the tibial component into the femoral component. In this way, suture ends can be used to apply appropriate tension onto the ACL 64 component. The ACL 64 would be fixed to the tibial component using a plug or screw either before of after the application of the tension to the suture 22. Additionally, tension can be set on the ACL 64 after the collapsible tube 76 has been compressed.



FIGS. 30A and 30B represent potential uses of the suture constructions 84 in FIG. 17 in an ACL repair. As can be seen in FIG. 30A, the longitudinal passage portion 30 of suture construction 86 can be first disposed within the tube 76. The tube 76 has a first profile which allows insertion of the tube 76 through the tunnel and a second collapsed profile which allows engagement with a positive locking surface 103. The collapsible tube 76 of the suture construction 84, member 60, and loops 46, 47 can then be passed through a femoral and tibial tunnel 62 using a suture 108. The tube 76 is positioned or coupled to the femur. At this point, a natural or artificial ACL 64 can be passed through a loop or loops 46, 47 formed in the suture construction 84. Tensioning of the first and second ends 24 and 26 applies tension to the loops 46, 47 thus pulling the ACL 64 into the tunnel. In this regard, the first and second ends 26 and 24 are pulled through the femoral and tibial tunnel, thus constricting the loops 46 about the ACL 64 (see FIG. 30B) and collapsing the tube 76 to form the anchoring mass 110. Force applied to graft 64 along axis 61 in the distal direction will seat tube 76 and form anchoring mass 110.


As shown, by holding the suture construction in place 108, the suture construction 84 allows for the application of force along an axis 61 defining the femoral tunnel 62. Specifically, the orientation of the suture construction 84 and, more specifically, the orientation of the longitudinal passage portion 30, the loops 46, and ends 24, 26 allow for tension to be applied to the construction 86 without applying non-seating forces to the tube 76. As an example, should the loops 24, 26 be positioned at the tube application of forces to the ends 24, 26 may reduce the seating force applied by the tube 76 onto the bone.


As best seen in FIG. 30B, the loop portions 46, 47 of the suture construction 84 remain disposed within to the tunnel 62. Further tension of the first ends draws the ACL 64 up through the tibial component into the femoral component. In this way, suture ends can be used to apply appropriate tension onto the ACL 64 component. The ACL 64 would be fixed to the tibial component using a plug or screw 60 adjacent the suture construction 84, as is known.


Alternatively, as shown in FIG. 30B, once the ACL is fastened to the tibia, further tensioning can be applied to the first and second ends 24, 26 placing a desired predetermined load on the ACL. This load is maintained by the suture configuration, it is equally envisioned that the fixation member 60 can be placed on the tibial component 66 and the ACL pulled into the tunnel through the femur. Further, it is envisioned that bone cement or biological materials may be inserted into the tunnel 62.



FIGS. 31A and 31B represent potential uses of the suture construction 70 in FIG. 14 in an ACL repair. The suture material 78 of suture construction 70 can be first coupled to a collapsible tube 76. The collapsible tube 76 can have a first profile which allows insertion of the construction 70 through the tunnel and a second profile which allows engagement with a positive locking surface 103 upon its compression. Prior to attachment to the femur, a natural or artificial ACL 64 can be passed through a loop or loops 46 formed in the suture material 78. Suture construction 70 can then be passed through a femoral and tibial tunnel 62. The tube 76 is positioned or coupled to the femur. Tensioning of the first and second ends 112 and 114 of the soft tissue applies tension to the loop 76, thus collapsing the tube 76 to form the fabric mass 110. Tension can be applied to the soft tissue which can then be fastened to the tibia using a fastener 60.



FIGS. 32A and 32B represent potential uses of the suture constructions 74 in FIG. 16 in an ACL repair. The loop of suture 78 is coupled to a collapsible tube 76. The construction 74 can have a first profile which allows insertion of the tube 76 through the tunnel and a second profile which allows engagement with a positive looking surface upon compression. The suture portion 78 of the suture construction 74, tube 76, and soft tissue 64 can then be passed through a femoral and tibial tunnel. The tube 76 is positioned or coupled to the femur 103 and collapsed by the application of tension to the soft tissue 64.


As best seen in FIG. 32B, the anchoring mass 110 of the suture construction 72 remains disposed outside the femoral tunnel. Tension is applied to the ends of the ACL 64 up through the tibial component into the femoral component. In this way, ends of the ACL 112, 114 can be used to apply appropriate tension onto the ACL 64 component. The ACL 64 would be fixed to the tibial component using a plug or screw as is known.



FIG. 33 represents a suture construction 100 according to the present teachings. The suture construction 100 is formed of a suture 102 having a plurality of collapsible tubes 104 disposed thereon. The collapsible tubes 104 can be knit suture material or a polymer tube. Formed on one or both ends of the suture 102 can be a knot 106. Optionally, the collapsible tube 104 can be coupled to the suture 102 using a stitch 108, to prevent translation of the collapsible tube 104 with respect to the suture 102.



FIGS. 34A-34C represent a tool 110 used to couple the suture construction 100 with soft tissue. In this regard, the tool 110 has a sharpened end 112 configured to pierce soft tissue 124. Disposed adjacent the sharpened end 112 is a recess 114 configured to support a collapsible tube 104. Disposed within the recess 114 is a collapsible tube holding member 116. This member 116 can be a flange or a retractable member which selectively engages the collapsible tube 104 to hold the collapsible tube within the recess 114. Disposed within the tool 100 actuatable member 118. The actuatable member 118 functions to deploy or deliver the collapsible tube 104 from the holding member 116 of the recess 114. This generally occurs after the collapsible tube 104 has been pressed through the soft tissue 124.


As shown in FIG. 34C, the sharpened end 112 can be pressed through soft tissue 124, thus positioning the collapsible tube 104 on an obverse side of the soft tissue 124. Application of force by the drive member 120 onto the actuatable member 118 causes an engagable member 122 to deliver the collapsible tube 104 from the recessed portion 114 of the tool 110. The engagable member 122 can be formed of Nitonol or can be pivotably coupled to the actuatable member 118. At this point, the sharpened end can be removed from the soft tissue 124, leaving the compressible tube and its associated suture 102 therethrough.


As shown in FIGS. 35A-35C, multiple collapsible tubes 104 on the suture 102 can be inserted through multiple apertures formed within the soft tissue 124. Additionally shown is an implantable orthopedic mesh 130. As best seen in FIG. 35B, the sharp end 112 of the tool 110 can be fed through a single aperture 128 formed in a layer of soft tissue 120 such as skin. The sharp end 112 is pressed through several apertures within the soft tissue 124 and through apertures within the implantable orthopedic mesh 130. The application of tensional force onto the suture 102 allows the ends 131 of the collapsible tubes 104 to engage the orthopedic mesh 130. This allows the collapsible tube 104 to form a loop structure locking the suture to the mesh 130. Further, the mesh is coupled to the soft tissue 124, bone, skin, tendon, xenograft, allograft and autograft.


As best seen in FIG. 35C, once the collapsible tube 104 has been positioned through the orthopedic mesh 130, the needle is withdrawn to allow the engagement of the next collapsible tube 104 within the recess 114 of the tool 110. The tool 110 is moved to position the sharp end 112 in a desired location on the soft tissue 124. Pressure is then applied to the tool 110 forming a hole within the soft tissue 124.


As described above, once the recess portion 114 is passed through the soft tissue 124 or the orthopedic sports mesh 130, the actuator 118 can be used to decouple the collapsible tube 104 from the recessed portion 114. The sports mesh can be one sold by Biomet Sports Medicine as Sport Mesh™. This allows the removal of the tool 110 while leaving collapsible tube 104 and associated suture 102 on the obverse side of the soft tissue 124 and the orthopedic mesh 130. The orthopedic mesh can be formed of resorbable materials.


As shown in FIGS. 36A-36C, the construction FIGS. 35A-35C and, particularly, the orthopedic mesh 130 can be used to repair torn soft tissue 124. In this regard, it is envisioned the mesh 130 can be placed over a muscle tear 132. A series of collapsible tubes 104 are disposed over a suture 102 and can be coupled to the soft tissue by pushing the collapsible tubes 104 through the soft tissue 124 and the mesh 130. Tension can be applied to the suture 102 to collapse the collapsible tube 104, thus coupling the sports mesh 130 to the two portions of soft tissue 124 which are being repaired.


As best seen in FIGS. 36B and 36C, several different stitching techniques can be used to couple multiple collapsible tubes 104 along the periphery of the orthopedic mesh 130 on either side of a tear 132. The orthopedic mesh 130 functions to distribute loads along the muscle 124, thus allowing the torn muscle 132 to heal properly.


As seen in FIG. 36C, sutures 134 can be added between the loops of collapsible tubes 104. It is envisioned that this functions to transfer loads from one portion of the muscle to a second, thus allowing the muscle tear 132 to heal more rapidly and compress the tear 132.



FIGS. 37A-39D represent various methods of inserting the suture constructions shown above into soft tissue. FIGS. 37A and 37B represent a collapsible tube having a single and double suture and constructions. These constructions are being threaded through a soft tissue 124, using a speed pass suture retriever from Biomet Spots Medicine. A passage is formed within a soft tissue 124 using the speed pass suture retriever has a deployable portion which can grab a suture and pull it through the passage. At this point, the suture construction having a suture 102 and collapsible tube is positioned within the speed pass and pulled through the aperture formed within the soft tissue 124. Tension is applied to the suture 102, thus collapsing the collapsible tube 104.


As seen in FIGS. 38A and 38B, by using a curved speed pass instrument, a pair of apertures can be formed within the soft tissue. The speed pass instrument is then used to pull the suture construction through the two apertures formed in the soft tissue 124. Alternatively, the suture construction may be pressed within the speed pass 125 and released (pushed out) after the speed pass 125 has pierced the soft tissue.


As seen in FIGS. 38A and 38B, the speed pass having a corkscrew shape can be used to form a pair of apertures in soft tissues which are generally perpendicular to the tool threading direction. In each of these conditions, tension is applied to the sutures 102 to compress the tubes 104. It is envisioned the speed pass can be used to feed the suture constructions through the orthopedic mesh as described above.



FIGS. 40-45 represent a tool 140 used to couple the suture construction 100 with soft tissue. In this regard, the tool 140 has a sharpened end 142 configured to pierce soft tissue 124. Disposed adjacent to the sharpened end 142 is a first portion 144 configured to support a collapsible tube anchor 146. Adjacent to the first portion 144 is a second portion 148 which can support a plurality of collapsible tube anchors 146. Disposed between the first 144 and second portions 148 is a generally conical portion 150. As shown in FIG. 41, the conical portion 150 facilitates movement of the collapsible tubes 146 from the second portion 148 to the first portion 144. Defined between the conical portion 150 and the first portion 144 is a generally flat or planar support surface 152. The flat surface 152 is configured to support and apply axial forces to an end 154 of the collapsible tube anchor 146.


As best seen in FIG. 43, the conical portion 150 can have an oblong cross-section. This cross-section can facilitate the passing of the suture through the soft tissue. The sharpened end 142 can be passed through soft tissue 124, thus placing the collapsible tube 146 on an obverse side of the soft tissue 124. At this point, the sharpened end 142 can be passed through another soft tissue layer, a shorts mesh, or skin.


As shown in FIG. 45, the tool 140 can be withdrawn leaving the collapsible tube 146 on the obverse side of the soft tissue. Force can then be applied to the suture 156, as described above, to collapse the collapsible tube 146.


The description of the invention is merely exemplary in nature and, thus, variations that do not depart from the gist of the invention are intended to be within the scope of the invention. For example, any of the above mentioned surgical procedures is applicable to repair of other body portions. For example, the procedures can be equally applied to the repair of wrists, elbows, ankles, and meniscal repair. The suture loops can be passed through bores formed in soft or hard tissue. It is equally envisioned that the loops can be passed through or formed around an aperture or apertures formed in prosthetic devices e.g. humeral, femoral or tibial stems. Such variations are not to be regarded as a departure from the spirit and scope of the invention.

Claims
  • 1. A suture anchor system, comprising: a suture anchor assembly, comprising:a suture; anda collapsible anchor coupled to the suture, the collapsible anchor including a middle section, a first end, and a second end; andan inserter carrying the suture anchor assembly, wherein said carrying includes the collapsible anchor in a folded delivery condition on a distal portion of the inserter with the suture extending back from the collapsible anchor toward a proximal end of the inserter,wherein the collapsible anchor is collapsible from the folded delivery condition to an anchoring condition inside a bone, the folded delivery condition permitting advancement of the collapsible anchor in a first direction through a tunnel formed in bone from a first end of the tunnel toward a second end of the tunnel, the anchoring condition forming an anchoring mass for contacting bone in the tunnel for inhibiting movement of the collapsible anchor back through the tunnel in a second direction opposite the first direction,wherein the collapsible anchor, in the folded delivery condition, includes the collapsible anchor folded along the middle section of the collapsible anchor such that, when the collapsible anchor in the folded delivery condition is advanced through the tunnel in the first direction, the middle section can lead the collapsible anchor through the tunnel with the first end and the second end of the collapsible anchor trailing the middle section through the tunnel,wherein the collapsible anchor being coupled to the suture includes the suture: (i) passing entirely through the collapsible anchor at a first location between the first end and the middle section of the collapsible anchor and again passing entirely through the collapsible anchor at a second location between the first end and the middle section of the collapsible anchor; and (ii) passing entirely through the collapsible anchor at a third location between the second end and the middle section of the collapsible anchor and again passing entirely through the collapsible anchor at a fourth location between the second end and the middle section of the collapsible anchor.
  • 2. The suture anchor system of claim 1, wherein the distal portion of the inserter includes a recessed portion in which the collapsible anchor in the folded delivery condition is received.
  • 3. The suture anchor system of claim 1, wherein the collapsible anchor includes at least: (i) a first curved section and a second curved section between the first end and the middle section of the collapsible anchor; and (ii) a third curved section and a fourth curved section between the second end and the middle section of the collapsible anchor.
  • 4. The suture anchor system of claim 3, wherein the first curved section and the second curved section curve in opposite directions along the collapsible anchor, and wherein the third curved section and the fourth curved section curve in opposite directions along the collapsible anchor.
  • 5. The suture anchor system of claim 1, wherein the collapsible anchor is formed entirely with a suture material.
  • 6. The suture anchor system of claim 1, wherein the collapsible anchor is formed entirely with a knit, woven, or braided material.
  • 7. The suture anchor system of claim 1, wherein the collapsible anchor comprises a tube.
  • 8. A suture anchor system, comprising: a suture anchor assembly, comprising:a suture; anda collapsible anchor coupled to the suture; andan inserter, the collapsible anchor mounted on a distal portion of the inserter with the suture extending back from the collapsible anchor toward a proximal end of the inserter,wherein the collapsible anchor being mounted on the distal portion of the inserter includes the collapsible anchor folded along a middle section of the collapsible anchor with a first end and a second end of the collapsible anchor extending back along the inserter away from the middle section such that, when the collapsible anchor is advanced through a bone tunnel, the middle section can lead the collapsible anchor through the bone tunnel with the first end and the second end of the collapsible anchor trailing the middle section through the bone tunnel,wherein the collapsible anchor being mounted on the distal portion of the inserter further includes the collapsible anchor exhibiting: (i) at least a first curved section and a second curved section along a first side of the collapsible anchor between the first end and the middle section of the collapsible anchor; and (ii) at least a third curved section and a fourth curved section along a second side of the collapsible anchor between the second end and the middle section of the collapsible anchor; the suture passing entirely through the collapsible anchor at least: (i) between the first curved section and the second curved section; and
  • 9. The suture anchor system of claim 8, wherein the first curved section and the second curved section curve in opposite directions along the first side of the collapsible anchor, and wherein the third curved section and the fourth curved section curve in opposite directions along the second side of the collapsible anchor.
  • 10. The suture anchor system of claim 8, wherein the collapsible anchor being mounted on the distal portion of the inserter includes the middle section of the collapsible anchor being received in a recessed portion of the inserter.
  • 11. The suture anchor system of claim 8, wherein the collapsible anchor is formed entirely with a suture material.
  • 12. The suture anchor system of claim 8, wherein the collapsible anchor comprises a tube.
  • 13. A suture anchor assembly for anchoring suture to bone, the suture anchor assembly comprising: a suture having a first free end and a second free end; anda collapsible anchor having a first anchor end and a second anchor end, the collapsible anchor received on the suture with the first free end and the second free end of the suture located outside the collapsible anchor, the collapsible anchor collapsible from a first condition to a second condition, the first condition of the collapsible anchor permitting advancement of the collapsible anchor in a first direction through a tunnel formed in bone from a first end of the tunnel toward a second end of the tunnel, the second condition of the collapsible anchor forming an anchoring mass for contacting bone in the tunnel for inhibiting movement of the collapsible anchor back through the tunnel in a second direction opposite the first direction,wherein the collapsible anchor, when in the first condition, is folded along a middle section of the collapsible anchor so that when the collapsible anchor in the first condition is advanced through the tunnel in the first direction the middle section can lead the collapsible anchor through the tunnel with the first anchor end and the second anchor end trailing the middle section through the tunnel,wherein the collapsible anchor, when in the first condition, includes: (i) a plurality of first anchor sections alternating with a plurality of second anchor sections along a first side of the collapsible anchor between the first end and the middle section of the collapsible anchor, wherein each of the plurality of first anchor sections is occupied by the suture, and wherein each of the plurality of second anchor sections is unoccupied by the suture and exhibits a curved shape; and (ii) a plurality of third anchor sections alternating with a plurality of fourth anchor sections along a second side of the collapsible anchor between the second end and the middle section of the collapsible anchor, wherein each of the plurality of third anchor sections is occupied by the suture, and wherein each of the plurality of fourth anchor sections is unoccupied by the suture and exhibits a curved shape.
  • 14. The suture anchor assembly of claim 13, wherein the plurality of second anchor sections includes curved sections curving in opposite directions along the first side of the collapsible anchor, and wherein the plurality of fourth anchor sections includes curved sections curving in opposite directions along the second side of the collapsible anchor.
  • 15. The suture anchor assembly of claim 13 in combination with an inserter carrying the collapsible anchor in the first condition.
  • 16. The suture anchor assembly of claim 15, wherein the inserter includes a distal recessed portion in which the collapsible anchor in the first condition is received.
  • 17. The suture anchor assembly of claim 13, wherein the collapsible anchor is formed entirely with a suture material.
  • 18. The suture anchor assembly of claim 13, wherein the collapsible anchor is formed entirely with a knit, woven, or braided material.
  • 19. The suture anchor assembly of claim 13, wherein the collapsible anchor comprises a tube.
  • 20. The suture anchor assembly of claim 13, wherein the first free end of the suture extends into the suture through a first opening in a sidewall of the suture and back out of the suture through a second opening in the sidewall of the suture to form an adjustable loop.
  • 21. The suture anchor assembly of claim 13, wherein the collapsible anchor is formed entirely with a braided nylon.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/941,481 filed Mar. 30, 2018, now U.S. Pat. No. 10,973,507 issued on Apr. 13, 2021, which is a continuation of U.S. patent application Ser. No. 14/983,747 filed Dec. 30, 2015, now U.S. Pat. No. 10,154,837 issued on Dec. 18, 2018 which is a continuation of U.S. patent application Ser. No. 13/751,846 filed Jan. 28, 2013, now U.S. Pat. No. 9,492,158 issued on Nov. 15, 2016, which is a divisional of U.S. patent application Ser. No. 12/489,168 filed Jun. 22, 2009, now U.S. Pat. No. 8,361,113 issued on Jan. 29, 2013, which is a continuation-in-part application of: (1.) U.S. patent application Ser. No. 12/474,802 filed on May 29, 2009, now U.S. Pat. No. 8,088,130 issued on Jan. 3, 2012; (2.) U.S. patent application Ser. No. 11/541,506 filed on Sep. 29, 2006, now U.S. Pat. No. 7,601,165 issued on Oct. 13, 2009; (3.) U.S. patent application Ser. No. 11/541,505 filed on Sep. 29, 2006, now U.S. Pat. No. 7,658,751 issued on Feb. 9, 2010; (4.) U.S. patent application Ser. No. 12/014,399 filed on Jan. 15, 2008, now U.S. Pat. No. 7,909,851 issued on Mar. 22, 2011; (5.) U.S. patent application Ser. No. 12/014,340 filed on Jan. 15, 2008, now U.S. Pat. No. 7,905,904 issued on Mar. 15, 2011; (6.) U.S. patent application Ser. No. 11/935,681 filed on Nov. 6, 2007, now U.S. Pat. No. 7,905,903 issued on Mar. 15, 2011; (7.) U.S. patent application Ser. No. 11/869,440 filed on Oct. 9, 2007, now U.S. Pat. No. 7,857,830 issued on Dec. 28, 2010; (8.) U.S. patent application Ser. No. 11/784,821 filed on Apr. 10, 2007; (9.) U.S. patent application Ser. No. 11/347,661 filed on Feb. 3, 2006, now U.S. Pat. No. 7,749,250 issued on Jul. 6, 2010; (10.) U.S. patent application Ser. No. 11/347,662 filed on Feb. 3, 2006, now abandoned; (11.) U.S. patent application Ser. No. 12/196,405 filed on Aug. 22, 2008, now U.S. Pat. No. 8,128,658 issued on Mar. 6, 2012; (12.) U.S. patent application Ser. No. 12/196,407, filed on Aug. 22, 2008, now U.S. Pat. No. 8,137,382 issued on Mar. 20, 2012; and (13.) U.S. patent application Ser. No. 12/196,410, filed on Aug. 22, 2008, now U.S. Pat. No. 8,118,836 issued on Feb. 21, 2012. The disclosures of the above applications are incorporated herein by reference.

US Referenced Citations (2433)
Number Name Date Kind
26501 Kendrick et al. Dec 1859 A
64499 Daubert May 1867 A
65499 Miller Jun 1867 A
126366 Wills Apr 1872 A
233475 Cook et al. Oct 1880 A
261501 Vandermark Jul 1882 A
268407 Hughes Dec 1882 A
330087 Binns Nov 1885 A
394739 Toulmin Dec 1888 A
401677 Autenrieth Apr 1889 A
417805 Beaman Dec 1889 A
445875 Brickell Feb 1891 A
487304 Todd Dec 1892 A
687221 Gaff et al. Nov 1901 A
762710 Hall Jun 1904 A
837767 Aims Dec 1906 A
838203 Neil Dec 1906 A
1059631 Popovics Apr 1913 A
1131155 Murphy Mar 1915 A
1153450 Schaff Sep 1915 A
1346940 Collins Jul 1920 A
1505470 Kelm Aug 1924 A
1635066 Wells Jul 1927 A
1950799 Jones Mar 1934 A
2042403 Andrew May 1936 A
2065659 Cullen Dec 1936 A
2108206 Meeker Feb 1938 A
2121193 Erich Jun 1938 A
2242003 Lorenzo May 1941 A
2267925 Johnston Dec 1941 A
2302986 Vollrath Nov 1942 A
2329398 Duffy Sep 1943 A
2379629 Eweson Jul 1945 A
2397216 Stellin Mar 1946 A
RE22857 Ogburn Mar 1947 E
2526959 Lorenzo Oct 1950 A
2528456 Thomas Oct 1950 A
2549382 Mitterway Apr 1951 A
2562419 Ferris Jul 1951 A
2581564 Jaime Jan 1952 A
2600395 Joseph et al. Jun 1952 A
2610631 Calicchio Sep 1952 A
2665597 Hill Jan 1954 A
2669774 Mitchell Feb 1954 A
2698986 Brown Jan 1955 A
2760488 Pierce Aug 1956 A
2833284 Springer May 1958 A
2846712 Moe Aug 1958 A
2860393 Brock Nov 1958 A
2880728 Rights Apr 1959 A
2881762 Lowrie Apr 1959 A
2883096 Horace Apr 1959 A
2913042 John Nov 1959 A
2947504 Ruhlman Aug 1960 A
3000009 Selstad Sep 1961 A
3003155 Mielzynski Oct 1961 A
3013559 Thomas Dec 1961 A
3037619 Ernest Jun 1962 A
3039460 Chandler Jun 1962 A
3081781 Stermer Mar 1963 A
3090386 William May 1963 A
3103666 Bone Sep 1963 A
3123077 Alcamo Mar 1964 A
3125095 Kaufman et al. Mar 1964 A
3209422 Arthur Oct 1965 A
3223083 Cobey Dec 1965 A
3234938 Robinson Feb 1966 A
3240379 Bremer et al. Mar 1966 A
3250271 Jack May 1966 A
3399432 Merser Sep 1968 A
3409014 Grant Nov 1968 A
RE26501 Himmelstein et al. Dec 1968 E
3435475 Bisk Apr 1969 A
3467089 Hasson Sep 1969 A
3470834 Bone Oct 1969 A
3470875 Johnson Oct 1969 A
3500820 Almen Mar 1970 A
3507274 Soichet Apr 1970 A
3513484 Hausner May 1970 A
3515132 Mcknight Jun 1970 A
3522803 Majzlin Aug 1970 A
3527223 Shein Sep 1970 A
3533406 Tatum Oct 1970 A
3541591 Hoegerman Nov 1970 A
3545008 Bader, Jr. Dec 1970 A
3547389 Mitchell Dec 1970 A
3579831 Stevens et al. May 1971 A
3590616 Schussler Jul 1971 A
3608095 Barry Sep 1971 A
3618447 Goins Nov 1971 A
3628530 Schwartz Dec 1971 A
3643649 Amato Feb 1972 A
3648705 Lary Mar 1972 A
3650274 Edwards et al. Mar 1972 A
3656483 Rudel Apr 1972 A
3659597 Wolfers May 1972 A
3664345 Dabbs et al. May 1972 A
3665560 Bennett et al. May 1972 A
3675639 Cimber Jul 1972 A
3683422 Stemmer et al. Aug 1972 A
3692022 Ewing Sep 1972 A
3695271 Chodorow Oct 1972 A
3699969 Allen Oct 1972 A
3716058 Tanner Feb 1973 A
3744488 Cox Jul 1973 A
3752516 Mumma Aug 1973 A
3757629 Schneider Sep 1973 A
3763856 Blomberg Oct 1973 A
3771520 Lerner Nov 1973 A
3777748 Abramson Dec 1973 A
3786801 Sartorius Jan 1974 A
3802438 Wolvek Apr 1974 A
3807407 Schweizer Apr 1974 A
3810456 Karman May 1974 A
3825010 McDonald Jul 1974 A
3840017 Violante Oct 1974 A
3842824 Neufeld Oct 1974 A
3842840 Schweizer Oct 1974 A
3845772 Smith Nov 1974 A
3867933 Kitrilakis Feb 1975 A
3867944 Samuels Feb 1975 A
3871368 Johnson et al. Mar 1975 A
3871379 Clarke Mar 1975 A
3874388 King et al. Apr 1975 A
3875648 Bone Apr 1975 A
3877570 Barry Apr 1975 A
3880156 Hoff Apr 1975 A
3881475 Gordon et al. May 1975 A
3889666 Lerner Jun 1975 A
3892240 Park Jul 1975 A
3896500 Rambert et al. Jul 1975 A
3896810 Akiyama Jul 1975 A
3907442 Reid Sep 1975 A
3910281 Kletschka Oct 1975 A
3918444 Hoff et al. Nov 1975 A
3918455 Coplan Nov 1975 A
3927666 Hoff Dec 1975 A
3931667 Merser et al. Jan 1976 A
3933153 Csatary et al. Jan 1976 A
3937217 Kosonen Feb 1976 A
3943932 Woo Mar 1976 A
3946446 Schofield Mar 1976 A
3946728 Bettex Mar 1976 A
3946740 Bassett Mar 1976 A
3949755 Vauquois Apr 1976 A
3953896 Treace May 1976 A
3954103 Garcia-roel et al. May 1976 A
3961632 Moossun Jun 1976 A
3973560 Emmett Aug 1976 A
3976079 Samuels et al. Aug 1976 A
3977050 Perez Aug 1976 A
3979799 Merser et al. Sep 1976 A
3985138 Jarvik Oct 1976 A
3990619 Russell Nov 1976 A
4005707 Moulding, Jr. Feb 1977 A
4006747 Kronenthal et al. Feb 1977 A
4007743 Blake Feb 1977 A
4013071 Rosenberg Mar 1977 A
4026281 Mayberry et al. May 1977 A
4036101 Burnett Jul 1977 A
4050100 Barry Sep 1977 A
4054954 Nakayama et al. Oct 1977 A
4084478 Simmons Apr 1978 A
4085466 Goodfellow et al. Apr 1978 A
4094313 Komamura et al. Jun 1978 A
4099750 Mcgrew Jul 1978 A
4103690 Harris Aug 1978 A
RE29819 Bone Oct 1978 E
4121487 Bone Oct 1978 A
4143656 Holmes Mar 1979 A
4144876 Deleo Mar 1979 A
4146022 Johnson et al. Mar 1979 A
4149277 Bokros Apr 1979 A
4157714 Foltz et al. Jun 1979 A
4158250 Ringwald Jun 1979 A
4160453 Miller Jul 1979 A
4164225 Johnson et al. Aug 1979 A
4172458 Pereyra Oct 1979 A
4175555 Herbert Nov 1979 A
4185636 Gabbay et al. Jan 1980 A
4196883 Einhorn et al. Apr 1980 A
4207627 Cloutier Jun 1980 A
4210148 Stivala Jul 1980 A
4235161 Kunreuther Nov 1980 A
4235238 Ogiu et al. Nov 1980 A
4237779 Kunreuther Dec 1980 A
4243037 Smith Jan 1981 A
4249525 Krzeminski Feb 1981 A
4263913 Malmin Apr 1981 A
4265246 Barry May 1981 A
4273117 Neuhauser Jun 1981 A
4275490 Bivins Jun 1981 A
4275717 Bolesky Jun 1981 A
4287807 Pacharis et al. Sep 1981 A
4291698 Fuchs et al. Sep 1981 A
4301551 Dore et al. Nov 1981 A
4302397 Frainier et al. Nov 1981 A
4307723 Finney Dec 1981 A
4312337 Donohue Jan 1982 A
4316469 Kapitanov Feb 1982 A
4319428 Fox Mar 1982 A
4326531 Shimonaka Apr 1982 A
4344193 Kenny Aug 1982 A
4345601 Fukuda Aug 1982 A
4349027 Difrancesco Sep 1982 A
4388921 Sutter et al. Jun 1983 A
4400833 Kurland Aug 1983 A
4402445 Green Sep 1983 A
4409974 Freedland et al. Oct 1983 A
4438769 Pratt et al. Mar 1984 A
4441489 Evans et al. Apr 1984 A
4454875 Pratt et al. Jun 1984 A
4462395 Johnson Jul 1984 A
4463753 Gustilo Aug 1984 A
4473102 Ohman et al. Sep 1984 A
4484570 Sutter et al. Nov 1984 A
4489446 Reed Dec 1984 A
4489464 Massari et al. Dec 1984 A
4493323 Albright et al. Jan 1985 A
4496468 House et al. Jan 1985 A
4505274 Speelman Mar 1985 A
4509516 Richmond Apr 1985 A
4531522 Bedi et al. Jul 1985 A
4532926 O'holla Aug 1985 A
4534350 Golden et al. Aug 1985 A
4535764 Ebert Aug 1985 A
4537185 Stednitz Aug 1985 A
4549545 Levy Oct 1985 A
4549652 Free Oct 1985 A
4561432 Mazor Dec 1985 A
4564007 Coombs Jan 1986 A
4570623 Ellison et al. Feb 1986 A
4573844 Smith Mar 1986 A
4576608 Homsy Mar 1986 A
4584722 Levy et al. Apr 1986 A
4587963 Leibinger et al. May 1986 A
4590928 Hunt et al. May 1986 A
4595007 Mericle Jun 1986 A
4596249 Freda et al. Jun 1986 A
4597766 Hilal et al. Jul 1986 A
4602635 Mulhollan et al. Jul 1986 A
4602636 Noiles Jul 1986 A
4604997 De et al. Aug 1986 A
4605414 Czajka Aug 1986 A
4616650 Green et al. Oct 1986 A
4621640 Mulhollan et al. Nov 1986 A
4624254 Mcgarry et al. Nov 1986 A
4632100 Somers et al. Dec 1986 A
4635637 Schreiber Jan 1987 A
4636121 Miller Jan 1987 A
4640271 Lower Feb 1987 A
4641652 Hutterer et al. Feb 1987 A
4649916 Frimberger Mar 1987 A
4649952 Jobe Mar 1987 A
4653486 Coker Mar 1987 A
4653487 Maale Mar 1987 A
4653489 Tronzo Mar 1987 A
4655771 Wallsten Apr 1987 A
4655777 Dunn Apr 1987 A
4662068 Polonsky May 1987 A
4667662 Titone et al. May 1987 A
4667675 Davis May 1987 A
4669473 Richards et al. Jun 1987 A
4683895 Pohndorf Aug 1987 A
4688561 Reese Aug 1987 A
4690169 Jobe Sep 1987 A
4696300 Anderson Sep 1987 A
4705040 Mueller et al. Nov 1987 A
4708132 Silvestrini Nov 1987 A
4711639 Grundei Dec 1987 A
4714474 Brooks, Jr. et al. Dec 1987 A
4714475 Grundei et al. Dec 1987 A
4716893 Fischer et al. Jan 1988 A
4719671 Ito et al. Jan 1988 A
4719917 Barrows et al. Jan 1988 A
4723540 Gilmer, Jr. Feb 1988 A
4724839 Bedi et al. Feb 1988 A
4728329 Mansat Mar 1988 A
4728332 Albrektsson Mar 1988 A
4730615 Sutherland et al. Mar 1988 A
4736746 Anderson Apr 1988 A
4738255 Goble et al. Apr 1988 A
4739751 Sapega et al. Apr 1988 A
4741330 Hayhurst May 1988 A
4741336 Failla et al. May 1988 A
4744353 Mcfarland May 1988 A
4744793 Parr et al. May 1988 A
4750492 Jacobs Jun 1988 A
4751922 Dipietropolo Jun 1988 A
4754685 Kite et al. Jul 1988 A
4760843 Fischer et al. Aug 1988 A
4760844 Kyle Aug 1988 A
4760848 Hasson Aug 1988 A
4770663 Hanslik et al. Sep 1988 A
4772261 Von Hoff et al. Sep 1988 A
4772286 Goble et al. Sep 1988 A
4773910 Chen et al. Sep 1988 A
4775380 Seedhom et al. Oct 1988 A
4776328 Frey et al. Oct 1988 A
4779372 Pozo Obeso Oct 1988 A
4781190 Lee Nov 1988 A
4784126 Hourahane Nov 1988 A
4787882 Claren Nov 1988 A
4790297 Luque Dec 1988 A
4790850 Dunn et al. Dec 1988 A
4793363 Ausherman et al. Dec 1988 A
4795468 Hodorek et al. Jan 1989 A
4809695 Gwathmey et al. Mar 1989 A
4813406 Ogle, II Mar 1989 A
4813416 Pollak et al. Mar 1989 A
4823780 Odensten et al. Apr 1989 A
4823794 Pierce Apr 1989 A
4828562 Kenna May 1989 A
4832026 Jones May 1989 A
4834098 Jones May 1989 A
4836080 Kite, III et al. Jun 1989 A
4838282 Strasser et al. Jun 1989 A
4841960 Garner Jun 1989 A
4846835 Grande Jul 1989 A
4851005 Hunt et al. Jul 1989 A
4858601 Glisson Aug 1989 A
4858603 Clemow et al. Aug 1989 A
4858608 Mcquilkin Aug 1989 A
4860513 Whitman Aug 1989 A
4863383 Grafelmann Sep 1989 A
4863471 Mansat Sep 1989 A
4870957 Goble et al. Oct 1989 A
4872450 Austad Oct 1989 A
4873976 Schreiber Oct 1989 A
4884572 Bays et al. Dec 1989 A
4887601 Richards Dec 1989 A
4889110 Galline et al. Dec 1989 A
4890615 Caspari et al. Jan 1990 A
4893619 Dale et al. Jan 1990 A
4893974 Fischer et al. Jan 1990 A
4895148 Bays et al. Jan 1990 A
4896668 Popoff et al. Jan 1990 A
4898156 Gatturna et al. Feb 1990 A
4899743 Nicholson et al. Feb 1990 A
4901721 Hakki Feb 1990 A
4917700 Aikins Apr 1990 A
4919667 Richmond Apr 1990 A
4922897 Sapega et al. May 1990 A
4923461 Caspari et al. May 1990 A
4927421 Goble et al. May 1990 A
4946377 Kovach Aug 1990 A
4946467 Ohi et al. Aug 1990 A
4946468 Li Aug 1990 A
4950270 Bowman et al. Aug 1990 A
4950285 Wilk Aug 1990 A
4959069 Brennan et al. Sep 1990 A
4960381 Niznick Oct 1990 A
4961741 Hayhurst Oct 1990 A
4962929 Melton, Jr. Oct 1990 A
4968315 Gatturna Nov 1990 A
4968317 Tormala et al. Nov 1990 A
4969886 Cziffer et al. Nov 1990 A
4974488 Spralja Dec 1990 A
4974656 Judkins Dec 1990 A
4976736 White et al. Dec 1990 A
4978350 Wagenknecht Dec 1990 A
4979956 Silvestrini Dec 1990 A
4983176 Cushman et al. Jan 1991 A
4983184 Steinemann Jan 1991 A
4983240 Orkin et al. Jan 1991 A
4988351 Paulos et al. Jan 1991 A
4994074 Bezwada et al. Feb 1991 A
4997433 Goble et al. Mar 1991 A
5002545 Whiteside et al. Mar 1991 A
5002550 Li Mar 1991 A
5002562 Oberlander Mar 1991 A
5002574 May et al. Mar 1991 A
5007921 Brown Apr 1991 A
5019093 Kaplan et al. May 1991 A
5020713 Kunreuther Jun 1991 A
5026398 May et al. Jun 1991 A
5028569 Cihon Jul 1991 A
5030224 Wright Jul 1991 A
5030235 Campbell, Jr. Jul 1991 A
5035701 Kabbara Jul 1991 A
5037422 Hayhurst et al. Aug 1991 A
5037426 Goble et al. Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5046513 Gatturna et al. Sep 1991 A
5047030 Draenert Sep 1991 A
5053046 Janese Oct 1991 A
5053047 Yoon Oct 1991 A
5059201 Asnis Oct 1991 A
5059206 Winters Oct 1991 A
5061277 Carpentier et al. Oct 1991 A
5062344 Gerker Nov 1991 A
5062843 Mahony, III Nov 1991 A
5064431 Gilbertson et al. Nov 1991 A
5067962 Campbell et al. Nov 1991 A
5071420 Paulos et al. Dec 1991 A
5074874 Yoon et al. Dec 1991 A
5078731 Hayhurst Jan 1992 A
5078843 Pratt Jan 1992 A
5080050 Dale Jan 1992 A
5080675 Lawes et al. Jan 1992 A
5084050 Draenert Jan 1992 A
5084058 Li Jan 1992 A
5085661 Moss Feb 1992 A
5087263 Li Feb 1992 A
5087309 Melton, Jr. Feb 1992 A
5089012 Prou Feb 1992 A
5092727 Moghe Mar 1992 A
5092866 Breard et al. Mar 1992 A
5098433 Freedland Mar 1992 A
5098435 Stednitz et al. Mar 1992 A
5100415 Hayhurst Mar 1992 A
5100417 Cerier Mar 1992 A
5108433 May et al. Apr 1992 A
5112335 Laboureau et al. May 1992 A
5116337 Johnson May 1992 A
5116373 Jakob et al. May 1992 A
5116375 Hofmann May 1992 A
5123913 Wilk et al. Jun 1992 A
5123914 Cope Jun 1992 A
5127783 Moghe et al. Jul 1992 A
5127785 Faucher Jul 1992 A
5129901 Decoste Jul 1992 A
5129902 Goble et al. Jul 1992 A
5129904 Illi Jul 1992 A
5129906 Ross et al. Jul 1992 A
5139498 Astudillo Ley Aug 1992 A
5139499 Small et al. Aug 1992 A
5139520 Rosenberg Aug 1992 A
5143498 Whitman Sep 1992 A
5147362 Goble Sep 1992 A
5149329 Richardson Sep 1992 A
5151104 Kenna Sep 1992 A
5152790 Rosenberg et al. Oct 1992 A
5154189 Oberlander Oct 1992 A
5156616 Meadows et al. Oct 1992 A
5163960 Bonutti Nov 1992 A
D331626 Hayhurst et al. Dec 1992 S
5169400 Muhling et al. Dec 1992 A
5171274 Fluckiger et al. Dec 1992 A
5176682 Chow Jan 1993 A
5178629 Kammerer Jan 1993 A
5183458 Marx Feb 1993 A
5190545 Corsi et al. Mar 1993 A
5192282 Draenert Mar 1993 A
5197987 Koch et al. Mar 1993 A
5199135 Gold Apr 1993 A
5203784 Ross et al. Apr 1993 A
5203787 Noblitt et al. Apr 1993 A
5207679 Li May 1993 A
5209753 Biedermann et al. May 1993 A
5209805 Spraggins May 1993 A
5211647 Schmieding May 1993 A
5211650 Noda May 1993 A
5214987 Fenton, Sr. Jun 1993 A
5217495 Kaplan et al. Jun 1993 A
5219359 McQuilkin et al. Jun 1993 A
5222976 Yoon Jun 1993 A
5224940 Dann et al. Jul 1993 A
5224946 Hayhurst et al. Jul 1993 A
5226914 Caplan et al. Jul 1993 A
5230699 Grasinger Jul 1993 A
5232436 Janevski Aug 1993 A
5234435 Seagrave, Jr. Aug 1993 A
5235238 Nomura et al. Aug 1993 A
5236445 Hayhurst et al. Aug 1993 A
5236461 Forte Aug 1993 A
5242447 Borzone Sep 1993 A
5246441 Ross et al. Sep 1993 A
5249899 Wilson Oct 1993 A
5250053 Snyder Oct 1993 A
5258015 Li et al. Nov 1993 A
5258016 Dipoto et al. Nov 1993 A
5258040 Bruchman et al. Nov 1993 A
5261908 Campbell, Jr. Nov 1993 A
5268001 Nicholson et al. Dec 1993 A
5269160 Wood Dec 1993 A
5269783 Sander Dec 1993 A
5269806 Sardelis et al. Dec 1993 A
5269809 Hayhurst et al. Dec 1993 A
5279311 Snyder Jan 1994 A
5281422 Badylak et al. Jan 1994 A
5282809 Kammerer et al. Feb 1994 A
5282832 Toso et al. Feb 1994 A
5282867 Mikhail Feb 1994 A
5282868 Bahler Feb 1994 A
5285040 Brandberg et al. Feb 1994 A
5290217 Campos Mar 1994 A
5290243 Chodorow et al. Mar 1994 A
5306301 Graf et al. Apr 1994 A
5312410 Miller et al. May 1994 A
5312422 Trott May 1994 A
5312438 Johnson May 1994 A
5314429 Goble May 1994 A
5318566 Miller Jun 1994 A
5318575 Chesterfield et al. Jun 1994 A
5318577 Li Jun 1994 A
5318578 Hasson Jun 1994 A
5320115 Kenna Jun 1994 A
5320626 Schmieding Jun 1994 A
5320633 Allen et al. Jun 1994 A
5324308 Pierce Jun 1994 A
5330489 Green et al. Jul 1994 A
5330534 Herrington et al. Jul 1994 A
5333625 Klein Aug 1994 A
5334204 Clewett et al. Aug 1994 A
5336229 Noda Aug 1994 A
5336231 Adair Aug 1994 A
5336240 Metzler et al. Aug 1994 A
5339870 Green et al. Aug 1994 A
5342369 Harryman, II Aug 1994 A
5344460 Turanyi et al. Sep 1994 A
5346462 Barber Sep 1994 A
5350380 Goble et al. Sep 1994 A
RE34762 Goble et al. Oct 1994 E
5354292 Braeuer et al. Oct 1994 A
5354298 Lee et al. Oct 1994 A
5354299 Coleman Oct 1994 A
5356412 Golds et al. Oct 1994 A
5356413 Martins et al. Oct 1994 A
5356417 Golds Oct 1994 A
5358511 Gatturna et al. Oct 1994 A
5358530 Hodorek Oct 1994 A
5358531 Goodfellow et al. Oct 1994 A
5360431 Puno et al. Nov 1994 A
5362294 Seitzinger Nov 1994 A
5362911 Cevasco et al. Nov 1994 A
5364400 Rego, Jr. et al. Nov 1994 A
5366461 Blasnik Nov 1994 A
5368599 Hirsch et al. Nov 1994 A
5370646 Reese et al. Dec 1994 A
5370661 Branch Dec 1994 A
5370662 Stone et al. Dec 1994 A
5372146 Branch Dec 1994 A
5372604 Trott Dec 1994 A
5372821 Badylak et al. Dec 1994 A
5374268 Sander Dec 1994 A
5374269 Rosenberg Dec 1994 A
5376118 Kaplan et al. Dec 1994 A
5379492 Glesser Jan 1995 A
5383878 Roger et al. Jan 1995 A
5383904 Totakura et al. Jan 1995 A
5385567 Goble Jan 1995 A
5391171 Schmieding Feb 1995 A
5391176 De La Torre Feb 1995 A
5391182 Chin Feb 1995 A
5393302 Clark et al. Feb 1995 A
RE34871 Mcguire et al. Mar 1995 E
5395374 Miller et al. Mar 1995 A
5395401 Bahler Mar 1995 A
5397356 Goble et al. Mar 1995 A
5403328 Shallman Apr 1995 A
5403329 Hinchcliffe Apr 1995 A
5403348 Bonutti Apr 1995 A
5405359 Pierce Apr 1995 A
5411550 Herweck et al. May 1995 A
5415658 Kilpela et al. May 1995 A
5417690 Sennett et al. May 1995 A
5417691 Hayhurst May 1995 A
5417698 Green et al. May 1995 A
5417712 Whittaker et al. May 1995 A
5423819 Small et al. Jun 1995 A
5423821 Pasque Jun 1995 A
5423823 Schmieding Jun 1995 A
5423824 Akerfeldt et al. Jun 1995 A
5423860 Lizardi et al. Jun 1995 A
5425733 Schmieding Jun 1995 A
5425766 Bowald Jun 1995 A
5433751 Christel et al. Jul 1995 A
5437680 Yoon Aug 1995 A
5437685 Blasnik Aug 1995 A
5439684 Prewett et al. Aug 1995 A
5441508 Gazielly et al. Aug 1995 A
5443468 Johnson Aug 1995 A
5443482 Stone et al. Aug 1995 A
5443483 Kirsch Aug 1995 A
5443509 Boucher et al. Aug 1995 A
5445833 Badylak et al. Aug 1995 A
5447512 Wilson et al. Sep 1995 A
5449361 Preissman Sep 1995 A
5451203 Lamb Sep 1995 A
5454811 Huebner Oct 1995 A
5454821 Harm et al. Oct 1995 A
5456685 Huebner Oct 1995 A
5456721 Legrand Oct 1995 A
5456722 Mcleod et al. Oct 1995 A
5458601 Young, Jr. et al. Oct 1995 A
5458604 Schmieding Oct 1995 A
5462542 Alesi, Jr. Oct 1995 A
5462560 Stevens Oct 1995 A
5464426 Bonutti Nov 1995 A
5464427 Curtis et al. Nov 1995 A
5464440 Johansson Nov 1995 A
5466237 Byrd, III et al. Nov 1995 A
5467786 Allen et al. Nov 1995 A
5470334 Ross et al. Nov 1995 A
5470337 Moss Nov 1995 A
5470338 Whitfield et al. Nov 1995 A
5470354 Hershberger et al. Nov 1995 A
5472452 Trott Dec 1995 A
5474565 Trott Dec 1995 A
5474568 Scott et al. Dec 1995 A
5474572 Hayhurst Dec 1995 A
5476465 Preissman Dec 1995 A
5478344 Stone et al. Dec 1995 A
5478345 Stone et al. Dec 1995 A
5480403 Lee et al. Jan 1996 A
5480406 Nolan et al. Jan 1996 A
5480446 Goodfellow et al. Jan 1996 A
5484442 Melker et al. Jan 1996 A
5486197 Le et al. Jan 1996 A
5486359 Caplan et al. Jan 1996 A
5489210 Hanosh Feb 1996 A
5490750 Gundy Feb 1996 A
5495974 Deschenes et al. Mar 1996 A
5496290 Ackerman Mar 1996 A
5496331 Xu et al. Mar 1996 A
5496348 Bonutti Mar 1996 A
5498302 Davidson Mar 1996 A
5500000 Feagin et al. Mar 1996 A
5505735 Li Apr 1996 A
5505736 Reimels et al. Apr 1996 A
5507754 Green et al. Apr 1996 A
5520691 Branch May 1996 A
5520694 Dance et al. May 1996 A
5520700 Beyar et al. May 1996 A
5520702 Sauer et al. May 1996 A
5522817 Sander et al. Jun 1996 A
5522820 Caspari et al. Jun 1996 A
5522843 Zang Jun 1996 A
5522844 Johnson Jun 1996 A
5522845 Wenstrom, Jr. Jun 1996 A
5522846 Bonutti Jun 1996 A
5524946 Thompson Jun 1996 A
5527321 Hinchliffe Jun 1996 A
5527342 Pietrzak et al. Jun 1996 A
5527343 Bonutti Jun 1996 A
5531759 Kensey et al. Jul 1996 A
5534011 Greene, Jr. et al. Jul 1996 A
5534012 Bonutti Jul 1996 A
5534033 Simpson Jul 1996 A
5536270 Songer et al. Jul 1996 A
5540698 Preissman Jul 1996 A
5540703 Barker, Jr. et al. Jul 1996 A
5540718 Bartlett Jul 1996 A
5545168 Burke Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5545228 Kambin Aug 1996 A
5549613 Goble et al. Aug 1996 A
5549617 Green et al. Aug 1996 A
5549619 Peters et al. Aug 1996 A
5549630 Bonutti Aug 1996 A
5549631 Bonutti Aug 1996 A
5562664 Durlacher et al. Oct 1996 A
5562668 Johnson Oct 1996 A
5562669 Mcguire Oct 1996 A
5562683 Chan Oct 1996 A
5562685 Mollenauer et al. Oct 1996 A
5562686 Sauer et al. Oct 1996 A
5569252 Justin et al. Oct 1996 A
5569269 Hart et al. Oct 1996 A
5569305 Bonutti Oct 1996 A
5569306 Thal Oct 1996 A
5570706 Howell Nov 1996 A
5571090 Sherts Nov 1996 A
5571104 Li Nov 1996 A
5571139 Jenkins, Jr. Nov 1996 A
5572655 Tuljapurkar et al. Nov 1996 A
5573286 Rogozinski Nov 1996 A
5573542 Stevens Nov 1996 A
5573547 LeVeen et al. Nov 1996 A
5573548 Nazre et al. Nov 1996 A
5577299 Thompson et al. Nov 1996 A
5578057 Wenstrom, Jr. Nov 1996 A
5584695 Sachdeva et al. Dec 1996 A
5584835 Greenfield Dec 1996 A
5584836 Ballintyn et al. Dec 1996 A
5584862 Bonutti Dec 1996 A
5586986 Hinchliffe Dec 1996 A
5588575 Davignon Dec 1996 A
5591180 Hinchliffe Jan 1997 A
5591181 Stone et al. Jan 1997 A
5591207 Coleman Jan 1997 A
5593407 Reis Jan 1997 A
5593425 Bonutti et al. Jan 1997 A
5601557 Hayhurst Feb 1997 A
5601559 Melker et al. Feb 1997 A
5601571 Moss Feb 1997 A
5603716 Morgan et al. Feb 1997 A
5607429 Hayano et al. Mar 1997 A
5607430 Bailey Mar 1997 A
5613971 Lower et al. Mar 1997 A
5618290 Toy et al. Apr 1997 A
5626611 Liu et al. May 1997 A
5626614 Hart May 1997 A
5628756 Barker, Jr. et al. May 1997 A
5628766 Johnson May 1997 A
5630824 Hart May 1997 A
5632745 Schwartz May 1997 A
5632748 Beck, Jr. et al. May 1997 A
5641256 Gundy Jun 1997 A
5643266 Li Jul 1997 A
5643269 Harle Jul 1997 A
5643273 Clark Jul 1997 A
5643295 Yoon Jul 1997 A
5643319 Green et al. Jul 1997 A
5643320 Lower et al. Jul 1997 A
5643321 Mcdevitt Jul 1997 A
5645546 Fard Jul 1997 A
5645547 Coleman Jul 1997 A
5645568 Chervitz et al. Jul 1997 A
5645588 Graf et al. Jul 1997 A
5647874 Hayhurst Jul 1997 A
5649959 Hannam et al. Jul 1997 A
5649960 Pavletic Jul 1997 A
5649963 Mcdevitt Jul 1997 A
5658289 Boucher et al. Aug 1997 A
5658299 Hart Aug 1997 A
5658313 Thal Aug 1997 A
5662658 Wenstrom, Jr. Sep 1997 A
5662663 Shallman Sep 1997 A
5662677 Wimmer Sep 1997 A
5662681 Nash et al. Sep 1997 A
5665112 Thal Sep 1997 A
5667513 Torrie et al. Sep 1997 A
5671695 Schroeder Sep 1997 A
5673546 Abraham et al. Oct 1997 A
5674224 Howell et al. Oct 1997 A
5679723 Cooper Oct 1997 A
5681334 Evans et al. Oct 1997 A
5681352 Clancy, III et al. Oct 1997 A
5683404 Johnson Nov 1997 A
5683419 Thal Nov 1997 A
5688284 Chervitz et al. Nov 1997 A
5688285 Yamada Nov 1997 A
5690655 Hart et al. Nov 1997 A
5690676 Dipoto et al. Nov 1997 A
5690678 Johnson Nov 1997 A
5693046 Songer et al. Dec 1997 A
5695497 Stahelin Dec 1997 A
5697929 Mellinger Dec 1997 A
5697969 Schmitt et al. Dec 1997 A
5699657 Paulson Dec 1997 A
5702397 Goble et al. Dec 1997 A
5702422 Stone Dec 1997 A
5702462 Oberlander Dec 1997 A
5702464 Lackey et al. Dec 1997 A
5707373 Sevrain et al. Jan 1998 A
5709708 Thal et al. Jan 1998 A
5711969 Patel et al. Jan 1998 A
5713005 Proebsting Jan 1998 A
5713897 Goble et al. Feb 1998 A
5713904 Errico et al. Feb 1998 A
5713905 Goble et al. Feb 1998 A
5713921 Bonutti Feb 1998 A
5715578 Knudson Feb 1998 A
5716359 Ojima et al. Feb 1998 A
5716397 Myers Feb 1998 A
5716616 Prockop et al. Feb 1998 A
5718717 Bonutti Feb 1998 A
5720747 Burke Feb 1998 A
5720765 Thal Feb 1998 A
5720766 Zang et al. Feb 1998 A
5722976 Brown Mar 1998 A
5723331 Tubo et al. Mar 1998 A
5725529 Nicholson et al. Mar 1998 A
5725549 Lam Mar 1998 A
5725556 Moser et al. Mar 1998 A
5725557 Gatturna et al. Mar 1998 A
5725581 Branemark Mar 1998 A
5725582 Bevan et al. Mar 1998 A
5726722 Uehara et al. Mar 1998 A
5728107 Zlock et al. Mar 1998 A
5728109 Schulze et al. Mar 1998 A
5728136 Thal Mar 1998 A
5733293 Scirica et al. Mar 1998 A
5733306 Bonutti Mar 1998 A
5733307 Dinsdale Mar 1998 A
5735875 Bonutti et al. Apr 1998 A
5741259 Chan Apr 1998 A
5741260 Songer et al. Apr 1998 A
5741281 Martin Apr 1998 A
5743912 Lahille et al. Apr 1998 A
5746751 Sherts May 1998 A
5746752 Burkhart May 1998 A
5746754 Chan May 1998 A
5749898 Schulze et al. May 1998 A
5755729 De La Torre et al. May 1998 A
5755791 Whitson et al. May 1998 A
5766176 Duncan Jun 1998 A
5766218 Arnott Jun 1998 A
5766250 Chervitz et al. Jun 1998 A
5769894 Ferragamo Jun 1998 A
5769899 Schwartz et al. Jun 1998 A
5772673 Cuny et al. Jun 1998 A
5776196 Matsuzaki et al. Jul 1998 A
5776200 Johnson et al. Jul 1998 A
5782845 Shewchuk Jul 1998 A
5782862 Bonutti Jul 1998 A
5782864 Lizardi Jul 1998 A
5782866 Wenstrom, Jr. Jul 1998 A
5782925 Collazo et al. Jul 1998 A
5785714 Morgan et al. Jul 1998 A
5786217 Tubo et al. Jul 1998 A
5792142 Galitzer Aug 1998 A
5792149 Sherts et al. Aug 1998 A
5796127 Hayafuji et al. Aug 1998 A
5797913 Dambreville et al. Aug 1998 A
5797915 Pierson, III et al. Aug 1998 A
5797916 McDowell Aug 1998 A
5797928 Kogasaka Aug 1998 A
5800407 Eldor Sep 1998 A
5800447 Wenstrom, Jr. Sep 1998 A
5800543 Mcleod et al. Sep 1998 A
5810824 Chan Sep 1998 A
5810848 Hayhurst Sep 1998 A
5811094 Caplan et al. Sep 1998 A
5814056 Prosst et al. Sep 1998 A
5814069 Schulze et al. Sep 1998 A
5814070 Borzone et al. Sep 1998 A
5814071 Mcdevitt et al. Sep 1998 A
5814072 Bonutti Sep 1998 A
5814073 Bonutti Sep 1998 A
5817095 Smith Oct 1998 A
5823980 Kopfer Oct 1998 A
5824011 Stone et al. Oct 1998 A
5824066 Gross Oct 1998 A
5827285 Bramlet Oct 1998 A
5830234 Wojciechowicz et al. Nov 1998 A
5836955 Buelna et al. Nov 1998 A
5843084 Hart et al. Dec 1998 A
5845645 Bonutti Dec 1998 A
5846254 Schulze et al. Dec 1998 A
5848983 Basaj et al. Dec 1998 A
5849012 Abboudi Dec 1998 A
5860973 Michelson Jan 1999 A
5860978 Mcdevitt et al. Jan 1999 A
5868740 LaVeen et al. Feb 1999 A
5868748 Burke Feb 1999 A
5868789 Huebner Feb 1999 A
5871456 Armstrong et al. Feb 1999 A
5871484 Spievack et al. Feb 1999 A
5871486 Huebner Feb 1999 A
5871490 Schulze et al. Feb 1999 A
5871542 Goodfellow et al. Feb 1999 A
5871543 Hofmann Feb 1999 A
5885294 Pedlick et al. Mar 1999 A
5891168 Thal Apr 1999 A
5893592 Schulze et al. Apr 1999 A
5895395 Yeung Apr 1999 A
5897564 Schulze et al. Apr 1999 A
5897574 Bonutti Apr 1999 A
5899902 Brown et al. May 1999 A
5899920 Desatnick et al. May 1999 A
5899938 Sklar et al. May 1999 A
5906934 Grande et al. May 1999 A
5908421 Beger Jun 1999 A
5908436 Cuschieri et al. Jun 1999 A
5910148 Reimels et al. Jun 1999 A
5911721 Nicholson et al. Jun 1999 A
5916557 Berlowitz-tarrant et al. Jun 1999 A
5918604 Whelan Jul 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5921986 Bonutti Jul 1999 A
5925008 Douglas Jul 1999 A
5928231 Klein et al. Jul 1999 A
5928267 Bonutti et al. Jul 1999 A
5928286 Ashby et al. Jul 1999 A
RE36289 Le et al. Aug 1999 E
5931838 Vito Aug 1999 A
5931844 Thompson et al. Aug 1999 A
5931869 Boucher et al. Aug 1999 A
5935119 Guy et al. Aug 1999 A
5935129 Mcdevitt et al. Aug 1999 A
5935133 Wagner et al. Aug 1999 A
5935134 Pedlick et al. Aug 1999 A
5935149 Ek Aug 1999 A
5938668 Scirica et al. Aug 1999 A
5941439 Kammerer et al. Aug 1999 A
5941900 Bonutti Aug 1999 A
5944739 Zlock et al. Aug 1999 A
5946783 Plociennik et al. Sep 1999 A
5947915 Thibodo, Jr. Sep 1999 A
5947982 Duran Sep 1999 A
5947999 Groiso Sep 1999 A
5948002 Bonutti Sep 1999 A
5951559 Burkhart Sep 1999 A
5951560 Simon et al. Sep 1999 A
5954747 Clark Sep 1999 A
5957953 Dipoto et al. Sep 1999 A
5961520 Beck, Jr. et al. Oct 1999 A
5961521 Roger Oct 1999 A
5961524 Crombie Oct 1999 A
5963869 Fehnel Oct 1999 A
5964764 West, Jr. et al. Oct 1999 A
5964767 Tapia et al. Oct 1999 A
5964769 Wagner et al. Oct 1999 A
5964783 Grafton et al. Oct 1999 A
5964808 Blaha et al. Oct 1999 A
5968045 Frazier Oct 1999 A
5968047 Reed Oct 1999 A
5968077 Wojciechowicz et al. Oct 1999 A
5968078 Grotz Oct 1999 A
5968099 Badorf et al. Oct 1999 A
5970697 Jacobs et al. Oct 1999 A
5972006 Sciaino, Jr. Oct 1999 A
5860947 Stamler Nov 1999 A
5976125 Graham Nov 1999 A
5976127 Lax Nov 1999 A
5980473 Korakianitis et al. Nov 1999 A
5980524 Justin et al. Nov 1999 A
5980539 Kontos Nov 1999 A
5980548 Evans et al. Nov 1999 A
5980558 Wiley Nov 1999 A
5980559 Bonutti Nov 1999 A
5989252 Fumex Nov 1999 A
5989256 Kuslich et al. Nov 1999 A
5989282 Bonutti Nov 1999 A
5989294 Marlow Nov 1999 A
5993452 Vandewalle Nov 1999 A
5993476 Groiso Nov 1999 A
5997542 Burke Dec 1999 A
5997552 Person et al. Dec 1999 A
5997575 Whitson et al. Dec 1999 A
6001100 Sherman et al. Dec 1999 A
6001106 Ryan et al. Dec 1999 A
6004351 Tomita et al. Dec 1999 A
6004352 Buni Dec 1999 A
6007538 Levin Dec 1999 A
6007567 Bonutti Dec 1999 A
6010525 Bonutti et al. Jan 2000 A
6013103 Kaufman et al. Jan 2000 A
6016727 Morgan Jan 2000 A
6019767 Howell Feb 2000 A
6022352 Vandewalle Feb 2000 A
6022373 Li Feb 2000 A
6023661 Sottery Feb 2000 A
6024758 Thal Feb 2000 A
6027523 Schmieding Feb 2000 A
6030410 Zurbrugg Feb 2000 A
6033429 Magovern Mar 2000 A
6033430 Bonutti Mar 2000 A
6036695 Smith Mar 2000 A
6039753 Meislin Mar 2000 A
6041485 Pedlick et al. Mar 2000 A
6042601 Smith Mar 2000 A
6042609 Giordano et al. Mar 2000 A
6045551 Bonutti Apr 2000 A
6045571 Hill et al. Apr 2000 A
6045572 Johnson et al. Apr 2000 A
6045573 Wenstrom, Jr. et al. Apr 2000 A
6045574 Thal Apr 2000 A
6047826 Kalinski et al. Apr 2000 A
6048343 Mathis et al. Apr 2000 A
6051006 Shluzas et al. Apr 2000 A
6051007 Hogendijk et al. Apr 2000 A
6053916 Moore Apr 2000 A
6053921 Wagner et al. Apr 2000 A
6056752 Roger May 2000 A
6056772 Bonutti May 2000 A
6056773 Bonutti May 2000 A
6059817 Bonutti et al. May 2000 A
6059818 Johnson et al. May 2000 A
6062344 Okabe et al. May 2000 A
6066146 Carroll et al. May 2000 A
6066173 Mckernan et al. May 2000 A
6068648 Cole et al. May 2000 A
6071305 Brown et al. Jun 2000 A
6074403 Nord Jun 2000 A
6077277 Mollenauer et al. Jun 2000 A
6077292 Bonutti Jun 2000 A
6080185 Johnson et al. Jun 2000 A
6083257 Taylor et al. Jul 2000 A
6086591 Bojarski Jul 2000 A
6086592 Rosenberg et al. Jul 2000 A
6086608 Ek et al. Jul 2000 A
6093200 Liu et al. Jul 2000 A
6096060 Fitts et al. Aug 2000 A
6099527 Hochschuler et al. Aug 2000 A
6099530 Simonian et al. Aug 2000 A
6099568 Simonian et al. Aug 2000 A
6102934 Li Aug 2000 A
6106545 Egan et al. Aug 2000 A
6110128 Andelin et al. Aug 2000 A
6110207 Eichhorn et al. Aug 2000 A
6113604 Whittaker et al. Sep 2000 A
6117160 Bonutti Sep 2000 A
6117162 Schmieding et al. Sep 2000 A
6123710 Pinczewski et al. Sep 2000 A
6127596 Brown et al. Oct 2000 A
6132433 Whelan Oct 2000 A
6132437 Omurtag Oct 2000 A
6136010 Modesitt et al. Oct 2000 A
6139565 Stone et al. Oct 2000 A
RE36974 Bonutti Nov 2000 E
6143017 Thal Nov 2000 A
6146406 Shluzas et al. Nov 2000 A
6146408 Bartlett Nov 2000 A
6149653 Deslauriers Nov 2000 A
6149669 Li Nov 2000 A
6150163 McPherson et al. Nov 2000 A
6152928 Wenstrom, Jr. Nov 2000 A
6152934 Harper et al. Nov 2000 A
6152936 Christy et al. Nov 2000 A
6152949 Bonutti Nov 2000 A
6156039 Thal Dec 2000 A
6156056 Kearns et al. Dec 2000 A
6159234 Bonutti et al. Dec 2000 A
6165203 Krebs Dec 2000 A
6168598 Martello Jan 2001 B1
6168628 Huebner Jan 2001 B1
6171310 Giordano et al. Jan 2001 B1
6174324 Egan et al. Jan 2001 B1
6179840 Bowman Jan 2001 B1
6183461 Matsuura et al. Feb 2001 B1
6183737 Zaleske et al. Feb 2001 B1
6187025 Machek Feb 2001 B1
6190348 Tiemann Feb 2001 B1
6190401 Green et al. Feb 2001 B1
6190411 Lo Feb 2001 B1
6190415 Cooke et al. Feb 2001 B1
6193754 Seedhom Feb 2001 B1
6200318 Har-shai et al. Mar 2001 B1
6200329 Fung et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6200606 Peterson et al. Mar 2001 B1
6200685 Davidson Mar 2001 B1
6203556 Evans et al. Mar 2001 B1
6203563 Fernandez Mar 2001 B1
6203565 Bonutti et al. Mar 2001 B1
6203572 Johnson et al. Mar 2001 B1
6203576 Afriat et al. Mar 2001 B1
6206883 Tunc Mar 2001 B1
6210376 Grayson Apr 2001 B1
6210381 Morse Apr 2001 B1
6210445 Zawadzki Apr 2001 B1
6214007 Anderson Apr 2001 B1
6214012 Karpman et al. Apr 2001 B1
6217580 Levin Apr 2001 B1
6221107 Steiner Apr 2001 B1
6228096 Marchand May 2001 B1
6231592 Bonutti et al. May 2001 B1
6234980 Bell May 2001 B1
6235057 Roger et al. May 2001 B1
6235058 Huene May 2001 B1
6238395 Bonutti May 2001 B1
6241734 Scribner et al. Jun 2001 B1
6241747 Ruff Jun 2001 B1
6241771 Gresser et al. Jun 2001 B1
6245024 Montagnino et al. Jun 2001 B1
6245081 Bowman Jun 2001 B1
6254604 Howell Jul 2001 B1
6258091 Sevrain et al. Jul 2001 B1
6267766 Burkhart Jul 2001 B1
6269716 Amis Aug 2001 B1
6270518 Pedlick et al. Aug 2001 B1
6273890 Frazier Aug 2001 B1
6280474 Cassidy et al. Aug 2001 B1
6283973 Hubbard et al. Sep 2001 B1
6283996 Chervitz et al. Sep 2001 B1
6287307 Abboudi Sep 2001 B1
6287325 Bonutti Sep 2001 B1
6293929 Smith et al. Sep 2001 B1
6293961 Schwartz et al. Sep 2001 B2
6296659 Foerster Oct 2001 B1
6299615 Huebner Oct 2001 B1
6302888 Mellinger et al. Oct 2001 B1
6302899 Johnson et al. Oct 2001 B1
6302915 Cooney, III et al. Oct 2001 B1
6303158 Odgaard et al. Oct 2001 B1
6306156 Clark Oct 2001 B1
6306158 Bartlett Oct 2001 B1
6306159 Schwartz et al. Oct 2001 B1
6309124 Gueret Oct 2001 B1
6309405 Bonutti Oct 2001 B1
6312448 Bonutti Nov 2001 B1
6315788 Roby Nov 2001 B1
6319224 Stout et al. Nov 2001 B1
6319271 Schwartz et al. Nov 2001 B1
6328758 Tornier et al. Dec 2001 B1
6334064 Fiddian-green Dec 2001 B1
6342060 Adams Jan 2002 B1
6343531 Amis Feb 2002 B2
6355066 Kim et al. Mar 2002 B1
6358270 Lerner Mar 2002 B1
6364897 Bonutti Apr 2002 B1
6368322 Luks et al. Apr 2002 B1
6368326 Dakin et al. Apr 2002 B1
6368343 Bonutti et al. Apr 2002 B1
6371124 Whelan Apr 2002 B1
6379361 Beck, Jr. et al. Apr 2002 B1
6383190 Preissman May 2002 B1
6383199 Carter et al. May 2002 B2
6387111 Barber May 2002 B1
6387113 Hawkins et al. May 2002 B1
6387129 Rieser et al. May 2002 B2
6391030 Wagner et al. May 2002 B1
6398785 Carchidi et al. Jun 2002 B2
6406456 Slate et al. Jun 2002 B1
6406479 Justin et al. Jun 2002 B1
6409743 Fenton, Jr. Jun 2002 B1
6413260 Berrevoets et al. Jul 2002 B1
6423073 Bowman Jul 2002 B2
6423088 Fenton, Jr. Jul 2002 B1
6425924 Rousseau Jul 2002 B1
6428562 Bonutti Aug 2002 B2
6432123 Schwartz et al. Aug 2002 B2
6436123 Magovern Aug 2002 B1
6436124 Anderson et al. Aug 2002 B1
6440134 Zaccherotti et al. Aug 2002 B1
6440136 Gambale et al. Aug 2002 B1
6447516 Bonutti Sep 2002 B1
6451030 Li et al. Sep 2002 B2
6454768 Jackson Sep 2002 B1
6458134 Songer et al. Oct 2002 B1
6458161 Gibbs et al. Oct 2002 B1
6461373 Wyman et al. Oct 2002 B2
6464690 Castaneda et al. Oct 2002 B1
6464713 Bonutti Oct 2002 B2
6468293 Bonutti et al. Oct 2002 B2
6471707 Miller et al. Oct 2002 B1
6475230 Bonutti et al. Nov 2002 B1
6478753 Reay-young Nov 2002 B2
6482210 Skiba et al. Nov 2002 B1
6485504 Johnson et al. Nov 2002 B1
6491714 Bennett Dec 2002 B1
6497901 Royer Dec 2002 B1
6500184 Chan et al. Dec 2002 B1
6500195 Bonutti Dec 2002 B2
6500208 Metzger et al. Dec 2002 B1
RE37963 Thal Jan 2003 E
6503267 Bonutti et al. Jan 2003 B2
6506190 Walshe Jan 2003 B1
6508820 Bales Jan 2003 B2
6508821 Schwartz et al. Jan 2003 B1
6508830 Steiner Jan 2003 B2
6511498 Fumex Jan 2003 B1
6511499 Schmieding et al. Jan 2003 B2
6514274 Boucher et al. Feb 2003 B1
6517542 Papay et al. Feb 2003 B1
6517552 Nord et al. Feb 2003 B1
6517564 Grafton et al. Feb 2003 B1
6517578 Hein Feb 2003 B2
6517579 Paulos et al. Feb 2003 B1
6520964 Tallarida et al. Feb 2003 B2
6520980 Foerster Feb 2003 B1
6524317 Ritchart et al. Feb 2003 B1
6527777 Justin Mar 2003 B2
6527794 Mcdevitt et al. Mar 2003 B1
6527795 Lizardi Mar 2003 B1
6533795 Tran et al. Mar 2003 B1
6533802 Bojarski et al. Mar 2003 B2
6537319 Whelan Mar 2003 B2
6540750 Burkhart Apr 2003 B2
6540769 Miller, III Apr 2003 B1
6540770 Tornier et al. Apr 2003 B1
6540783 Whittaker et al. Apr 2003 B1
6543094 D'addario Apr 2003 B2
6544281 Elattrache et al. Apr 2003 B2
6547564 Hansson Apr 2003 B1
6547778 Sklar et al. Apr 2003 B1
6547800 Foerster et al. Apr 2003 B2
6551330 Bain et al. Apr 2003 B1
6551343 Tormala et al. Apr 2003 B1
6551353 Baker et al. Apr 2003 B1
6553802 Jacob Apr 2003 B1
6554830 Chappius Apr 2003 B1
6554852 Oberlander Apr 2003 B1
6554862 Hays et al. Apr 2003 B2
6558389 Clark et al. May 2003 B2
6562071 Jarvinen May 2003 B2
6565572 Chappius May 2003 B2
6565573 Ferrante May 2003 B1
6569167 Bobechko et al. May 2003 B1
6569186 Winters et al. May 2003 B1
6569187 Bonutti et al. May 2003 B1
6572635 Bonutti Jun 2003 B1
6572655 Johnson Jun 2003 B1
6575925 Noble Jun 2003 B1
6579295 Supinski Jun 2003 B1
6582453 Tran et al. Jun 2003 B1
6585730 Foerster Jul 2003 B1
6585740 Schlapfer et al. Jul 2003 B2
6585750 Bonutti et al. Jul 2003 B2
6589245 Weiler et al. Jul 2003 B1
6589246 Hack et al. Jul 2003 B1
6592609 Bonutti Jul 2003 B1
6592622 Ferguson Jul 2003 B1
6595911 Lovuolo Jul 2003 B2
6599289 Bojarski et al. Jul 2003 B1
6599319 Knudsen et al. Jul 2003 B2
6605096 Ritchart Aug 2003 B1
6607548 Pohjonen et al. Aug 2003 B2
6610064 Goble et al. Aug 2003 B1
6610079 Li et al. Aug 2003 B1
6613018 Bagga et al. Sep 2003 B2
6616694 Hart Sep 2003 B1
6620166 Wenstrom, Jr. et al. Sep 2003 B1
6620185 Harvie et al. Sep 2003 B1
6620195 Goble et al. Sep 2003 B2
6620329 Rosen et al. Sep 2003 B2
6620349 Lopez Sep 2003 B1
6623492 Berube et al. Sep 2003 B1
6623524 Schmieding Sep 2003 B2
6626910 Hugues Sep 2003 B1
6626919 Swanstrom Sep 2003 B1
6626930 Allen et al. Sep 2003 B1
6629977 Wolf Oct 2003 B1
6629997 Mansmann Oct 2003 B2
6632245 Kim Oct 2003 B2
6635073 Bonutti Oct 2003 B2
6638279 Bonutti Oct 2003 B2
6638286 Burbank et al. Oct 2003 B1
6638312 Plouhar et al. Oct 2003 B2
6641596 Lizardi Nov 2003 B1
6641597 Burkhart et al. Nov 2003 B2
6645169 Slate et al. Nov 2003 B1
6645211 Magana Nov 2003 B2
6645227 Fallin et al. Nov 2003 B2
6648903 Pierson, III Nov 2003 B1
6648921 Anderson et al. Nov 2003 B2
6652450 Neisz et al. Nov 2003 B2
6652533 O'Neil Nov 2003 B2
6652560 Gerke et al. Nov 2003 B1
6652562 Collier et al. Nov 2003 B2
6652563 Dreyfuss Nov 2003 B2
6656182 Hayhurst Dec 2003 B1
6656183 Colleran et al. Dec 2003 B2
6658182 Gonthier Dec 2003 B1
6660008 Foerster et al. Dec 2003 B1
6660022 Li et al. Dec 2003 B1
6663634 Ahrens et al. Dec 2003 B2
6663656 Schmieding et al. Dec 2003 B2
6666868 Fallin Dec 2003 B2
6666877 Morgan et al. Dec 2003 B2
6669707 Swanstrom et al. Dec 2003 B1
6679889 West, Jr. et al. Jan 2004 B1
6682533 Dinsdale et al. Jan 2004 B1
6682549 Bartlett Jan 2004 B2
6685728 Sinnott et al. Feb 2004 B2
6689137 Reed Feb 2004 B2
6689153 Skiba Feb 2004 B1
6689154 Bartlett Feb 2004 B2
6692499 Tormala et al. Feb 2004 B2
6692516 West, Jr. et al. Feb 2004 B2
6695852 Gleason Feb 2004 B2
6712849 Re et al. Mar 2004 B2
6712859 Rousseau Mar 2004 B2
6716190 Glines et al. Apr 2004 B1
6716224 Singhatat Apr 2004 B2
6716234 Grafton et al. Apr 2004 B2
6716957 Tunc Apr 2004 B2
6730092 Songer May 2004 B2
6730124 Steiner May 2004 B2
6736799 Erbe et al. May 2004 B1
6737053 Goh et al. May 2004 B1
6746483 Bojarski et al. Jun 2004 B1
6752780 Stout et al. Jun 2004 B2
6752810 Gao et al. Jun 2004 B1
6752831 Sybert et al. Jun 2004 B2
6755836 Lewis Jun 2004 B1
6755868 Rousseau Jun 2004 B2
6761722 Cole et al. Jul 2004 B2
6761739 Shepard Jul 2004 B2
6767037 Wenstrom, Jr. Jul 2004 B2
6770076 Foerster Aug 2004 B2
6770084 Bain et al. Aug 2004 B1
6773450 Leung et al. Aug 2004 B2
6779701 Bailly et al. Aug 2004 B2
6780190 Maroney Aug 2004 B2
6780198 Gregoire et al. Aug 2004 B1
6790210 Cragg et al. Sep 2004 B1
6793595 Monnet Sep 2004 B1
6802862 Roger et al. Oct 2004 B1
6808502 Nguyen Oct 2004 B2
6808526 Magerl et al. Oct 2004 B1
6814741 Bowman et al. Nov 2004 B2
6830572 Mcdevitt et al. Dec 2004 B2
6833005 Mantas Dec 2004 B1
6835377 Goldberg et al. Dec 2004 B2
6840953 Martinek Jan 2005 B2
6860885 Bonutti Mar 2005 B2
6860895 Akerfeldt et al. Mar 2005 B1
6863671 Strobel et al. Mar 2005 B1
6872040 Deeg et al. Mar 2005 B2
6872210 Hearn Mar 2005 B2
6875216 Wolf Apr 2005 B2
6884249 May et al. Apr 2005 B2
6887243 Culbert May 2005 B2
6887259 Lizardi May 2005 B2
6887271 Justin et al. May 2005 B2
6890354 Steiner et al. May 2005 B2
6893448 O'quinn et al. May 2005 B2
6896686 Weber May 2005 B2
6899722 Bonutti May 2005 B2
6902573 Strobel et al. Jun 2005 B2
6905513 Metzger Jun 2005 B1
6908466 Bonutti et al. Jun 2005 B1
6911202 Amir et al. Jun 2005 B2
6916292 Morawski et al. Jul 2005 B2
6916321 Tenhuisen et al. Jul 2005 B2
6921402 Contiliano et al. Jul 2005 B2
6923823 Bartlett et al. Aug 2005 B1
6923824 Morgan et al. Aug 2005 B2
6923832 Sharkey et al. Aug 2005 B1
6939379 Sklar Sep 2005 B2
6946001 Sanford et al. Sep 2005 B2
6949102 Andrews Sep 2005 B2
6951565 Keane et al. Oct 2005 B2
6960214 Burkinshaw Nov 2005 B2
6966887 Chin Nov 2005 B1
6966916 Kumar Nov 2005 B2
6969391 Gazzani Nov 2005 B1
6969398 Stevens et al. Nov 2005 B2
6972027 Fallin et al. Dec 2005 B2
6980903 Daniels et al. Dec 2005 B2
6984237 Hatch et al. Jan 2006 B2
6986781 Smith Jan 2006 B2
6989034 Hammer et al. Jan 2006 B2
6994719 Grafton Feb 2006 B2
6994725 Goble Feb 2006 B1
7001429 Ferguson Feb 2006 B2
7004959 Bonutti Feb 2006 B2
7008451 Justin et al. Mar 2006 B2
7011682 Lashinski et al. Mar 2006 B2
7033397 Webster et al. Apr 2006 B2
7048754 Martin et al. May 2006 B2
7052499 Steger et al. May 2006 B2
7060101 O'Connor et al. Jun 2006 B2
7066942 Treace Jun 2006 B2
7066944 Laufer et al. Jun 2006 B2
7081126 Mcdevitt et al. Jul 2006 B2
7083638 Foerster Aug 2006 B2
7087064 Hyde Aug 2006 B1
7087073 Bonutti Aug 2006 B2
7090690 Foerster et al. Aug 2006 B2
7097654 Freedland Aug 2006 B1
7101395 Tremulis et al. Sep 2006 B2
7105010 Hart et al. Sep 2006 B2
7105026 Johnson et al. Sep 2006 B2
7112221 Harris Sep 2006 B2
7118578 West, Jr. et al. Oct 2006 B2
7118583 O'Quinn et al. Oct 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7131467 Gao et al. Nov 2006 B2
7137996 Steiner et al. Nov 2006 B2
7141066 Steiner et al. Nov 2006 B2
7144414 Harvie et al. Dec 2006 B2
7148209 Hoemann et al. Dec 2006 B2
7153127 Struble et al. Dec 2006 B2
7153307 Scribner Dec 2006 B2
7153312 Torrie et al. Dec 2006 B1
7153327 Metzger Dec 2006 B1
7160285 Sklar et al. Jan 2007 B2
7160333 Plouhar et al. Jan 2007 B2
7172626 Andrews Feb 2007 B1
7179259 Gibbs Feb 2007 B1
7201722 Krueger Apr 2007 B2
7207993 Baldwin et al. Apr 2007 B1
7229441 Trieu et al. Jun 2007 B2
7235091 Thornes Jun 2007 B2
7255675 Gertner et al. Aug 2007 B2
7255700 Kaiser et al. Aug 2007 B2
7255715 Metzger Aug 2007 B2
7261716 Strobel et al. Aug 2007 B2
7264634 Schmieding Sep 2007 B2
7279008 Brown et al. Oct 2007 B2
7285124 Foerster Oct 2007 B2
7291177 Gibbs Nov 2007 B2
7303577 Dean Dec 2007 B1
7306417 Dorstewitz Dec 2007 B2
7309355 Donnelly et al. Dec 2007 B2
7326222 Dreyfuss et al. Feb 2008 B2
7329272 Burkhart et al. Feb 2008 B2
7354354 Palumbo et al. Apr 2008 B2
7361179 Rousseau et al. Apr 2008 B2
7377845 Stewart et al. May 2008 B2
7390329 Westra et al. Jun 2008 B2
7390332 Selvitelli et al. Jun 2008 B2
7399018 Khachaturian Jul 2008 B1
7442210 Segal et al. Oct 2008 B2
7462198 Webster et al. Dec 2008 B2
7463198 Deaett et al. Dec 2008 B2
7465308 Sikora et al. Dec 2008 B2
7468074 Caborn Dec 2008 B2
7481814 Metzger Jan 2009 B1
7484539 Huang Feb 2009 B1
7485149 White Feb 2009 B1
7494506 Brulez et al. Feb 2009 B2
D587807 Wolf et al. Mar 2009 S
7500983 Kaiser et al. Mar 2009 B1
7513910 Buskirk et al. Apr 2009 B2
7517357 Abrams et al. Apr 2009 B2
7572275 Fallin et al. Aug 2009 B2
7572298 Roller et al. Aug 2009 B2
7578825 Huebner Aug 2009 B2
7585311 Green et al. Sep 2009 B2
7588587 Barbieri et al. Sep 2009 B2
7591823 Tipirneni Sep 2009 B2
7597705 Forsberg et al. Oct 2009 B2
7601165 Stone Oct 2009 B2
7604636 Walters et al. Oct 2009 B1
7608092 Schaffhasen Oct 2009 B1
7608098 Stone et al. Oct 2009 B1
7615076 Cauthen, III et al. Nov 2009 B2
7621937 Pipenhagen et al. Nov 2009 B2
7632287 Baker et al. Dec 2009 B2
7651509 Bojarski et al. Jan 2010 B2
7658750 Li Feb 2010 B2
7658751 Stone et al. Feb 2010 B2
7670279 Gertner Mar 2010 B2
7678123 Chanduszko Mar 2010 B2
7686810 West, Jr. et al. Mar 2010 B2
7691112 Chanduszko et al. Apr 2010 B2
7695493 Saadat et al. Apr 2010 B2
7695503 Kaiser Apr 2010 B1
7703372 Shakespeare Apr 2010 B1
7713188 Bouffier May 2010 B2
7713285 Stone et al. May 2010 B1
7717929 Fallman May 2010 B2
7731732 Ken Jun 2010 B2
7736364 Stone Jun 2010 B2
7736379 Ewers et al. Jun 2010 B2
7749250 Stone et al. Jul 2010 B2
7758594 Lamson et al. Jul 2010 B2
7758611 Kato Jul 2010 B2
7762942 Neisz et al. Jul 2010 B2
7771482 Karmon Aug 2010 B1
7776041 Walters Aug 2010 B1
7780701 Meridew et al. Aug 2010 B1
7790945 Watson, Jr. Sep 2010 B1
7803173 Burkhart et al. Sep 2010 B2
7819895 Ginn et al. Oct 2010 B2
7828820 Stone et al. Nov 2010 B2
7828850 Cauthen, III et al. Nov 2010 B2
7856698 Hays Dec 2010 B2
7857830 Stone et al. Dec 2010 B2
7867252 Criscuolo et al. Jan 2011 B2
7867264 Mcdevitt et al. Jan 2011 B2
7875058 Holmes, Jr. Jan 2011 B2
7878058 Blendinger et al. Feb 2011 B2
7887586 Linares Feb 2011 B2
7896907 Mcdevitt et al. Mar 2011 B2
7905903 Stone et al. Mar 2011 B2
7905904 Stone et al. Mar 2011 B2
7909851 Stone et al. Mar 2011 B2
7914539 Stone et al. Mar 2011 B2
7938847 Fanton et al. May 2011 B2
7951198 Sucec et al. May 2011 B2
7955388 Jensen et al. Jun 2011 B2
7959650 Kaiser et al. Jun 2011 B2
7976565 Meridew Jul 2011 B1
7981140 Burkhart Jul 2011 B2
7998203 Blum Aug 2011 B2
8034090 Stone et al. Oct 2011 B2
8062334 Green et al. Nov 2011 B2
8066776 O'Connor et al. Nov 2011 B2
8075574 May et al. Dec 2011 B2
8075626 Dun Dec 2011 B2
8088108 Kraft Jan 2012 B2
8088130 Kaiser et al. Jan 2012 B2
8109867 Rosenblatt Feb 2012 B2
8114127 West, Jr. Feb 2012 B2
8114128 Cauldwell et al. Feb 2012 B2
8118835 Weisel et al. Feb 2012 B2
8118836 Denham et al. Feb 2012 B2
8118868 May et al. Feb 2012 B2
8128658 Kaiser et al. Mar 2012 B2
8137354 Stone Mar 2012 B2
8137382 Denham et al. Mar 2012 B2
8137407 Todd et al. Mar 2012 B2
8142510 Lee et al. Mar 2012 B2
8147557 Lee et al. Apr 2012 B2
8147558 Lee et al. Apr 2012 B2
8162997 Struhl Apr 2012 B2
8167906 Cauldwell et al. May 2012 B2
8177810 Ferree May 2012 B2
8202295 Kaplan Jun 2012 B2
8202318 Willobee Jun 2012 B2
8221454 Schaffhasen Jul 2012 B2
8231654 Kaiser et al. Jul 2012 B2
8251998 Hoeppner et al. Aug 2012 B2
8252022 Holman et al. Aug 2012 B2
8273106 Stone et al. Sep 2012 B2
8292921 Stone et al. Oct 2012 B2
8298262 Stone et al. Oct 2012 B2
8298284 Cassani Oct 2012 B2
8303589 Tyber et al. Nov 2012 B2
8303604 Stone et al. Nov 2012 B2
8317825 Stone Nov 2012 B2
8328806 Tyber et al. Dec 2012 B2
8333788 Maiorino Dec 2012 B2
8337525 Stone et al. Dec 2012 B2
8343155 Fisher et al. Jan 2013 B2
8343227 Metzger et al. Jan 2013 B2
8361054 Ducharme et al. Jan 2013 B2
8361113 Stone et al. Jan 2013 B2
8409253 Stone et al. Apr 2013 B2
8454635 Paolitto et al. Jun 2013 B2
8486114 Gillard et al. Jul 2013 B2
8500818 Metzger et al. Aug 2013 B2
8506597 Kaiser et al. Aug 2013 B2
8545535 Hiratsuka et al. Oct 2013 B2
8551140 Denham et al. Oct 2013 B2
8562645 Stone et al. Oct 2013 B2
8562647 Kaiser et al. Oct 2013 B2
8574235 Stone Nov 2013 B2
8579901 Foerster Nov 2013 B1
8579944 Holloway et al. Nov 2013 B2
8591544 Jolly et al. Nov 2013 B2
8597327 Stone et al. Dec 2013 B2
8608777 Kaiser et al. Dec 2013 B2
8632566 Olson Jan 2014 B2
8632569 Stone et al. Jan 2014 B2
8652171 Stone et al. Feb 2014 B2
8652172 Denham et al. Feb 2014 B2
8672904 Schultz Mar 2014 B1
8672968 Stone et al. Mar 2014 B2
8672969 Stone et al. Mar 2014 B2
8702718 Bhatnagar et al. Apr 2014 B2
8715297 Foerster et al. May 2014 B1
8721650 Fanton et al. May 2014 B2
8721684 Denham et al. May 2014 B2
8771316 Denham et al. Jul 2014 B2
8771352 Conner et al. Jul 2014 B2
8777956 Hoeppner et al. Jul 2014 B2
8801783 Stone et al. Aug 2014 B2
8808374 Eggli Aug 2014 B2
8814903 Sengun et al. Aug 2014 B2
8828067 Tipirneni et al. Sep 2014 B2
8840645 Denham et al. Sep 2014 B2
8858642 Metzger et al. Oct 2014 B2
8894715 Metzger et al. Nov 2014 B2
8900314 Metzger et al. Dec 2014 B2
8926613 Kaiser et al. Jan 2015 B2
8932331 Kaiser et al. Jan 2015 B2
8936621 Denham et al. Jan 2015 B2
8961548 Buser Feb 2015 B2
8968364 Berelsman Mar 2015 B2
8998949 Stone et al. Apr 2015 B2
9005287 Stone Apr 2015 B2
9017381 Kaiser et al. Apr 2015 B2
9023058 Jaramillo et al. May 2015 B2
9028509 Chu et al. May 2015 B2
9078644 Stone Jul 2015 B2
9149267 Norton et al. Oct 2015 B2
9173651 Stone et al. Nov 2015 B2
9179950 Zajac et al. Nov 2015 B2
9198673 Stone Dec 2015 B2
9216078 Conner et al. Dec 2015 B2
9271713 Denham et al. Mar 2016 B2
9271826 Eggli et al. Mar 2016 B2
9289285 Eggli Mar 2016 B2
9314235 Bojarski et al. Apr 2016 B2
9314241 Stone et al. Apr 2016 B2
9357991 Denham et al. Jun 2016 B2
9357992 Stone et al. Jun 2016 B2
9370350 Norton Jun 2016 B2
9381013 Norton Jul 2016 B2
9402621 Stone et al. Aug 2016 B2
9408599 Kaiser et al. Aug 2016 B2
9414833 Stone et al. Aug 2016 B2
9414925 Metzger et al. Aug 2016 B2
9468433 Denham et al. Oct 2016 B2
9486211 Stone et al. Nov 2016 B2
9492158 Stone et al. Nov 2016 B2
9498204 Denham et al. Nov 2016 B2
9504460 Stone et al. Nov 2016 B2
9510819 Stone et al. Dec 2016 B2
9510821 Denham et al. Dec 2016 B2
9532777 Kaiser et al. Jan 2017 B2
9538998 Stone et al. Jan 2017 B2
9539003 Stone et al. Jan 2017 B2
9561025 Stone et al. Feb 2017 B2
9572655 Denham Feb 2017 B2
9585651 Lam et al. Mar 2017 B2
9603591 Denham et al. Mar 2017 B2
9622736 Stone et al. Apr 2017 B2
9642661 Stone et al. May 2017 B2
9681940 Stone et al. Jun 2017 B2
9724090 Kaiser et al. Aug 2017 B2
9743919 Manos et al. Aug 2017 B2
9757119 Norton et al. Sep 2017 B2
9763656 Stone et al. Sep 2017 B2
9782245 Mujwid et al. Oct 2017 B2
9788876 Stone Oct 2017 B2
9801620 Kaiser et al. Oct 2017 B2
9801708 Denham et al. Oct 2017 B2
9833230 Stone Dec 2017 B2
9861351 Kaiser et al. Jan 2018 B2
9918826 Berelsman et al. Mar 2018 B2
9918827 Berelsman et al. Mar 2018 B2
9993241 Denham et al. Jun 2018 B2
10004489 Kaiser et al. Jun 2018 B2
10004493 Stone et al. Jun 2018 B2
10004588 Berelsman et al. Jun 2018 B2
10022118 Norton et al. Jul 2018 B2
10092288 Denham et al. Oct 2018 B2
10098629 Kaiser et al. Oct 2018 B2
10154837 Stone et al. Dec 2018 B2
10167582 Pilgeram et al. Jan 2019 B1
10251637 Stone et al. Apr 2019 B2
10265064 Stone et al. Apr 2019 B2
10265159 Denham et al. Apr 2019 B2
10321906 Stone et al. Jun 2019 B2
10349931 Stone Jul 2019 B2
10363028 Norton Jul 2019 B2
10368856 Stone et al. Aug 2019 B2
10398428 Denham et al. Sep 2019 B2
10398430 Stone et al. Sep 2019 B2
10441264 Stone et al. Oct 2019 B2
10517587 Denham et al. Dec 2019 B2
10517714 Stone et al. Dec 2019 B2
10542967 Kaiser et al. Jan 2020 B2
10595851 Kaiser et al. Mar 2020 B2
10603029 Kaiser et al. Mar 2020 B2
10610217 Stone et al. Apr 2020 B2
10675073 Stone et al. Jun 2020 B2
10687803 Denham et al. Jun 2020 B2
10695045 Kaiser et al. Jun 2020 B2
10695052 Denham et al. Jun 2020 B2
10702259 Stone et al. Jul 2020 B2
10716557 Denham et al. Jul 2020 B2
10729421 Stone et al. Aug 2020 B2
10729423 Kaiser et al. Aug 2020 B2
10729430 Denham et al. Aug 2020 B2
10743925 Stone et al. Aug 2020 B2
10758221 Berelsman et al. Sep 2020 B2
10835232 Stone et al. Nov 2020 B2
10932770 Stone et al. Mar 2021 B2
10973507 Stone et al. Apr 2021 B2
10987099 Stone et al. Apr 2021 B2
11039826 Denham et al. Jun 2021 B2
11065103 Berelsman et al. Jul 2021 B2
11096684 Stone et al. Aug 2021 B2
11109857 Stone et al. Sep 2021 B2
11116495 Stone et al. Sep 2021 B2
11185320 Kaiser Nov 2021 B2
11241305 Denham et al. Feb 2022 B2
11259792 Denham et al. Mar 2022 B2
11259794 Stone et al. Mar 2022 B2
11284884 Denham et al. Mar 2022 B2
20010002439 Bonutti et al. May 2001 A1
20010010005 Kammerer et al. Jul 2001 A1
20010014825 Burke et al. Aug 2001 A1
20010019649 Field et al. Sep 2001 A1
20010027341 Gianotti Oct 2001 A1
20010029387 Wolf et al. Oct 2001 A1
20010037131 Schmieding et al. Nov 2001 A1
20010037153 Charles, Jr. et al. Nov 2001 A1
20010041916 Bonutti Nov 2001 A1
20010041937 Rieser et al. Nov 2001 A1
20010041938 Hein Nov 2001 A1
20010044627 Justin Nov 2001 A1
20010044639 Levinson Nov 2001 A1
20010047206 Sklar et al. Nov 2001 A1
20010051815 Esplin Dec 2001 A1
20010051816 Enzerink et al. Dec 2001 A1
20010053934 Schmieding Dec 2001 A1
20010056299 Thompson Dec 2001 A1
20020001964 Choi Jan 2002 A1
20020004669 Bartlett Jan 2002 A1
20020007182 Kim Jan 2002 A1
20020010513 Schmieding Jan 2002 A1
20020013607 Lemer Jan 2002 A1
20020013608 Elattrache et al. Jan 2002 A1
20020019649 Sikora et al. Feb 2002 A1
20020029048 Miller Mar 2002 A1
20020029066 Foerster Mar 2002 A1
20020032465 Lerner Mar 2002 A1
20020045902 Bonutti Apr 2002 A1
20020052628 Bowman May 2002 A1
20020055780 Sklar May 2002 A1
20020058966 Tormala et al. May 2002 A1
20020068254 Campbell Jun 2002 A1
20020077629 Hoffman et al. Jun 2002 A1
20020077659 Johnson et al. Jun 2002 A1
20020082220 Hoemann et al. Jun 2002 A1
20020091391 Cole et al. Jul 2002 A1
20020099411 Bartlett Jul 2002 A1
20020111591 Mckinnon et al. Aug 2002 A1
20020111653 Foerster Aug 2002 A1
20020120270 Trieu et al. Aug 2002 A1
20020120292 Morgan Aug 2002 A1
20020123752 Schultheiss et al. Sep 2002 A1
20020128654 Steger et al. Sep 2002 A1
20020128684 Foerster Sep 2002 A1
20020129820 Ryan et al. Sep 2002 A1
20020143336 Hearn Oct 2002 A1
20020147463 Martinek Oct 2002 A1
20020156475 Lerch et al. Oct 2002 A1
20020161401 Steiner Oct 2002 A1
20020161439 Strobel et al. Oct 2002 A1
20020165548 Jutley Nov 2002 A1
20020165611 Enzerink et al. Nov 2002 A1
20020169452 Tormala et al. Nov 2002 A1
20020169477 Demopulos et al. Nov 2002 A1
20020169478 Schwartz et al. Nov 2002 A1
20020173788 Bojarski et al. Nov 2002 A1
20020177853 Chervitz et al. Nov 2002 A1
20020188298 Chan Dec 2002 A1
20020193830 Bonutti Dec 2002 A1
20030004545 Burkhart et al. Jan 2003 A1
20030009235 Manrique et al. Jan 2003 A1
20030023268 Lizardi Jan 2003 A1
20030032961 Pelo et al. Feb 2003 A1
20030033021 Plouhar et al. Feb 2003 A1
20030033022 Plouhar et al. Feb 2003 A1
20030036797 Malaviya et al. Feb 2003 A1
20030036801 Schwartz et al. Feb 2003 A1
20030050667 Grafton et al. Mar 2003 A1
20030065361 Dreyfuss Apr 2003 A1
20030065391 Re et al. Apr 2003 A1
20030065402 Anderson et al. Apr 2003 A1
20030078585 Johnson et al. Apr 2003 A1
20030078603 Schaller et al. Apr 2003 A1
20030078617 Schwartz et al. Apr 2003 A1
20030083662 Middleton May 2003 A1
20030083694 Archibald, III May 2003 A1
20030088251 Braun et al. May 2003 A1
20030088272 Smith May 2003 A1
20030093156 Metzger et al. May 2003 A1
20030105477 Schwartz et al. Jun 2003 A1
20030105489 Eichhorn et al. Jun 2003 A1
20030114929 Knudsen Jun 2003 A1
20030120309 Colleran et al. Jun 2003 A1
20030130670 Anderson et al. Jul 2003 A1
20030130694 Bojarski et al. Jul 2003 A1
20030130695 Mcdevitt et al. Jul 2003 A1
20030135214 Fetto Jul 2003 A1
20030135239 Gabriel et al. Jul 2003 A1
20030135265 Stinson Jul 2003 A1
20030135963 Holbrook et al. Jul 2003 A1
20030139752 Pasricha et al. Jul 2003 A1
20030139775 Grafton Jul 2003 A1
20030149448 Foerster et al. Aug 2003 A1
20030152522 Miller et al. Aug 2003 A1
20030153947 Koseki Aug 2003 A1
20030167072 Oberlander Sep 2003 A1
20030167090 Chervitz et al. Sep 2003 A1
20030171811 Steiner et al. Sep 2003 A1
20030176865 Supinski Sep 2003 A1
20030176919 Schmieding Sep 2003 A1
20030176920 Sklar et al. Sep 2003 A1
20030181925 Bain et al. Sep 2003 A1
20030018751 Hyde Oct 2003 A1
20030195528 Ritchart Oct 2003 A1
20030195564 Tran et al. Oct 2003 A1
20030195565 Bonutti Oct 2003 A1
20030020821 Dreyfuss et al. Nov 2003 A1
20030208209 Gambale et al. Nov 2003 A1
20030212456 Lipchitz et al. Nov 2003 A1
20030216809 Ferguson Nov 2003 A1
20030220646 Thelen et al. Nov 2003 A1
20030220660 Kortenbach et al. Nov 2003 A1
20030225459 Hammer et al. Dec 2003 A1
20030229361 Jackson Dec 2003 A1
20030229396 Andrews Dec 2003 A1
20030236555 Thornes Dec 2003 A1
20040002734 Fallin et al. Jan 2004 A1
20040006345 Vlahos et al. Jan 2004 A1
20040006346 Holmen et al. Jan 2004 A1
20040013380 Jimenez Jan 2004 A1
20040015171 Bojarski et al. Jan 2004 A1
20040015172 Biedermann et al. Jan 2004 A1
20040024456 Charles, Jr. et al. Feb 2004 A1
20040024457 Boyce et al. Feb 2004 A1
20040039389 Hugh, Jr. et al. Feb 2004 A1
20040044351 Searle Mar 2004 A1
20040044391 Porter Mar 2004 A1
20040059357 Koseki Mar 2004 A1
20040073176 Utterberg Apr 2004 A1
20040087981 Berube et al. May 2004 A1
20040092936 Miller et al. May 2004 A1
20040093031 Burkhart et al. May 2004 A1
20040093032 Sinnott et al. May 2004 A1
20040098051 Fallin et al. May 2004 A1
20040098053 Tran May 2004 A1
20040098099 McCullagh et al. May 2004 A1
20040111117 Colleran et al. Jun 2004 A1
20040122431 Biedermann et al. Jun 2004 A1
20040122454 Wang et al. Jun 2004 A1
20040127907 Dakin et al. Jul 2004 A1
20040133206 Stevens et al. Jul 2004 A1
20040133211 Raskin et al. Jul 2004 A1
20040133238 Cerier Jul 2004 A1
20040133239 Singhatat Jul 2004 A1
20040138664 Bowman Jul 2004 A1
20040138683 Shelton et al. Jul 2004 A1
20040138704 Gambale et al. Jul 2004 A1
20040138706 Abrams et al. Jul 2004 A1
20040138747 Kaladelfos Jul 2004 A1
20040138755 O'Connor et al. Jul 2004 A1
20040143344 Malaviya et al. Jul 2004 A1
20040144535 Kalman et al. Jul 2004 A1
20040147932 Burkinshaw et al. Jul 2004 A1
20040147958 Lam et al. Jul 2004 A1
20040148030 Ek Jul 2004 A1
20040153103 Schwartz et al. Aug 2004 A1
20040153153 Elson et al. Aug 2004 A1
20040162579 Foerster Aug 2004 A1
20040166169 Malaviya et al. Aug 2004 A1
20040181234 Mcdevitt et al. Sep 2004 A1
20040182968 Gentry Sep 2004 A1
20040187314 Johnson Sep 2004 A1
20040193185 Mcbrayer Sep 2004 A1
20040199169 Koons et al. Oct 2004 A1
20040204722 Sikora et al. Oct 2004 A1
20040220574 Pelo et al. Nov 2004 A1
20040225183 Michlitsch et al. Nov 2004 A1
20040225292 Sasso et al. Nov 2004 A1
20040225305 Ewers et al. Nov 2004 A1
20040230302 May et al. Nov 2004 A1
20040236353 Bain et al. Nov 2004 A1
20040236373 William, III Nov 2004 A1
20040243139 Lewis et al. Dec 2004 A1
20040243178 Haut et al. Dec 2004 A1
20040243180 Donnelly et al. Dec 2004 A1
20040243235 Goh et al. Dec 2004 A1
20040249394 Morris et al. Dec 2004 A1
20040260296 Kaiser et al. Dec 2004 A1
20040260298 Kaiser et al. Dec 2004 A1
20040267164 Rhodes et al. Dec 2004 A1
20040267265 Kyle Dec 2004 A1
20040267270 Jacobs et al. Dec 2004 A1
20040267276 Camino et al. Dec 2004 A1
20040267277 Zannis et al. Dec 2004 A1
20040267286 Gao et al. Dec 2004 A1
20040267304 Zannis et al. Dec 2004 A1
20040267309 Garvin Dec 2004 A1
20040267317 Higgins et al. Dec 2004 A1
20040267361 Donnelly et al. Dec 2004 A1
20040267362 Hwang et al. Dec 2004 A1
20050004670 Gebhardt et al. Jan 2005 A1
20050021087 Koseki Jan 2005 A1
20050021148 Gibbs Jan 2005 A1
20050027307 Schwartz et al. Feb 2005 A1
20050033289 Warren et al. Feb 2005 A1
20050033362 Grafton Feb 2005 A1
20050033363 Bojarski et al. Feb 2005 A1
20050038426 Chan Feb 2005 A1
20050049598 West, Jr. et al. Mar 2005 A1
20050055027 Yeung et al. Mar 2005 A1
20050055037 Fathauer, Jr. Mar 2005 A1
20050064042 Vunjak-novakovic et al. Mar 2005 A1
20050065521 Steger et al. Mar 2005 A1
20050065526 Drew et al. Mar 2005 A1
20050070906 Clark et al. Mar 2005 A1
20050070928 Heino et al. Mar 2005 A1
20050074495 Schwartz et al. Apr 2005 A1
20050076478 Miyazaki et al. Apr 2005 A1
20050085819 Ellis et al. Apr 2005 A1
20050090827 Gedebou Apr 2005 A1
20050090828 Alford Apr 2005 A1
20050090862 Mcdevitt et al. Apr 2005 A1
20050096696 Forsberg May 2005 A1
20050096697 Forsberg et al. May 2005 A1
20050096743 Schmieding et al. May 2005 A1
20050101957 Buskirk et al. May 2005 A1
20050107795 Morris et al. May 2005 A1
20050107828 Reese May 2005 A1
20050107882 Stone et al. May 2005 A1
20050119531 Sharratt Jun 2005 A1
20050119696 Walters et al. Jun 2005 A1
20050124996 Hearn Jun 2005 A1
20050125031 Pipenhagen et al. Jun 2005 A1
20050125036 Roby Jun 2005 A1
20050125073 Orban et al. Jun 2005 A1
20050130301 Mckay et al. Jun 2005 A1
20050131413 O'driscoll et al. Jun 2005 A1
20050137600 Jacobs et al. Jun 2005 A1
20050137624 Fallman Jun 2005 A1
20050143734 Cachia et al. Jun 2005 A1
20050149033 Mcguire et al. Jul 2005 A1
20050149118 Koyfman et al. Jul 2005 A1
20050149119 Koyfman et al. Jul 2005 A1
20050149122 Mcdevitt et al. Jul 2005 A1
20050149187 Clark et al. Jul 2005 A1
20050154471 Aram et al. Jul 2005 A1
20050159812 Dinger, III et al. Jul 2005 A1
20050160656 Safwat et al. Jul 2005 A1
20050165416 Bojarski et al. Jul 2005 A1
20050165482 Goldhahn et al. Jul 2005 A1
20050171547 Aram Aug 2005 A1
20050171603 Justin et al. Aug 2005 A1
20050171604 Michalow Aug 2005 A1
20050177237 Shappley et al. Aug 2005 A1
20050187565 Baker et al. Aug 2005 A1
20050187577 Selvitelli et al. Aug 2005 A1
20050187635 Metzger Aug 2005 A1
20050192581 Molz et al. Sep 2005 A1
20050192632 Geissler et al. Sep 2005 A1
20050197711 Cachia Sep 2005 A1
20050203620 Steiner et al. Sep 2005 A1
20050209703 Fell Sep 2005 A1
20050222618 Dreyfuss et al. Oct 2005 A1
20050222619 Dreyfuss et al. Oct 2005 A1
20050228448 Li Oct 2005 A1
20050229433 Cachia Oct 2005 A1
20050234549 Kladakis et al. Oct 2005 A1
20050240198 Albertson et al. Oct 2005 A1
20050025121 Westra et al. Nov 2005 A1
20050251153 Sakamoto et al. Nov 2005 A1
20050251159 Ewers et al. Nov 2005 A1
20050251177 Saadat et al. Nov 2005 A1
20050251207 Flores et al. Nov 2005 A1
20050251208 Elmer et al. Nov 2005 A1
20050251209 Saadat et al. Nov 2005 A1
20050261642 Weston Nov 2005 A1
20050267479 Morgan et al. Dec 2005 A1
20050267533 Gertner Dec 2005 A1
20050277088 Fischer et al. Dec 2005 A1
20050277939 Miller, III Dec 2005 A1
20050277961 Stone et al. Dec 2005 A1
20050277985 Wert et al. Dec 2005 A1
20050283040 Greenhalgh Dec 2005 A1
20050283156 Schmieding et al. Dec 2005 A1
20050283158 West, Jr. Dec 2005 A1
20050283192 Torrie et al. Dec 2005 A1
20050283220 Gobran et al. Dec 2005 A1
20050288710 Fallin et al. Dec 2005 A1
20060000441 Nobis et al. Jan 2006 A1
20060004364 Green et al. Jan 2006 A1
20060004460 Engh et al. Jan 2006 A1
20060015103 Burke Jan 2006 A1
20060015106 Lerch et al. Jan 2006 A1
20060015107 Sklar Jan 2006 A1
20060030884 Yeung et al. Feb 2006 A1
20060030948 Manrique et al. Feb 2006 A1
20060036265 Dant et al. Feb 2006 A1
20060052787 Re et al. Mar 2006 A1
20060052818 Drake et al. Mar 2006 A1
20060064125 Henderson et al. Mar 2006 A1
20060064126 Fallin et al. Mar 2006 A1
20060069334 Moskowitz Mar 2006 A1
20060079904 Thal Apr 2006 A1
20060084943 Rosenman et al. Apr 2006 A1
20060085000 Mohr et al. Apr 2006 A1
20060089525 Mamo et al. Apr 2006 A1
20060089672 Martinek Apr 2006 A1
20060095130 Caborn et al. May 2006 A1
20060095131 Justin et al. May 2006 A1
20060100627 Stone et al. May 2006 A1
20060100637 Rathbun et al. May 2006 A1
20060106423 Weisel et al. May 2006 A1
20060111721 Puricelli May 2006 A1
20060116685 Urbanski et al. Jun 2006 A1
20060121084 Borden et al. Jun 2006 A1
20060122608 Fallin et al. Jun 2006 A1
20060122611 Morales et al. Jun 2006 A1
20060135958 Marissen et al. Jun 2006 A1
20060149258 Sousa Jul 2006 A1
20060149266 Cordasco Jul 2006 A1
20060155287 Montgomery et al. Jul 2006 A1
20060155328 Foerster Jul 2006 A1
20060161161 Shifrin et al. Jul 2006 A1
20060167458 Gabele Jul 2006 A1
20060167481 Baker et al. Jul 2006 A1
20060167482 Swain et al. Jul 2006 A1
20060173492 Akerfeldt et al. Aug 2006 A1
20060178680 Nelson et al. Aug 2006 A1
20060178701 Schmieding Aug 2006 A1
20060178743 Carter Aug 2006 A1
20060189993 Stone Aug 2006 A1
20060190041 Fallin et al. Aug 2006 A1
20060190042 Stone et al. Aug 2006 A1
20060195101 Stevens Aug 2006 A1
20060195106 Jones et al. Aug 2006 A1
20060200235 Bianchi et al. Sep 2006 A1
20060212055 Karabey et al. Sep 2006 A1
20060229623 Bonutti et al. Oct 2006 A1
20060229671 Steiner et al. Oct 2006 A1
20060229676 Doll et al. Oct 2006 A1
20060235407 Wang et al. Oct 2006 A1
20060235413 Denham et al. Oct 2006 A1
20060241624 Kizuka et al. Oct 2006 A1
20060241776 Brown et al. Oct 2006 A1
20060241781 Brown et al. Oct 2006 A1
20060247642 Stone et al. Nov 2006 A1
20060253130 Wolniewicz Nov 2006 A1
20060259048 Koseki Nov 2006 A1
20060259076 Burkhart Nov 2006 A1
20060264944 Cole Nov 2006 A1
20060271192 Olsen et al. Nov 2006 A1
20060276793 Berry Dec 2006 A1
20060276809 Oliveira Dec 2006 A1
20060276818 Buser et al. Dec 2006 A1
20060276841 Barbieri et al. Dec 2006 A1
20060276896 Fallin et al. Dec 2006 A1
20060280768 Hwang et al. Dec 2006 A1
20060280803 Kumar et al. Dec 2006 A1
20060282082 Fanton et al. Dec 2006 A1
20060282083 Fanton et al. Dec 2006 A1
20060282085 Stone Dec 2006 A1
20060293709 Bojarski et al. Dec 2006 A1
20070005068 Sklar Jan 2007 A1
20070005080 Wolniewicz, III et al. Jan 2007 A1
20070010857 Sugimoto et al. Jan 2007 A1
20070016305 Chudik Jan 2007 A1
20070021779 Garvin et al. Jan 2007 A1
20070027476 Harris et al. Feb 2007 A1
20070032800 Ortiz et al. Feb 2007 A1
20070032823 Tegg Feb 2007 A1
20070038218 Grevious Feb 2007 A1
20070043371 Teague Feb 2007 A1
20070055249 Jensen et al. Mar 2007 A1
20070055251 Huebner et al. Mar 2007 A1
20070055255 Siegel Mar 2007 A1
20070060922 Dreyfuss Mar 2007 A1
20070067025 Schwartz Mar 2007 A1
20070071568 Dorstewitz Mar 2007 A1
20070073307 Scribner et al. Mar 2007 A1
20070073319 Mikkaichi et al. Mar 2007 A1
20070073322 Mikkaichi et al. Mar 2007 A1
20070078435 Stone et al. Apr 2007 A1
20070078517 Engh et al. Apr 2007 A1
20070083236 Sikora et al. Apr 2007 A1
20070088362 Bonutti et al. Apr 2007 A1
20070093847 Scribner et al. Apr 2007 A1
20070100350 Deffenbaugh et al. May 2007 A1
20070112384 Conlon et al. May 2007 A1
20070118217 Brulez et al. May 2007 A1
20070123883 Ellis et al. May 2007 A1
20070123984 Hodorek May 2007 A1
20070129809 Meridew et al. Jun 2007 A1
20070135843 Burkhart Jun 2007 A1
20070142838 Jordan Jun 2007 A1
20070156174 Kaiser et al. Jul 2007 A1
20070162018 Jensen et al. Jul 2007 A1
20070162120 Bouffier Jul 2007 A1
20070167926 Blott et al. Jul 2007 A1
20070167950 Tauro et al. Jul 2007 A1
20070173948 Meridew et al. Jul 2007 A1
20070185488 Pohjonen et al. Aug 2007 A1
20070185532 Stone et al. Aug 2007 A1
20070185568 Schwartz Aug 2007 A1
20070191849 Elattrache et al. Aug 2007 A1
20070191853 Stone Aug 2007 A1
20070198022 Lang et al. Aug 2007 A1
20070198036 Sklar et al. Aug 2007 A1
20070219558 Deutsch Sep 2007 A1
20070225715 Deffenbaugh et al. Sep 2007 A1
20070225719 Stone et al. Sep 2007 A1
20070225763 Zwolinski et al. Sep 2007 A1
20070225805 Schmieding Sep 2007 A1
20070233241 Graf et al. Oct 2007 A1
20070239209 Fallman Oct 2007 A1
20070239275 Willobee Oct 2007 A1
20070244565 Stchur Oct 2007 A1
20070250059 Weisshaupt et al. Oct 2007 A1
20070250163 Cassani Oct 2007 A1
20070250175 Meridew et al. Oct 2007 A1
20070255282 Simonton et al. Nov 2007 A1
20070260251 Weier et al. Nov 2007 A1
20070260279 Hotter et al. Nov 2007 A1
20070265704 Mayer et al. Nov 2007 A1
20070270856 Morales et al. Nov 2007 A1
20070270878 Leisinger Nov 2007 A1
20070276387 Morales et al. Nov 2007 A1
20070288023 Pellegrino et al. Dec 2007 A1
20080009904 Bourque et al. Jan 2008 A1
20080027430 Montgomery et al. Jan 2008 A1
20080027440 Marissen et al. Jan 2008 A1
20080027446 Stone et al. Jan 2008 A1
20080033549 Marshall et al. Feb 2008 A1
20080046009 Albertorio et al. Feb 2008 A1
20080051834 Mazzocca et al. Feb 2008 A1
20080051836 Foerster et al. Feb 2008 A1
20080058787 Gertner Mar 2008 A1
20080065114 Stone et al. Mar 2008 A1
20080071299 Allinniemi et al. Mar 2008 A1
20080082101 Reisberg Apr 2008 A1
20080082127 Stone et al. Apr 2008 A1
20080082128 Stone Apr 2008 A1
20080086138 Stone et al. Apr 2008 A1
20080097430 Bernstein et al. Apr 2008 A1
20080103528 Zirps et al. May 2008 A1
20080114460 Willobee et al. May 2008 A1
20080119892 Brailovski et al. May 2008 A1
20080132753 Goddard Jun 2008 A1
20080132932 Hoeppner et al. Jun 2008 A1
20080132948 Surti et al. Jun 2008 A1
20080133007 Donnelly et al. Jun 2008 A1
20080137624 Silverstrim et al. Jun 2008 A1
20080140092 Stone et al. Jun 2008 A1
20080140093 Stone et al. Jun 2008 A1
20080140128 Smisson et al. Jun 2008 A1
20080147127 Tipirneni et al. Jun 2008 A1
20080147187 Bollinger et al. Jun 2008 A1
20080154260 Hoof Jun 2008 A1
20080154314 Mcdevitt Jun 2008 A1
20080161806 Donnelly et al. Jul 2008 A1
20080161852 Kaiser et al. Jul 2008 A1
20080161861 Huebner Jul 2008 A1
20080161864 Beck et al. Jul 2008 A1
20080166421 Buhr et al. Jul 2008 A1
20080172097 Lerch et al. Jul 2008 A1
20080177302 Shurnas Jul 2008 A1
20080183290 Baird et al. Jul 2008 A1
20080188933 Koob et al. Aug 2008 A1
20080188935 Saylor et al. Aug 2008 A1
20080188936 Ball et al. Aug 2008 A1
20080208252 Holmes Aug 2008 A1
20080217263 Higgins et al. Sep 2008 A1
20080221527 Bradley et al. Sep 2008 A1
20080221578 Zeitani Sep 2008 A1
20080228186 Gall et al. Sep 2008 A1
20080228271 Stone et al. Sep 2008 A1
20080234730 Cotton et al. Sep 2008 A1
20080243260 Lee et al. Oct 2008 A1
20080243261 Wyss et al. Oct 2008 A1
20080243262 Lee Oct 2008 A1
20080255613 Kaiser et al. Oct 2008 A1
20080257363 Schoenefeld et al. Oct 2008 A1
20080262544 Burkhart Oct 2008 A1
20080268064 Woodell-may Oct 2008 A1
20080269674 Stone Oct 2008 A1
20080275469 Fanton et al. Nov 2008 A1
20080275477 Sterrett et al. Nov 2008 A1
20080281428 Meyers et al. Nov 2008 A1
20080288070 Lo Nov 2008 A1
20080300611 Houser et al. Dec 2008 A1
20080312689 Denham et al. Dec 2008 A1
20080319478 Foerster et al. Dec 2008 A1
20090018589 Smisson, III et al. Jan 2009 A1
20090018654 Schmieding et al. Jan 2009 A1
20090018655 Brunelle et al. Jan 2009 A1
20090043342 Freedland Feb 2009 A1
20090054928 Denham et al. Feb 2009 A1
20090062847 Ken Mar 2009 A1
20090062854 Kaiser et al. Mar 2009 A1
20090082790 Shad et al. Mar 2009 A1
20090082805 Kaiser et al. Mar 2009 A1
20090084491 Uthgenannt et al. Apr 2009 A1
20090099598 Mcdevitt et al. Apr 2009 A1
20090105717 Bluechel Apr 2009 A1
20090105754 Sethi Apr 2009 A1
20090118774 Miller, III May 2009 A1
20090118775 Burke May 2009 A1
20090125073 Rehm May 2009 A1
20090138002 Fenton May 2009 A1
20090138054 Teaguex et al. May 2009 A1
20090156997 Trenhaile Jun 2009 A1
20090163949 Rolnick et al. Jun 2009 A1
20090177233 Malek Jul 2009 A1
20090182335 Struhl Jul 2009 A1
20090192468 Stone Jul 2009 A1
20090198277 Gordon et al. Aug 2009 A1
20090204146 Kaiser et al. Aug 2009 A1
20090216325 May et al. Aug 2009 A1
20090228015 Ellis Sep 2009 A1
20090228042 Koogle, Jr. et al. Sep 2009 A1
20090234357 Morales et al. Sep 2009 A1
20090234358 Morales et al. Sep 2009 A1
20090234451 Manderson Sep 2009 A1
20090240251 Gabele Sep 2009 A1
20090240335 Arcenio et al. Sep 2009 A1
20090241497 Imai et al. Oct 2009 A1
20090248091 Teague et al. Oct 2009 A1
20090254089 Tipirneni et al. Oct 2009 A1
20090265014 May et al. Oct 2009 A1
20090265015 May et al. Oct 2009 A1
20090287215 Fisher et al. Nov 2009 A1
20090299409 Coe et al. Dec 2009 A1
20090306711 Stone et al. Dec 2009 A1
20090312776 Kaiser et al. Dec 2009 A1
20090312793 Huxel et al. Dec 2009 A1
20090318960 Burkhart Dec 2009 A1
20090318961 Stone et al. Dec 2009 A1
20090318965 Burkhart Dec 2009 A1
20100016891 Kennedy et al. Jan 2010 A1
20100016899 Gelfand Jan 2010 A1
20100030321 Mach Feb 2010 A1
20100042114 Schaffhausen et al. Feb 2010 A1
20100063540 Maiorino Mar 2010 A1
20100063541 Brunelle et al. Mar 2010 A1
20100087857 Stone et al. Apr 2010 A1
20100094341 Raju Apr 2010 A1
20100094355 Trenhaile Apr 2010 A1
20100106254 Delsignore Apr 2010 A1
20100121348 Van Der Burg et al. May 2010 A1
20100145384 Stone et al. Jun 2010 A1
20100152752 Denove et al. Jun 2010 A1
20100191319 Lilburn et al. Jul 2010 A1
20100191342 Byrd et al. Jul 2010 A1
20100204700 Falahee Aug 2010 A1
20100211071 Lettmann et al. Aug 2010 A1
20100211075 Stone Aug 2010 A1
20100256677 Albertorio et al. Oct 2010 A1
20100268273 Albertorio et al. Oct 2010 A1
20100268275 Stone et al. Oct 2010 A1
20100270306 Shiffer Oct 2010 A1
20100274282 Olson Oct 2010 A1
20100292792 Stone et al. Nov 2010 A1
20100298872 Berndt et al. Nov 2010 A1
20100298952 Busold et al. Nov 2010 A1
20100030571 Metzger Dec 2010 A1
20100305698 Metzger et al. Dec 2010 A1
20100305709 Metzger et al. Dec 2010 A1
20100312245 Tipirneni et al. Dec 2010 A1
20100312341 Kaiser et al. Dec 2010 A1
20100324676 Albertorio Dec 2010 A1
20100331881 Hart Dec 2010 A1
20110009885 Graf et al. Jan 2011 A1
20110022083 Dimatteo et al. Jan 2011 A1
20110026141 Barrows Feb 2011 A1
20110040387 Ries et al. Feb 2011 A1
20110046733 Eggli Feb 2011 A1
20110087225 Fritzinger Apr 2011 A1
20110087280 Albertorio Apr 2011 A1
20110087284 Stone et al. Apr 2011 A1
20110098727 Kaiser et al. Apr 2011 A1
20110106153 Stone et al. May 2011 A1
20110112537 Bernstein et al. May 2011 A1
20110112538 Dell'oca May 2011 A1
20110124954 Ogdahl et al. May 2011 A1
20110125153 Tyber et al. May 2011 A1
20110160767 Stone et al. Jun 2011 A1
20110160768 Stone et al. Jun 2011 A1
20110166608 Duggal et al. Jul 2011 A1
20110184227 Altman et al. Jul 2011 A1
20110208239 Stone et al. Aug 2011 A1
20110208240 Stone et al. Aug 2011 A1
20110213367 Tyber et al. Sep 2011 A1
20110213416 Kaiser Sep 2011 A1
20110218625 Berelsman et al. Sep 2011 A1
20110224799 Stone Sep 2011 A1
20110245868 Teeslink et al. Oct 2011 A1
20110264141 Denham et al. Oct 2011 A1
20110270278 Overes et al. Nov 2011 A1
20110270306 Denham et al. Nov 2011 A1
20110295284 Purdue et al. Dec 2011 A1
20110319932 Avelar et al. Dec 2011 A1
20120004669 Overes et al. Jan 2012 A1
20120024134 Dow et al. Feb 2012 A1
20120029561 Olson Feb 2012 A1
20120041485 Kaiser et al. Feb 2012 A1
20120041486 Stone et al. Feb 2012 A1
20120041496 Walker Feb 2012 A1
20120042768 Chou et al. Feb 2012 A1
20120046693 Denham et al. Feb 2012 A1
20120053630 Denham et al. Mar 2012 A1
20120059417 Norton et al. Mar 2012 A1
20120059418 Denham et al. Mar 2012 A1
20120059468 Mattern et al. Mar 2012 A1
20120060278 Mccurdy Mar 2012 A1
20120083837 Ferragamo et al. Apr 2012 A1
20120089193 Stone et al. Apr 2012 A1
20120095470 Kaiser et al. Apr 2012 A1
20120109156 Overes et al. May 2012 A1
20120116409 Stone May 2012 A1
20120116450 Mcdevitt et al. May 2012 A1
20120116452 Stone et al. May 2012 A1
20120123447 Corrao et al. May 2012 A1
20120123474 Zajac et al. May 2012 A1
20120123541 Albertorio et al. May 2012 A1
20120130423 Sengun et al. May 2012 A1
20120130492 Eggli et al. May 2012 A1
20120143215 Corrao et al. Jun 2012 A1
20120150223 Manos et al. Jun 2012 A1
20120150297 Denham et al. Jun 2012 A1
20120165864 Hernandez et al. Jun 2012 A1
20120165866 Kaiser et al. Jun 2012 A1
20120165867 Denham et al. Jun 2012 A1
20120165938 Denham et al. Jun 2012 A1
20120192455 Hansen et al. Aug 2012 A1
20120197271 Astorino et al. Aug 2012 A1
20120215257 Mcdevitt et al. Aug 2012 A1
20120239159 Metzger et al. Sep 2012 A1
20120245585 Kaiser et al. Sep 2012 A1
20120265219 Rushdy et al. Oct 2012 A1
20120265294 Nishigishi Oct 2012 A1
20120271403 Gries Oct 2012 A1
20120273085 David et al. Nov 2012 A1
20120290002 Astorino Nov 2012 A1
20120290003 Dreyfuss Nov 2012 A1
20120290004 Lombardo et al. Nov 2012 A1
20120296427 Conner et al. Nov 2012 A1
20120310245 Hoeppner et al. Dec 2012 A1
20130018375 Dell'Oca Jan 2013 A1
20130018416 Lombardo et al. Jan 2013 A1
20130023928 Dreyfuss Jan 2013 A1
20130023929 Sullivan et al. Jan 2013 A1
20130023930 Stone et al. Jan 2013 A1
20130035698 Stone Feb 2013 A1
20130035722 Mcdevitt et al. Feb 2013 A1
20130046341 Stone et al. Feb 2013 A1
20130060323 Mchugo Mar 2013 A1
20130090720 Mahr et al. Apr 2013 A1
20130090731 Walker Apr 2013 A1
20130103082 Kaiser et al. Apr 2013 A1
20130012381 Brown et al. May 2013 A1
20130110165 Burkhart et al. May 2013 A1
20130110251 Metzger et al. May 2013 A1
20130116730 Denham May 2013 A1
20130123813 Stone et al. May 2013 A1
20130131722 Marchand et al. May 2013 A1
20130138123 Stone et al. May 2013 A1
20130144337 Stone et al. Jun 2013 A1
20130144338 Stone et al. Jun 2013 A1
20130158599 Hester et al. Jun 2013 A1
20130158601 Stone et al. Jun 2013 A1
20130172942 Lewis et al. Jul 2013 A1
20130190818 Norton Jul 2013 A1
20130190819 Norton Jul 2013 A1
20130204276 Stone et al. Aug 2013 A1
20130211452 Stone et al. Aug 2013 A1
20130231700 Gedet et al. Sep 2013 A1
20130237997 Arai et al. Sep 2013 A1
20130245761 Conner et al. Sep 2013 A1
20130267956 Terrill et al. Oct 2013 A1
20130274812 Dell'oca Oct 2013 A1
20130289564 Bernstein et al. Oct 2013 A1
20130317621 Metzger et al. Nov 2013 A1
20130331742 Aupperle et al. Dec 2013 A1
20130331848 Kaiser et al. Dec 2013 A1
20140005754 Finley et al. Jan 2014 A1
20140018804 Foerster Jan 2014 A1
20140046367 Stone et al. Feb 2014 A1
20140046368 Kaiser et al. Feb 2014 A1
20140052179 Dreyfuss et al. Feb 2014 A1
20140058436 Rosenbluth et al. Feb 2014 A1
20140067081 Stone Mar 2014 A1
20140081322 Sengun et al. Mar 2014 A1
20140088655 Stone et al. Mar 2014 A1
20140094913 Berelsman et al. Apr 2014 A1
20140128985 Sanders et al. May 2014 A1
20140135835 Stone et al. May 2014 A1
20140163613 Stone et al. Jun 2014 A1
20140163614 Denham et al. Jun 2014 A1
20140194927 Kaiser et al. Jul 2014 A1
20140200583 Stone et al. Jul 2014 A1
20140257378 Norton et al. Sep 2014 A1
20140276992 Stone et al. Sep 2014 A1
20140277447 Berelsman et al. Sep 2014 A1
20140324101 Denham et al. Oct 2014 A1
20140330311 Denham et al. Nov 2014 A1
20140336760 Eggli Nov 2014 A1
20140350674 Stone et al. Nov 2014 A1
20150012094 Denham et al. Jan 2015 A1
20150032216 Metzger et al. Jan 2015 A1
20150057665 Neal et al. Feb 2015 A1
20150057757 Metzger et al. Feb 2015 A1
20150066081 Martin Mar 2015 A1
20150119890 Kaiser et al. Apr 2015 A1
20150127051 Kaiser et al. May 2015 A1
20150128792 Zachariades et al. May 2015 A1
20150134000 Denham et al. May 2015 A1
20150143981 Dunker May 2015 A1
20150148888 Milner et al. May 2015 A1
20150173753 Spivey et al. Jun 2015 A1
20150173887 Berelsman et al. Jun 2015 A1
20150257750 Kaiser et al. Sep 2015 A1
20150320026 Toddes Nov 2015 A1
20160000483 Stone Jan 2016 A1
20160022261 Stone et al. Jan 2016 A1
20160038187 Mcdonnell Feb 2016 A1
20160058436 Stone et al. Mar 2016 A1
20160058484 Mccombs-stearnes et al. Mar 2016 A1
20160074049 Russell et al. Mar 2016 A1
20160081789 Denham et al. Mar 2016 A1
20160106414 Stone et al. Apr 2016 A1
20160128684 Stone et al. May 2016 A1
20160183935 Stone Jun 2016 A1
20160199053 Norton et al. Jul 2016 A1
20160213369 Stone et al. Jul 2016 A1
20160242760 Kaiser et al. Aug 2016 A1
20170014225 Denham et al. Jan 2017 A1
20170020507 Denham et al. Jan 2017 A1
20170020569 Grant Jan 2017 A1
20170035411 Kaiser et al. Feb 2017 A1
20170049557 Denham et al. Feb 2017 A1
20170065278 Stone Mar 2017 A1
20170071593 Stone Mar 2017 A1
20170071595 Stone et al. Mar 2017 A1
20170086816 Norton Mar 2017 A1
20170119382 Denham et al. May 2017 A1
20170128061 Stone et al. May 2017 A1
20170181746 Denham et al. Jun 2017 A1
20170189011 Stone et al. Jul 2017 A1
20170189197 Werber et al. Jul 2017 A1
20170202587 Stone et al. Jul 2017 A1
20170273686 Denham et al. Sep 2017 A1
20170311947 Kaiser et al. Nov 2017 A1
20170319194 Mayeski et al. Nov 2017 A1
20170319195 Denham et al. Nov 2017 A1
20170319204 Norton et al. Nov 2017 A1
20170325808 Stone et al. Nov 2017 A1
20170333176 Stone et al. Nov 2017 A1
20170360425 Stone et al. Dec 2017 A1
20180000477 Kaiser et al. Jan 2018 A1
20180014864 Stone et al. Jan 2018 A1
20180020762 Jamison Jan 2018 A1
20180021036 Kaiser et al. Jan 2018 A1
20180021125 Berelsman et al. Jan 2018 A1
20180042609 Denham et al. Feb 2018 A1
20180098858 Valderrabano et al. Apr 2018 A1
20180125476 Kaiser et al. May 2018 A1
20180125477 Stone May 2018 A1
20180153538 Kaiser et al. Jun 2018 A1
20180153558 Bake et al. Jun 2018 A1
20180161030 Stone et al. Jun 2018 A1
20180177501 Kaiser et al. Jun 2018 A1
20180193015 Denham et al. Jul 2018 A1
20180221017 Stone et al. Aug 2018 A1
20180235747 Berelsman et al. Aug 2018 A1
20180249997 Stone et al. Sep 2018 A1
20180256153 Stone et al. Sep 2018 A1
20190083233 Denham et al. Mar 2019 A1
20190150909 Stone et al. May 2019 A1
20190150923 Stone et al. May 2019 A1
20190231348 Stone et al. Aug 2019 A1
20190274681 Denham et al. Sep 2019 A1
20190282227 Norton et al. Sep 2019 A1
20190290258 Denham et al. Sep 2019 A1
20190298345 Denham et al. Oct 2019 A1
20190328382 Stone et al. Oct 2019 A1
20190365376 Stone et al. Dec 2019 A1
20200029955 Stone et al. Jan 2020 A1
20200085562 Stone et al. Mar 2020 A1
20200178959 Denham et al. Jun 2020 A1
20200187932 Kaiser et al. Jun 2020 A1
20200187933 Kaiser et al. Jun 2020 A1
20200197002 Stone et al. Jun 2020 A1
20200297338 Stone et al. Sep 2020 A1
20200367880 Stone et al. Nov 2020 A1
20210177397 Stone et al. Jun 2021 A1
20210228203 Denham et al. Jul 2021 A1
20210361286 Stone et al. Nov 2021 A1
20220015757 Stone et al. Jan 2022 A1
20220054123 Kaiser et al. Feb 2022 A1
20220096074 Denham et al. Mar 2022 A1
20220096081 Denham et al. Mar 2022 A1
Foreign Referenced Citations (201)
Number Date Country
4957264 Mar 1966 AU
440266 Oct 1967 AU
4381268 Apr 1970 AU
5850469 Jan 1971 AU
5963869 Feb 1971 AU
1505470 Nov 1971 AU
2223767 May 1973 AU
3615171 May 1973 AU
440266 Sep 1973 AU
5028569 Sep 1973 AU
7110887 Oct 1987 AU
639410 Nov 1989 AU
1713188 Nov 1989 AU
651929 Aug 1994 AU
3877493 Aug 1994 AU
1010569 Oct 1998 BE
1720872 Jan 2006 CN
1777450 May 2006 CN
101083954 Dec 2007 CN
101584592 Nov 2009 CN
105208970 Dec 2015 CN
2529669 Mar 1976 DE
2747312 Apr 1979 DE
2818254 Oct 1979 DE
2919009 Nov 1979 DE
3027138 Dec 1981 DE
3225620 Feb 1983 DE
3136083 Mar 1983 DE
233303 Feb 1986 DE
4127550 Feb 1993 DE
4302397 Jul 1993 DE
29621340 Apr 1998 DE
19841252 Mar 2000 DE
29922088 Apr 2000 DE
20207781 Aug 2002 DE
0019062 Nov 1980 EP
0108912 May 1984 EP
0129422 Dec 1984 EP
0129442 Dec 1984 EP
0172130 Feb 1986 EP
0241240 Oct 1987 EP
0241792 Oct 1987 EP
0260970 Mar 1988 EP
0270704 Jun 1988 EP
0282789 Sep 1988 EP
0315371 May 1989 EP
0317406 May 1989 EP
0340159 Nov 1989 EP
0346183 Dec 1989 EP
0349173 Jan 1990 EP
0374088 Jun 1990 EP
0409364 Jan 1991 EP
0415915 Mar 1991 EP
0440991 Aug 1991 EP
0441065 Aug 1991 EP
0447065 Sep 1991 EP
0451932 Oct 1991 EP
0464480 Jan 1992 EP
0490417 Jun 1992 EP
0497079 Aug 1992 EP
0502509 Sep 1992 EP
0502698 Sep 1992 EP
0520177 Dec 1992 EP
520177 Dec 1992 EP
0546726 Jun 1993 EP
0552950 Jul 1993 EP
0574707 Dec 1993 EP
0582514 Feb 1994 EP
0591991 Apr 1994 EP
0598219 May 1994 EP
0611551 Aug 1994 EP
0627203 Dec 1994 EP
0651979 May 1995 EP
0669110 Aug 1995 EP
0686373 Dec 1995 EP
0702933 Mar 1996 EP
0775473 May 1997 EP
0913123 May 1999 EP
0913131 May 1999 EP
0995409 Apr 2000 EP
1013229 Jun 2000 EP
1093773 Apr 2001 EP
1093774 Apr 2001 EP
1555945 Jul 2005 EP
1741412 Jan 2007 EP
1864617 Dec 2007 EP
2238944 Oct 2010 EP
2544607 Jan 2013 EP
2709557 Mar 2014 EP
2895112 Jul 2015 EP
2934379 Oct 2015 EP
2434987 Jun 2016 EP
2775935 May 2017 EP
2622790 May 1989 FR
2634373 Jan 1990 FR
2655840 Jun 1991 FR
2663837 Jan 1992 FR
2682867 Apr 1993 FR
2687911 Sep 1993 FR
2688689 Sep 1993 FR
2704140 Oct 1994 FR
2717070 Sep 1995 FR
2723528 Feb 1996 FR
2734709 Dec 1996 FR
2744010 Aug 1997 FR
2745999 Sep 1997 FR
2770764 May 1999 FR
401677 Nov 1933 GB
1413477 Nov 1975 GB
1485681 Sep 1977 GB
2083751 Mar 1982 GB
2118474 Nov 1983 GB
2129306 May 1984 GB
2227175 Jul 1990 GB
2253147 Sep 1992 GB
2312376 Oct 1997 GB
2403416 Jan 2005 GB
2454251 May 2009 GB
5362911 May 1978 JP
5362912 May 1978 JP
5374942 Jun 1978 JP
5378230 Jun 1978 JP
54166092 Nov 1979 JP
54166093 Nov 1979 JP
54176284 Dec 1979 JP
54178988 Dec 1979 JP
5362911 Jul 1987 JP
62159647 Jul 1987 JP
62159647 Oct 1987 JP
62295657 Dec 1987 JP
5269160 Oct 1993 JP
5300917 Nov 1993 JP
751292 Feb 1995 JP
10127672 May 1998 JP
10211213 Aug 1998 JP
5362911 Dec 2013 JP
5362912 Dec 2013 JP
5374942 Dec 2013 JP
5378230 Dec 2013 JP
2051647 Jan 1996 RU
2076667 Apr 1997 RU
WO-8300615 Mar 1983 WO
WO-8603666 Jul 1986 WO
WO-8701270 Mar 1987 WO
WO-8901767 Mar 1989 WO
WO-8909030 Oct 1989 WO
WO-8910096 Nov 1989 WO
WO-9008510 Aug 1990 WO
WO-9203980 Mar 1992 WO
WO-9314705 Aug 1993 WO
WO-9315694 Aug 1993 WO
WO-9502373 Jan 1995 WO
WO-9503003 Feb 1995 WO
WO-9529637 Nov 1995 WO
WO-9532670 Dec 1995 WO
WO-9609797 Apr 1996 WO
WO-9629029 Sep 1996 WO
WO-9737603 Oct 1997 WO
WO-9812991 Apr 1998 WO
WO-9812992 Apr 1998 WO
WO-9822047 May 1998 WO
WO-9822048 May 1998 WO
WO-9901084 Jan 1999 WO
WO-9912480 Mar 1999 WO
WO-9937219 Jul 1999 WO
WO-9944544 Sep 1999 WO
WO-9952472 Oct 1999 WO
WO-0004159 Jan 2000 WO
WO-0040159 Jul 2000 WO
WO-0139671 Jun 2001 WO
WO-0236020 May 2002 WO
WO-03005914 Jan 2003 WO
WO-03071962 Sep 2003 WO
WO-03077772 Sep 2003 WO
WO-03092551 Nov 2003 WO
WO-2004091412 Oct 2004 WO
WO-05104992 Nov 2005 WO
WO-2005122954 Dec 2005 WO
WO-2006011786 Feb 2006 WO
WO-2006023661 Mar 2006 WO
WO-2006055823 May 2006 WO
WO-2007045460 Apr 2007 WO
WO-2007103562 Sep 2007 WO
WO-2007109280 Sep 2007 WO
WO-2007119057 Oct 2007 WO
WO-2008002550 Jan 2008 WO
WO-2008015171 Feb 2008 WO
WO-2008073588 Jun 2008 WO
WO-2009012021 Jan 2009 WO
WO-2009083047 Jul 2009 WO
WO-2009131820 Oct 2009 WO
WO-2010138832 Dec 2010 WO
WO-2011112371 Sep 2011 WO
WO-2011150238 Dec 2011 WO
WO-2012134999 Oct 2012 WO
WO-2012158583 Nov 2012 WO
WO-2013066974 May 2013 WO
WO-2013074525 May 2013 WO
WO-2014043078 Mar 2014 WO
WO-2014100109 Jun 2014 WO
WO-2014151766 Sep 2014 WO
Non-Patent Literature Citations (1367)
Entry
US 6,238,418 B1, 05/2001, Schwartz (withdrawn)
U.S. Appl. No. 11/541,506 U.S. Pat. No. 7,601,165, filed Sep. 29, 2006, Method and Apparatus for Forming a Self-Locking Adjustable Suture Loop.
U.S. Appl. No. 11/784,821 U.S. Pat. No. 9,017,381, filed Apr. 10, 2007, Adjustable Knotless Loops.
U.S. Appl. No. 14/697,140 U.S. Pat. No. 9,861,351, filed Apr. 27, 2015, Adjustable Knotless Loops.
U.S. Appl. No. 15/720,997, filed Sep. 29, 2017, Adjustable Knotless Loops.
U.S. Appl. No. 15/903,261, filed Feb. 23, 2018, Adjustable Knotless Loops.
U.S. Appl. No. 11/347,661 U.S. Pat. No. 7,749,250, filed Feb. 3, 2006, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 12/828,977 U.S. Pat. No. 8,409,253, filed Jul. 1, 2010, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 13/767,401 U.S. Pat. No. 9,414,833, filed Feb. 14, 2013, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 15/361,917, filed Nov. 28, 2016, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 14/936,831, filed Nov. 10, 2015, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 16/251,342, filed Jan. 18, 2019, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 11/541,505 U.S. Pat. No. 7,658,751, filed Sep. 29, 2006, Method for Implanting Soft Tissue.
U.S. Appl. No. 12/702,067 U.S. Pat. No. 8,672,968, filed Feb. 8, 2010, Method for Implanting Soft Tissue.
U.S. Appl. No. 14/211,977 U.S. Pat. No. 9,486,211, filed Mar. 14, 2014, Method for Implanting Soft Tissue.
U.S. Appl. No. 15/061,352 U.S. Pat. No. 10,004,493, filed Mar. 4, 2016, Method for Implanting Soft Tissue.
U.S. Appl. No. 15/664,572, filed Jul. 31, 2017, Method for Implanting Soft Tissue.
U.S. Appl. No. 11/935,681 U.S. Pat. No. 7,905,903, filed Nov. 6, 2007, Method for Tissue Fixation.
U.S. Appl. No. 12/196,398 U.S. Pat. No. 7,959,650, filed Aug. 22, 2008, Adjustable Knotless Loops.
U.S. Appl. No. 13/102,182 U.S. Pat. No. 8,231,654, filed May 6, 2011, Adjustable Knotless Loops.
U.S. Appl. No. 10/984,624 U.S. Pat. No. 7,608,098, filed Nov. 9, 2004, Bone Fixation Device.
U.S. Appl. No. 11/294,694 U.S. Pat. No. 7,914,539, filed Dec. 5, 2005, Tissue Fixation Device.
U.S. Appl. No. 11/408,282, filed Apr. 20, 2006, Soft Tissue Conduit Device.
U.S. Appl. No. 12/419,491 U.S. Pat. No. 8,317,825, filed Apr. 7, 2009, Soft Tissue Conduit Device and Method.
U.S. Appl. No. 11/869,440 U.S. Pat. No. 7,857,830, filed Oct. 9, 2007, Soft Tissue Repair and Conduit Device.
U.S. Appl. No. 12/976,328 U.S. Pat. No. 8,273,106, filed Dec. 22, 2010, Soft Tissue Repair and Conduit Device.
U.S. Appl. No. 12/489,168 U.S. Pat. No. 8,361,113, filed Jun. 22, 2009, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 13/751,846 U.S. Pat. No. 9,492,158, filed Jan. 28, 2013, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 14/983,747 U.S. Pat. No. 10,154,837, filed Dec. 30, 2015, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/941,481, filed Mar. 30, 2018, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 12/014,399 U.S. Pat. No. 7,909,851, filed Jan. 15, 2008, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 13/045,691 U.S. Pat. No. 8,292,921, filed Mar. 11, 2011, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 13/656,821 U.S. Pat. No. 9,173,651, filed Oct. 22, 2012, Soft Tissue Repair Device and Associated Methods.
U.S. Appl. No. 14/876,167 U.S. Pat. No. 10,251,637, filed Oct. 6, 2015, Soft Tissue Repair Device and Associated Methods.
U.S. Appl. No. 15/891,049, filed Feb. 7, 2018, Soft Tissue Repair Device and Associated Methods.
U.S. Appl. No. 12/014,340 U.S. Pat. No. 7,905,904, filed Jan. 15, 2008, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 13/045,689 U.S. Pat. No. 8,337,525, filed Mar. 11, 2011, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 13/721,970 U.S. Pat. No. 8,632,569, filed Dec. 20, 2012, Soft Tissue Repair Assembly and Associated Method.
U.S. Appl. No. 13/838,755 U.S. Pat. No. 9,510,819, filed Mar. 15, 2013, Soft Tissue Repair Device and Associated Methods.
U.S. Appl. No. 13/833,567 U.S. Pat. No. 9,561,025, filed Mar. 15, 2013, Soft Tissue Repair Device and Associated Methods.
U.S. Appl. No. 14/159,094 U.S. Pat. No. 9,622,736, filed Jan. 20, 2014, Soft Tissue Repair Device and Associated Methods.
U.S. Appl. No. 15/412,676, filed Jan. 23, 2017, Soft Tissue Repair Device and Associated Methods.
U.S. Appl. No. 12/489,181 U.S. Pat. No. 8,298,262, filed Jun. 22, 2009, Method for Tissue Fixation.
U.S. Appl. No. 13/625,413 U.S. Pat. No. 9,402,621, filed Sep. 24, 2012, Method for Tissue Fixation.
U.S. Appl. No. 14/983,108, filed Dec. 29, 2015, Method for Tissue Fixation.
U.S. Appl. No. 15/945,425, filed Apr. 4, 2018, Method for Tissue Fixation.
U.S. Appl. No. 16/380,742, filed Apr. 10, 2019, Method for Tissue Fixation.
U.S. Appl. No. 10/983,236, filed Nov. 5, 2004, Tissue Repair Assembly.
U.S. Appl. No. 11/347,662, filed Feb. 3, 2006, Tissue Repair Assembly.
U.S. Appl. No. 12/196,410 U.S. Pat. No. 8,118,836, filed Aug. 22, 2008, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 13/399,125 U.S. Pat. No. 8,840,645, filed Feb. 17, 2012, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 14/492,590 U.S. Pat. No. 9,572,655, filed Sep. 22, 2014, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 14/956,724 U.S. Pat. No. 9,801,708, filed Dec. 2, 2015, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/278,777 U.S. Pat. No. 10,092,288, filed Sep. 28, 2016, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/455,895, filed Mar. 10, 2017, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/622,718, filed Jun. 14, 2017, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/793,216, filed Oct. 25, 2017, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 12/196,407 U.S. Pat. No. 8,137,382, filed Aug. 22, 2008, Method and Apparatus for Forming a Self-Locking Adjustable Suture Loop.
U.S. Appl. No. 13/412,116 U.S. Pat. No. 8,771,316, filed Mar. 5, 2012, Method and Apparatus for Coupling Anatomical Features.
U.S. Appl. No. 14/324,688 U.S. Pat. No. 9,498,204, filed Jul. 7, 2014, Method and Apparatus for Coupling Anatomical Features.
U.S. Appl. No. 13/412,127 U.S. Pat. No. 8,721,684, filed Mar. 5, 2012, Method and Apparatus for Coupling Anatomical Features.
U.S. Appl. No. 14/275,548 U.S. Pat. No. 9,510,821, filed May 12, 2014, Method and Apparatus for Coupling Anatomical Features.
U.S. Appl. No. 15/288,183, filed Oct. 7, 2016, Method and Apparatus for Coupling Anatomical Features.
U.S. Appl. No. 15/662,572, filed Jul. 28, 2017, Method and Apparatus for Coupling Anatomical Features.
U.S. Appl. No. 12/196,405 U.S. Pat. No. 8,128,658, filed Aug. 22, 2008, Method and Apparatus for Coupling Soft Tissue to Bone.
U.S. Appl. No. 13/181,729 U.S. Pat. No. 8,551,140, filed Jul. 13, 2011, Method and Apparatus for Coupling Soft Tissue to Bone.
U.S. Appl. No. 13/412,105 U.S. Pat. No. 8,932,331, filed Mar. 5, 2012, Method and Apparatus for Coupling Soft Tissue to Bone.
U.S. Appl. No. 14/594,285 U.S. Pat. No. 9,801,620, filed Jan. 12, 2015, Method and Apparatus for Coupling Soft Tissue to Bone.
U.S. Appl. No. 15/703,727, filed Sep. 13, 2017, Method and Apparatus for Coupling Soft Tissue to Bone.
U.S. Appl. No. 12/474,802 U.S. Pat. No. 8,088,130, filed May 29, 2009, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 13/278,341 U.S. Pat. No. 8,608,777, filed Oct. 21, 2011, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 14/107,350 U.S. Pat. No. 9,532,777, filed Dec. 16, 2013, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/074,553 U.S. Pat. No. 10,004,489, filed Mar. 18, 2016, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/297,844 U.S. Pat. No. 10,098,629, filed Oct. 19, 2016, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/865,938, filed Jan. 9, 2018, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/886,712, filed Feb. 1, 2018, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 12/570,854 U.S. Pat. No. 8,303,604, filed Sep. 30, 2009, Soft Tissue Repair Device and Method.
U.S. Appl. No. 13/645,964 U.S. Pat. No. 9,504,460, filed Oct. 5, 2012, Soft Tissue Repair Device and Method.
U.S. Appl. No. 15/332,590 U.S. Pat. No. 10,265,064, filed Oct. 24, 2016, Soft Tissue Repair Device and Method.
U.S. Appl. No. 16/255,300, filed Jan. 23, 2019, Soft Tissue Repair Device and Method.
U.S. Appl. No. 12/719,337 U.S. Pat. No. 9,078,644, filed Mar. 8, 2010, Fracture Fixation Device.
U.S. Appl. No. 14/794,309 U.S. Pat. No. 9,833,230, filed Jul. 8, 2015, Fracture Fixation Device.
U.S. Appl. No. 15/060,007, filed Mar. 3, 2016, Fracture Fixation Device.
U.S. Appl. No. 15/866,089, filed Jan. 9, 2018, Fracture Fixation Device.
U.S. Appl. No. 12/915,962 U.S. Pat. No. 8,562,647, filed Oct. 29, 2010, Method and Apparatus for Securing Soft Tissue to Bone.
U.S. Appl. No. 14/055,172 U.S. Pat. No. 9,724,090, filed Oct. 16, 2013, Method and Apparatus for Attaching Soft Tissue to Bone.
U.S. Appl. No. 15/654,386, filed Jul. 19, 2017, Method and Apparatus for Attaching Soft Tissue to Bone.
U.S. Appl. No. 12/938,902 U.S. Pat. No. 8,597,327, filed Nov. 3, 2010, Method and Apparatus for Securing Soft Tissue to Bone.
U.S. Appl. No. 14/094,311 U.S. Pat. No. 9,642,661, filed Dec. 2, 2013, Method and Apparatus for Sternal Closure.
U.S. Appl. No. 15/461,675, filed Mar. 17, 2017, Method and Apparatus for Sternal Closure.
U.S. Appl. No. 11/504,882 U.S. Pat. No. 8,998,949, filed Aug. 16, 2006, Soft Tissue Conduit Device.
U.S. Appl. No. 12/029,861 U.S. Pat. No. 8,251,998, filed Feb. 12, 2008, Chondral Defect Repair.
U.S. Appl. No. 13/587,374 U.S. Pat. No. 8,777,956, filed Aug. 16, 2012, Chondral Defect Repair.
U.S. Appl. No. 11/740,035, filed Apr. 25, 2007, Method for Treating Cartilage Defects.
U.S. Appl. No. 11/739,768 U.S. Pat. No. 8,137,354, filed Apr. 25, 2007, Localized Cartilage Defect Therapy.
U.S. Appl. No. 13/350,985 U.S. Pat. No. 9,198,673, filed Jan. 16, 2012, Localized Cartilage Defect Therapy.
U.S. Appl. No. 14/923,506, filed Oct. 27, 2015, Localized Cartilage Defect Therapy.
U.S. Appl. No. 13/111,564 U.S. Pat. No. 8,574,235, filed May 19, 2011, Method for Trochanteric Reattachment.
U.S. Appl. No. 14/071,295 U.S. Pat. No. 9,005,287, filed Nov. 4, 2013, Method for Bone Reattachment.
U.S. Appl. No. 13/288,459 U.S. Pat. No. 9,468,433, filed Nov. 3, 2011, Method and Apparatus for Forming a Self-Locking Adjustable Loop.
U.S. Appl. No. 15/294,994, filed Oct. 17, 2016, Method and Apparatus for Forming a Self-Locking Adjustable Loop.
U.S. Appl. No. 13/288,463 U.S. Pat. No. 8,936,621, filed Nov. 3, 2011, Method and Apparatus for Forming a Self-Locking Adjustable Loop.
U.S. Appl. No. 14/599,909 U.S. Pat. No. 9,993,241, filed Jan. 19, 2015, Method and Apparatus for Forming a Self-Locking Adjustable Loop.
U.S. Appl. No. 15/917,143, filed Mar. 9, 2018, Method and Apparatus for Forming a Self-Locking Adjustable Loop.
U.S. Appl. No. 13/720,648 U.S. Pat. No. 9,357,991, filed Dec. 19, 2012, Method and Apparatus for Stitching Tendons.
U.S. Appl. No. 15/166,480 U.S. Pat. No. 10,265,159, filed May 27, 2016, Method and Apparatus for Stitching Tendons.
U.S. Appl. No. 16/160,559, filed Oct. 15, 2018, Method and Apparatus for Stitching Tendons.
U.S. Appl. No. 14/095,639 U.S. Pat. No. 9,918,827, filed Dec. 3, 2013, Scaffold for Spring Ligament Repair.
U.S. Appl. No. 14/095,614 U.S. Pat. No. 9,918,826, filed Dec. 3, 2013, Scaffold for Spring Ligament Repair.
U.S. Appl. No. 15/722,002, filed Oct. 2, 2017, Scaffold for Spring Ligament Repair.
U.S. Appl. No. 13/098,897 U.S. Pat. No. 8,562,645, filed May 2, 2011, Method and Apparatus for Forming a Self-Locking Adjustable Loop.
U.S. Appl. No. 14/055,191 U.S. Pat. No. 9,539,003, filed Oct. 16, 2013, Method and Apparatus for Forming a Self-Locking Adjustable Loop.
U.S. Appl. No. 15/401,768, filed Jan. 9, 2017, Method and Apparatus for Forming a Self-Locking Adjustable Loop.
U.S. Appl. No. 15/972,646, filed May 7, 2018, Method and Apparatus for Forming a Self-Locking Adjustable Loop.
U.S. Appl. No. 13/098,927 U.S. Pat. No. 8,652,171, filed May 2, 2011, Method and Apparatus for Soft Tissue Fixation.
U.S. Appl. No. 14/182,038 U.S. Pat. No. 9,763,656, filed Feb. 17, 2014, Method and Apparatus for Soft Tissue Fixation.
U.S. Appl. No. 15/682,187, filed Aug. 21, 2017, Method and Apparatus for Soft Tissue Fixation.
U.S. Appl. No. 12/788,978 U.S. Pat. No. 8,801,783, filed May 27, 2010, Prosthetic Ligament System for Knee Joint.
U.S. Appl. No. 14/456,286 U.S. Pat. No. 9,681,940, filed Aug. 11, 2014, Ligament System for Knee Joint.
U.S. Appl. No. 15/626,384, filed Jun. 19, 2017, Ligament System for Knee Joint.
U.S. Appl. No. 11/386,071 U.S. Pat. No. 8,034,090, filed Mar. 21, 2006, Bone Fixation Device.
U.S. Appl. No. 13/293,825 U.S. Pat. No. 9,149,267, filed Nov. 10, 2011, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 14/854,308 U.S. Pat. No. 10,022,118, filed Sep. 15, 2015, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 13/071,563 U.S. Pat. No. 8,926,613, filed Mar. 25, 2011, Method and Apparatus for Forming a Bone Hole.
U.S. Appl. No. 14/589,101, filed Jan. 5, 2015, Method and Apparatus for Forming a Bone Hole.
U.S. Appl. No. 13/311,936 U.S. Pat. No. 9,408,599, filed Dec. 6, 2011, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/231,074, filed Aug. 8, 2016, Method and Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 13/757,003 U.S. Pat. No. 9,357,992, filed Feb. 1, 2013, Method for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 13/295,126 U.S. Pat. No. 9,271,713, filed Nov. 14, 2011, Method and Apparatus for Tensioning a Suture.
U.S. Appl. No. 13/281,009 U.S. Pat. No. 9,538,998, filed Oct. 25, 2011, Method and Apparatus for Fracture Fixation.
U.S. Appl. No. 13/269,097 U.S. Pat. No. 8,672,969, filed Oct. 7, 2011, Fracture Fixation Device.
U.S. Appl. No. 14/215,550 U.S. Pat. No. 9,788,876, filed Mar. 17, 2014, Fracture Fixation Device.
U.S. Appl. No. 15/715,731, filed Sep. 26, 2017, Fracture Fixation Device.
U.S. Appl. No. 13/757,019 U.S. Pat. No. 9,314,241, filed Feb. 1, 2013, Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/131,663, filed Apr. 18, 2016, Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 13/790,982 U.S. Pat. No. 9,370,350, filed Mar. 8, 2013, Apparatus for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 13/790,997 U.S. Pat. No. 9,381,013, filed Mar. 8, 2013, Method for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 15/200,546, filed Jul. 1, 2016, Method for Coupling Soft Tissue to a Bone.
U.S. Appl. No. 12/788,973 U.S. Pat. No. 8,500,818, filed May 27, 2010, Knee Prosthesis Assembly With Ligament Link.
U.S. Appl. No. 13/959,145 U.S. Pat. No. 9,414,925, filed Aug. 5, 2013, Method of Implanting a Knee Prosthesis Assembly With Ligament Link.
U.S. Appl. No. 13/109,672 U.S. Pat. No. 8,968,364, filed May 17, 2011, Method and Apparatus for Fixation of an ACL Graft.
U.S. Appl. No. 14/635,055 U.S. Pat. No. 10,004,588, filed Mar. 2, 2015, Method and Apparatus for Fixation of an ACL Graft.
U.S. Appl. No. 15/956,444, filed Apr. 18, 2018, Method and Apparatus for Fixation of an ACL Graft.
U.S. Appl. No. 13/109,667 U.S. Pat. No. 8,771,352, filed May 17, 2011, Method and Apparatus for Tibial Fixation of an ACL Graft.
U.S. Appl. No. 13/889,851 U.S. Pat. No. 9,216,078, filed May 8, 2013, Method and Apparatus for Tibial Fixation of an ACL Graft.
U.S. Appl. No. 14/974,516, filed Dec. 18, 2015, Method and Apparatus for Tibial Fixation of an ACL Graft.
U.S. Appl. No. 13/177,153 U.S. Pat. No. 8,652,172, filed Jul. 6, 2011, Flexible Anchors for Tissue Fixation.
U.S. Appl. No. 14/182,046 U.S. Pat. No. 9,603,591, filed Feb. 17, 2014, Flexible Anchors for Tissue Fixation.
U.S. Appl. No. 12/107,437, filed Apr. 22, 2008, Method And Apparatus For Attaching Soft Tissue To Bone.
U.S. Appl. No. 12/398,548 U.S. Pat. No. 8,118,868, filed Mar. 5, 2009, Method And Apparatus For Attaching Soft Tissue To Bone.
“U.S. Appl. No. 15/361,917, Advisory Action dated Nov. 19, 2019”, 3 pgs.
“U.S. Appl. No. 15/361,917, Notice of Allowance dated Mar. 4, 2020”, 8 pgs.
“U.S. Appl. No. 15/361,917, Response filed Nov. 4, 2019 to Final Office Action dated Sep. 3, 2019”, 8 pgs.
“U.S. Appl. No. 15/401,768, Notice of Allowance dated Nov. 20, 2019”, 9 pgs.
“U.S. Appl. No. 15/412,676, Notice of Allowance dated Dec. 30, 2019”, 8 pgs.
“U.S. Appl. No. 15/412,676, Response filed Oct. 23, 2019 to Non Final Office Action dated Jul. 23, 2019”, 12 pgs.
“U.S. Appl. No. 15/455,895, Examiner Interview Summary dated Nov. 25, 2019”, 3 pgs.
“U.S. Appl. No. 15/455,895, Notice of Allowance dated Feb. 13, 2020”, 7 pgs.
“U.S. Appl. No. 15/455,895, Response filed Jan. 28, 2020 to Non Final Office Action dated Sep. 5, 2019”, 14 pgs.
“U.S. Appl. No. 15/461,675, Notice of Allowance dated Jan. 30, 2020”, 7 pgs.
“U.S. Appl. No. 15/461,675, Response filed Nov. 12, 2019 to Non Final Office Action dated Aug. 9, 2019”, 11 pgs.
“U.S. Appl. No. 15/622,718, Examiner Interview Summary dated Nov. 22, 2019”, 3 pgs.
“U.S. Appl. No. 15/622,718, Notice of Allowance dated Feb. 13, 2020”, 8 pgs.
“U.S. Appl. No. 15/622,718, Response filed Jan. 28, 2020 to Non Final Office Action dated Aug. 28, 2019”, 11 pgs.
“U.S. Appl. No. 15/626,384, Notice of Allowability dated Oct. 18, 2019”, 2 pgs.
“U.S. Appl. No. 15/654,386, Non Final Office Action dated Nov. 7, 2019”, 10 pgs.
“U.S. Appl. No. 15/654,386, Notice of Allowance dated Feb. 20, 2020”, 8 pgs.
“U.S. Appl. No. 15/654,386, Response filed Feb. 5, 2020 to Non Final Office Action dated Nov. 7, 2019”, 12 pgs.
“U.S. Appl. No. 15/662,572, Non Final Office Action dated Oct. 10, 2019”, 14 pgs.
“U.S. Appl. No. 15/662,572, Notice of Allowance dated Mar. 11, 2020”, 9 pgs.
“U.S. Appl. No. 15/662,572, Response filed Jan. 8, 2020 to Non Final Office Action dated Oct. 10, 2019”, 10 pgs.
“U.S. Appl. No. 15/682,187, Non Final Office Action dated Dec. 16, 2019”, 10 pgs.
“U.S. Appl. No. 15/682,187, Notice of Allowance dated Mar. 25, 2020”, 9 pgs.
“U.S. Appl. No. 15/682,187, Response filed Feb. 27, 2020 to Non Final Office Action dated Dec. 16, 2019”, 11 pgs.
“U.S. Appl. No. 15/703,727, Notice of Allowance dated Nov. 20, 2019”, 7 pgs.
“U.S. Appl. No. 15/703,727, Response filed Nov. 1, 2019 to Non Final Office Action dated Aug. 1, 2019”, 10 pgs.
“U.S. Appl. No. 15/715,731, Non Final Office Action dated Jan. 21, 2020”, 8 pgs.
“U.S. Appl. No. 15/715,731, Notice of Allowance dated Apr. 8, 2020”, 9 pgs.
“U.S. Appl. No. 15/715,731, Response filed Feb. 27, 2020 to Non Final Office Action dated Jan. 21, 2020”, 12 pgs.
“U.S. Appl. No. 15/715,731, Response Filed Nov. 4, 2019 to Restriction Requirement dated Sep. 4, 2019”, 9 pgs.
“U.S. Appl. No. 15/420,997, Advisory Action dated Oct. 13, 2020”, 2 pgs.
“U.S. Appl. No. 15/420,997, Final Office Action dated Apr. 7, 2021”, 9 pgs.
“U.S. Appl. No. 15/420,997, Final Office Action dated Aug. 4, 2020”, 10 pgs.
“U.S. Appl. No. 15/720,997, Non Final Office Action dated Jan. 6, 2020”, 10 pgs.
“U.S. Appl. No. 15/720,997, Non Final Office Action dated Nov. 23, 2020”, 7 pgs.
“U.S. Appl. No. 15/720,997, Response filed Jan. 25, 2021 to Non Final Office Action dated Nov. 23, 2020”, 9 pgs.
“U.S. Appl. No. 15/720,997, Response filed Mar. 27, 2020 to Non Final Office Action dated Jan. 6, 2020”, 10 pgs.
“U.S. Appl. No. 15/720,997, Response filed Sep. 30, 2020 to Final Office Action dated Aug. 4, 2020”, 11 pgs.
“U.S. Appl. No. 15/420,997, Response filed Oct. 3, 2019 to Non-Final Office Action dated Jul. 16, 2019”, 9 pgs.
“U.S. Appl. No. 15/722,002, Non Final Office Action dated Feb. 4, 2020”, 8 pgs.
“U.S. Appl. No. 15/722,002, Notice of Allowance dated Apr. 8, 2020”, 7 pgs.
“U.S. Appl. No. 15/722,002, Response filed Mar. 5, 2020 to Non Final Office Action dated Feb. 4, 2020”, 7 pgs.
“U.S. Appl. No. 15/722,002, Response filed Nov. 14, 2019 to Restriction Requirement dated Sep. 17, 2019”, 6 pgs.
“U.S. Appl. No. 15/493,216, Examiner Interview Summary dated Nov. 4, 2019”, 4 pgs.
“U.S. Appl. No. 15/493,216, Notice of Allowance dated Mar. 23, 2020”, 7 pgs.
“U.S. Appl. No. 15/493,216, Response filed Jan. 28, 2020 to Non Final Office Action dated Aug. 1, 2019”, 13 pgs.
“U.S. Appl. No. 15/866,089, Corrected Notice of Allowability dated Aug. 27, 2020”, 2 pgs.
“U.S. Appl. No. 15/866,089, Final Office Action dated Mar. 25, 2020”, 15 pgs.
“U.S. Appl. No. 15/866,089, Non Final Office Action dated Dec. 4, 2019”, 16 pgs.
“U.S. Appl. No. 15/866,089, Notice of Allowance dated Jul. 15, 2020”, 5 pgs.
“U.S. Appl. No. 15/866,089, Response filed Feb. 27, 2020 to Non Final Office Action dated Dec. 4, 2019”, 10 pgs.
“U.S. Appl. No. 15/866,089, Response filed Jun. 18, 2020 to Final Office Action dated Mar. 25, 2020”, 11 pgs.
“U.S. Appl. No. 15/886,712, Non Final Office Action dated Sep. 27, 2019”, 8 pgs.
“U.S. Appl. No. 15/886,712, Notice of Allowance dated Nov. 14, 2019”, 7 pgs.
“U.S. Appl. No. 15/886,712, Response filed Oct. 18, 2019 to Non Final Office Action dated Sep. 27, 2019”, 9 pgs.
“U.S. Appl. No. 15/891,049, Examiner Interview Summary dated Aug. 10, 2020”, 3 pgs.
“U.S. Appl. No. 15/891,049, Examiner Interview Summary dated Dec. 4, 2020”, 2 pgs.
“U.S. Appl. No. 15/891,049, Final Office Action dated Nov. 10, 2020”, 10 pgs.
“U.S. Appl. No. 15/891,049, Non Final Office Action dated Jul. 14, 2020”, 16 pgs.
“U.S. Appl. No. 15/891,049, Notice of Allowance dated Dec. 22, 2020”, 8 pgs.
“U.S. Appl. No. 15/891,049, Response filed May 29, 2020 to Restriction Requirement dated May 5, 2020”, 9 pgs.
“U.S. Appl. No. 15/891,049, Response filed Aug. 17, 2020 to Non Final Office Action dated Jul. 14, 2020”, 18 pgs.
“U.S. Appl. No. 15/891,049, Response filed Dec. 1, 2020 to Final Office Action dated Nov. 10, 2020”, 12 pgs.
“U.S. Appl. No. 15/891,049, Restriction Requirement dated May 5, 2020”, 6 pgs.
“U.S. Appl. No. 15/903,261, Supplemental Preliminary Amendment filed Dec. 20, 2019”, 8 pgs.
“U.S. Appl. No. 15/903,261, Notice of Allowance dated Mar. 26, 2020”, 9 pgs.
“U.S. Appl. No. 15/917,143, Non Final Office Action dated Aug. 7, 2020”, 6 pgs.
“U.S. Appl. No. 15/917,143, Notice of Allowance dated Feb. 24, 2021”, 8 pgs.
“U.S. Appl. No. 15/917,143, Response filed Jun. 17, 2020 to Restriction Requirement dated May 5, 2020”, 8 pgs.
“U.S. Appl. No. 15/917,143, Response filed Oct. 29, 2020 to Non Final Office Action dated Aug. 7, 2020”, 11 pgs.
“U.S. Appl. No. 15/917,143, Restriction Requirement dated May 5, 2020”, 6 pgs.
“U.S. Appl. No. 15/941,481, Non Final Office Action dated Aug. 14, 2020”, 21 pgs.
“U.S. Appl. No. 15/941,481, Notice of Allowance dated Dec. 3, 2020”, 8 pgs.
“U.S. Appl. No. 15/941,481, Response filed Jun. 24, 2020 to Restriction Requirement dated May 19, 2020”, 8 pgs.
“U.S. Appl. No. 15/941,481, Response filed Nov. 16, 2020 to Non Final Office Action dated Aug. 14, 2020”, 15 pgs.
“U.S. Appl. No. 15/941,481, Restriction Requirement dated May 19, 2020”, 7 pgs.
“U.S. Appl. No. 15/945,425, Non Final Office Action dated Aug. 25, 2020”, 11 pgs.
“U.S. Appl. No. 15/945,425, Notice of Allowance dated Dec. 24, 2020”, 8 pgs.
“U.S. Appl. No. 15/945,425, Response filed Jun. 24, 2020 to Restriction Requirement dated May 19, 2020”, 7 pgs.
“U.S. Appl. No. 15/945,425, Response filed Nov. 23, 2020 to Non Final Office Action dated Aug. 25, 2020”, 10 pgs.
“U.S. Appl. No. 15/945,425, Restriction Requirement dated May 19, 2020”, 7 pgs.
“U.S. Appl. No. 15/956,444, Non Final Office Action dated Dec. 7, 2020”, 7 pgs.
“U.S. Appl. No. 15/956,444, Notice of Allowance dated Mar. 11, 2021”, 8 pgs.
“U.S. Appl. No. 15/956,444, Response filed Feb. 23, 2021 to Non Final Office Action dated Dec. 7, 2020”, 11 pgs.
“U.S. Appl. No. 15/956,444, Response filed Sep. 14, 2020 to Restriction Requirement dated Jul. 14, 2020”, 8 pgs.
“U.S. Appl. No. 15/956,444, Restriction Requirement dated Jul. 14, 2020”, 7 pgs.
“U.S. Appl. No. 15/972,646, Non Final Office Action dated Dec. 7, 2020”, 11 pgs.
“U.S. Appl. No. 15/972,646, Notice of Allowance dated Apr. 21, 2021”, 8 pgs.
“U.S. Appl. No. 15/972,646, Response filed Feb. 22, 2021 to Non Final Office Action dated Dec. 7, 2020”, 13 pgs.
“U.S. Appl. No. 15/972,646, Response filed Sep. 21, 2020 to Restriction Requirement dated Jul. 27, 2020”, 7 pgs.
“U.S. Appl. No. 15/972,646, Restriction Requirement dated Jul. 27, 2020”, 6 pgs.
“U.S. Appl. No. 16/160,559, Response filed Mar. 2, 2021 to Restriction Requirement dated Jan. 27, 2021”, 7 pgs.
“U.S. Appl. No. 16/160,559, Restriction Requirement dated Jan. 27, 2021”, 6 pgs.
“U.S. Appl. No. 16/251,342, Response filed May 3, 2021 to Restriction Requirement dated Apr. 30, 2021”, 8 pgs.
“U.S. Appl. No. 16/251,342, Restriction Requirement dated Apr. 30, 2021”, 6 pgs.
“U.S. Appl. No. 16/251,342, Supplemental Preliminary Amendment filed Oct. 28, 2020”, 7 pgs.
“U.S. Appl. No. 16/251,342, Supplemental Preliminary Amendment filed Nov. 4, 2020”, 7 pgs.
“U.S. Appl. No. 16/255,300 Supplemental Preliminary Amendment Filed Nov. 12, 2020”, 8 pgs.
“U.S. Appl. No. 16/544,293, Supplemental Preliminary Amendment filed Mar. 1, 2021”, 5 pgs.
“U.S. Appl. No. 16/544,293, Supplemental Preliminary Amendment filed Oct. 28, 2020”, 6 pgs.
“U.S. Appl. No. 16/593,022, Preliminary Amendment filed Oct. 30, 2019”, 8 pgs.
“U.S. Appl. No. 16/593,022, Supplemental Preliminary Amendment filed Oct. 21, 2020”, 8 pgs.
“U.S. Appl. No. 16/593,022, Supplemental Preliminary Amendment filed Dec. 5, 2019”, 8 pgs.
“U.S. Appl. No. 16/593,022, Supplemental Preliminary Amendment filed Dec. 20, 2019”, 5 pgs.
“U.S. Appl. No. 16/690,671, Preliminary Amendment filed Dec. 11, 2019”, 7 pgs.
“U.S. Appl. No. 16/795,181, Preliminary Amendment filed Feb. 20, 2020”, 6 pgs.
“U.S. Appl. No. 16/802,228, Preliminary Amendment filed Mar. 4, 2020”, 7 pgs.
“U.S. Appl. No. 16/802,248, Preliminary Amendment filed Mar. 5, 2020”, 8 pgs.
“U.S. Appl. No. 16/806,611, Preliminary Amendment filed Mar. 4, 2020”, 7 pgs.
“U.S. Appl. No. 16/895,246, Preliminary Amendment filed Jun. 9, 2020”, 6 pgs.
“U.S. Appl. No. 17/190,686, Supplemental Preliminary Amendment filed Oct. 21, 2020”, 8 pgs.
“U.S. Appl. No. 17/190,686, Preliminary Amendment filed Mar. 10, 2021”, 7 pgs.
“European Application Serial No. 14716173.1, Communication Pursuant to Article 94(3) EPC dated Jul. 13, 2020”, 4 pgs.
“U.S. Appl. No. 15/720,997, Advisory Action dated Jun. 15, 2021”, 3 pgs.
“U.S. Appl. No. 15/720,997, Notice of Allowance dated Jul. 29, 2021”, 7 pgs.
“U.S. Appl. No. 15/720,997, Response filed Jun. 2, 2021 to Final Office Action dated Apr. 7, 2021”, 9 pgs.
“U.S. Appl. No. 15/720,997, Response filed Jul. 7, 2021 to Advisory Action dated Jun. 15, 2021”, 6 pgs.
“U.S. Appl. No. 15/956,444, PTO Response to Rule 312 Communication dated Jun. 8, 2021”, 2 pgs.
“U.S. Appl. No. 16/160,559, Non Final Office Action dated May 14, 2021”, 12 pgs.
“U.S. Appl. No. 16/160,559, Notice of Allowance dated Sep. 16, 2021”, 14 pgs.
“U.S. Appl. No. 16/160,559, Response filed Aug. 11, 2021 to Non Final Office Action dated May 14, 2021”, 10 pgs.
“U.S. Appl. No. 16/251,342, Notice of Allowance dated Jul. 26, 2021”, 8 pgs.
“U.S. Appl. No. 16/255,300, Notice of Allowance dated Jul. 19, 2021”, 10 pgs.
“U.S. Appl. No. 16/380,742, Response filed Oct. 20, 2021 to Restriction Requirement dated Aug. 20, 2021”, 6 pgs.
“U.S. Appl. No. 16/380,742, Restriction Requirement dated Aug. 20, 2021”, 7 pgs.
“U.S. Appl. No. 16/420,676, Non Final Office Action dated Jul. 20, 2021”, 11 pgs.
“U.S. Appl. No. 16/436,023, Response filed Oct. 20, 2021 to Non Final Office Action dated Jul. 20, 2021”, 14 pgs.
“U.S. Appl. No. 16/436,023, Examiner Interview Summary dated Aug. 23, 2021”, 2 pgs.
“U.S. Appl. No. 16/436,023, Non Final Office Action dated May 19, 2021”, 18 pgs.
“U.S. Appl. No. 16/436,023, Notice of Allowance dated Oct. 27, 2021”, 8 pgs.
“U.S. Appl. No. 16/436,023, Response filed Aug. 19, 2021 to Non Final Office actio dated May 19, 2021”, 9 pgs.
“U.S. Appl. No. 16/443,391, Non Final Office Action dated Aug. 31, 2021”, 11 pgs.
“U.S. Appl. No. 16/508,764, Notice of Allowance dated Oct. 20, 2021”, 10 pgs.
“U.S. Appl. No. 16/508,764, Supplemental Amendment filed Sep. 30, 2021”, 6 pgs.
“U.S. Appl. No. 17/392,971, Preliminary Amendment filed Aug. 18, 2021”, 9 pgs.
“U.S. Appl. No. 17/492,082, Preliminary Amendment filed Oct. 25, 2021”, 6 pgs.
“U.S. Appl. No. 17/516,664, Preliminary Amendment filed Nov. 10, 2021”.
“U.S. Appl. No. 14/936,831, Notice of Allowance dated Jul. 3, 2019”, 8 pgs.
“U.S. Appl. No. 15/288,183, Corrected Notice of Allowability dated Jun. 21, 2019”, 7 pgs.
“U.S. Appl. No. 15/288,183, Notice of Allowance dated May 9, 2019”, 11 pgs.
“U.S. Appl. No. 15/294,994, Notice of Allowance dated May 22, 2019”, 10 pgs.
“U.S. Appl. No. 15/361,917, Final Office Action dated Sep. 3, 2019”, 8 pgs.
“U.S. Appl. No. 15/361,917, Response filed Jun. 19, 2019 to Non Final Office Action dated Apr. 19, 2019”, 9 pgs.
“U.S. Appl. No. 15/401,768, Non Final Office Action dated Jul. 22, 2019”, 10 pgs.
“U.S. Appl. No. 15/401,768, Response filed May 15, 2019 to Restriction Requirement dated Mar. 15, 2019”, 7 pgs.
“U.S. Appl. No. 15/401,768, Response filed Aug. 28, 2019 to Non Final Office Action dated Jul. 22, 2019”, 10 pgs.
“U.S. Appl. No. 15/412,676, Non Final Office Action dated Jul. 23, 2019”, 11 pgs.
“U.S. Appl. No. 15/412,676, Response filed May 15, 2019 to Restriction Requirement dated Mar. 15, 2019”, 7 pgs.
“U.S. Appl. No. 15/455,895, Non Final Office Action dated Sep. 5, 2019”, 11 pgs.
“U.S. Appl. No. 15/455,895, Supplemental Preliminary Amendment filed May 24, 2019”, 6 pgs.
“U.S. Appl. No. 15/461,675, Non Final Office Action dated Aug. 9, 2019”, 10 pgs.
“U.S. Appl. No. 15/461,675, Response filed May 24, 2019 to Restriction Requirement dated Mar. 26, 2019”, 6 pgs.
“U.S. Appl. No. 15/622,718, Non Final Office Action dated Aug. 28, 2019”, 14 pgs.
“U.S. Appl. No. 15/622,718, Response filed Jul. 31, 2019 to Restriction Requirement dated Jun. 7, 2019”, 8 pgs.
“U.S. Appl. No. 15/622,718, Restriction Requirement dated Jun. 7, 2019”, 6 pgs.
“U.S. Appl. No. 15/626,384, Notice of Allowance dated Aug. 21, 2019”, 7 pgs.
“U.S. Appl. No. 15/626,384, Response filed Jul. 31, 2019 to Non-Final Office Action dated May 3, 2019”, 13 pgs.
“U.S. Appl. No. 15/654,386, Response filed Aug. 23, 2019 to Restriction Requirement dated Jul. 16, 2019”, 9 pgs.
“U.S. Appl. No. 15/654,386, Restriction Requirement dated Jul. 16, 2019”, 6 pgs.
“U.S. Appl. No. 15/662,572, Response filed Aug. 23, 2019 to Restriction Requirement dated Jul. 1, 2019”, 8 pgs.
“U.S. Appl. No. 15/662,572, Restriction Requirement dated Jul. 1, 2019”, 6 pgs.
“U.S. Appl. No. 15/664,572, Non Final Office Action dated May 15, 2019”, 8 pgs.
“U.S. Appl. No. 15/664,572, Notice of Allowance dated Jun. 12, 2019”, 8 pgs.
“U.S. Appl. No. 15/664,572, Response filed May 17, 2019 to Non Final Office Action dated May 15, 2019”, 9 pgs.
“U.S. Appl. No. 15/682,187, Response filed Sep. 18, 2019 to Restriction Requirement dated Aug. 9, 2019”, 7 pgs.
“U.S. Appl. No. 15/682,187, Restriction Requirement dated Aug. 9, 2019”, 6 pgs.
“U.S. Appl. No. 15/703,727, Non Final Office Action dated Aug. 1, 2019”, 11 pgs.
“U.S. Appl. No. 15/715,731, Restriction Requirement dated Sep. 4, 2019”, 6 pgs.
“U.S. Appl. No. 15/720,997, Non Final Office Action dated Jul. 16, 2019”, 11 pgs.
“U.S. Appl. No. 15/722,002, Restriction Requirement dated Sep. 17, 2019”, 6 pgs.
“U.S. Appl. No. 15/793,216, Non Final Office Action dated Aug. 1, 2019”, 21 pgs.
“U.S. Appl. No. 15/865,938, Notice of Allowance dated Sep. 17, 2019”, 11 pgs.
“U.S. Appl. No. 16/420,676, Preliminary Amendment filed Jun. 3, 2019”, 5 pgs.
“U.S. Appl. No. 16/428,277, Preliminary Amendment filed Jun. 3, 2019”, 5 pgs.
“U.S. Appl. No. 16/436,023, Preliminary Amendment filed Jun. 12, 2019”, 6 pgs.
“U.S. Appl. No. 16/443,391, Preliminary Amendment filed Jun. 19, 2019”, 6 pgs.
“U.S. Appl. No. 16/508,764, Preliminary Amendment filed Jul. 12, 2019”, 7 pgs.
“U.S. Appl. No. 16/544,293, Preliminary Amendment filed Aug. 21, 2019”, 7 pgs.
“U.S. Appl. No. 15/060,007, Corrected Notice of Allowability dated May 1, 2019”, 2 pgs.
“U.S. Appl. No. 15/626,384, Non Final Office Action dated May 3, 2019”, 27 pgs.
Dolphin, Sutures, “Information of Polydioxanone”, [Online] Retrieved from the internet: <https://www.dolphinsutures.com/resoucres/information-on-polydioxanone>, (2018), 2 pgs.
“U.S. Appl. No. 16/160,559, PTO Response to Rule 312 Communication dated Dec. 24, 2021”, 2 pgs.
“U.S. Appl. No. 16/380,742, Notice of Allowance dated Jan. 3, 2022”, 13 pgs.
“U.S. Appl. No. 16/420,676, Notice of Allowance dated Nov. 15, 2021”, 9 pgs.
“U.S. Appl. No. 16/428,277, Response filed Apr. 11, 2022 to Restriction Requirement dated Feb. 11, 2022”, 8 pgs.
“U.S. Appl. No. 16/428,277, Restriction Requirement dated Feb. 11, 2022”, 6 pgs.
“U.S. Appl. No. 16/443,391, Notice of Allowance dated Jan. 7, 2022”, 5 pgs.
“U.S. Appl. No. 16/443,391, Response filed Nov. 15, 2021 to Non Final Office Action dated Aug. 31, 2021”, 9 pgs.
“U.S. Appl. No. 16/690,671, Non Final Office Action dated Nov. 15, 2021”, 8 pgs.
“U.S. Appl. No. 16/690,671, Notice of Allowance dated Mar. 2, 2022”, 7 pgs.
“U.S. Appl. No. 16/690,671, Response filed Feb. 4, 2022 to Non Final Office Action dated Nov. 15, 2021”, 10 pgs.
“U.S. Appl. No. 16/795,181, Non Final Office Action dated Jan. 24, 2022”, 12 pgs.
“U.S. Appl. No. 17/545,668, Preliminary Amendment filed Dec. 9, 2021”, 5 pgs.
“U.S. Appl. No. 17/550,074, Preliminary Amendment filed Dec. 15, 2021”, 5 pgs.
“U.S. Appl. No. 17/577,188, Preliminary Amendment filed Jan. 19, 2022”, 7 pgs.
“AperFix® System Surgical Technique Guide. Single Tunnel Double Bundle.™”, Cayenne Medical brochure, (Aug. 2008), 8 pgs.
“U.S. Appl. No. 10/984,624, Final Office Action dated Jan. 5, 2009”, 9 pgs.
“U.S. Appl. No. 10/984,624, Non Final Office Action dated Jul. 10, 2008”, 9 pgs.
“U.S. Appl. No. 10/984,624, Notice of Allowance dated Jun. 12, 2009”, 9 pgs.
“U.S. Appl. No. 10/984,624, Response filed Apr. 1, 2009 to Final Office Action dated Jan. 5, 2009”, 16 pgs.
“U.S. Appl. No. 10/984,624, Response filed Apr. 15, 2008 to Restriction Requirement dated Mar. 24, 2008”, 1 pg.
“U.S. Appl. No. 10/984,624, Response filed Oct. 10, 2008 to Non Final Office Action dated Jul. 10, 2008”, 12 pgs.
“U.S. Appl. No. 10/984,624, Restriction Requirement dated Mar. 24, 2008”, 5 pgs.
“U.S. Appl. No. 11/294,694, Final Office Action dated Sep. 1, 2010”, 14 pgs.
“U.S. Appl. No. 11/294,694, Non Final Office Action dated Mar. 16, 2010”, 19 pgs.
“U.S. Appl. No. 11/294,694, Notice of Allowance dated Nov. 17, 2010”, 4 pgs.
“U.S. Appl. No. 11/294,694, Preliminary Amendment filed Jan. 13, 2010”, 9 pgs.
“U.S. Appl. No. 11/294,694, Response filed Jun. 16, 10 to Non Final Office Action dated Mar. 16, 2010”, 16 pgs.
“U.S. Appl. No. 11/294,694, Response filed Nov. 1, 2010 to Final Office Action dated Sep. 1, 2010”, 10 pgs.
“U.S. Appl. No. 11/294,694, Response filed Dec. 22, 2009 to Restriction Requirement dated Nov. 25, 2009”, 1 pg.
“U.S. Appl. No. 11/294,694, Restriction Requirement dated Nov. 25, 2009”, 9 pgs.
“U.S. Appl. No. 11/347,661, Examiner Interview Summary dated Sep. 11, 2009”, 2 pgs.
“U.S. Appl. No. 11/347,661, Final Office Action dated Mar. 3, 2009”, 15 pgs.
“U.S. Appl. No. 11/347,661, Non Final Office Action dated Aug. 13, 2009”, 19 pgs.
“U.S. Appl. No. 11/347,661, Non Final Office Action dated Aug. 21, 2008”, 11 pgs.
“U.S. Appl. No. 11/347,661, Notice of Allowance dated Feb. 24, 2010”, 8 pgs.
“U.S. Appl. No. 11/347,661, Notice of Allowance dated May 5, 2010”, 8 pgs.
“U.S. Appl. No. 11/347,661, Response filed May 29, 2008 to Restriction Requirement dated Apr. 30, 2008”, 1 pg.
“U.S. Appl. No. 11/347,661, Response filed Jun. 3, 2009 to Final Office Action dated Mar. 3, 2009”, 19 pgs.
“U.S. Appl. No. 11/347,661, Response filed Nov. 6, 2009 to Non Final Office Action dated Aug. 13, 2009”, 16 pgs.
“U.S. Appl. No. 11/347,661, Response filed Nov. 19, 2008 to Non Final Office Action dated Aug. 21, 2008”, 12 pgs.
“U.S. Appl. No. 11/347,661, Restriction Requirement dated Apr. 30, 2008”, 6 pgs.
“U.S. Appl. No. 11/347,662, Examiner Interview Summary dated Jun. 24, 2010”, 3 pgs.
“U.S. Appl. No. 11/347,662, Examiner Interview Summary dated Nov. 9, 2009”, 3 pgs.
“U.S. Appl. No. 11/347,662, Final Office Action dated Sep. 16, 2009”, 13 pgs.
“U.S. Appl. No. 11/347,662, Final Office Action dated Oct. 26, 2010”, 10 pgs.
“U.S. Appl. No. 11/347,662, Non Final Office Action dated Mar. 9, 2009”, 11 pgs.
“U.S. Appl. No. 11/347,662, Non Final Office Action dated May 21, 2010”, 19 pgs.
“U.S. Appl. No. 11/347,662, Non Final Office Action dated Oct. 28, 2008”, 13 pgs.
“U.S. Appl. No. 11/347,662, Response filed Jan. 16, 2009 to Non Final Office Action dated Oct. 28, 2008”, 16 pgs.
“U.S. Appl. No. 11/347,662, Response filed Feb. 12, 2010 to Final Office Action dated Sep. 16, 2009”, 21 pgs.
“U.S. Appl. No. 11/347,662, Response filed Jun. 5, 2009 to Non Final Office Action dated Mar. 9, 2009”, 13 pgs.
“U.S. Appl. No. 11/347,662, Response filed Aug. 20, 2010 to Non Final Office Action dated May 21, 2010”, 13 pgs.
“U.S. Appl. No. 11/386,071, Advisory Action dated Dec. 23, 2010”, 3 pgs.
“U.S. Appl. No. 11/386,071, Examiner Interview Summary dated Jan. 31, 2011”, 3 pgs.
“U.S. Appl. No. 11/386,071, Examiner Interview Summary dated Jul. 21, 2010”, 3 pgs.
“U.S. Appl. No. 11/386,071, Final Office Action dated Oct. 27, 2010”, 10 pgs.
“U.S. Appl. No. 11/386,071, Non Final Office Action dated May 12, 2010”, 13 pgs.
“U.S. Appl. No. 11/386,071, Notice of Allowance dated Jun. 6, 2011”, 6 pgs.
“U.S. Appl. No. 11/386,071, Response filed Jan. 26, 2011 to Advisory Action dated Dec. 23, 2010”, 13 pgs.
“U.S. Appl. No. 11/386,071, Response filed Aug. 12, 2010 to Non Final Office Action dated May 12, 2010”, 14 pgs.
“U.S. Appl. No. 11/386,071, Response filed Dec. 15, 2010 to Final Office Action dated Oct. 27, 2010”, 14 pgs.
“U.S. Appl. No. 11/408,282, Final Office Action dated Dec. 15, 2008”, 8 pgs.
“U.S. Appl. No. 11/408,282, Non Final Office Action dated May 23, 2008”, 12 pgs.
“U.S. Appl. No. 11/408,282, Response filed Aug. 21, 2008 to Non Final Office Action dated May 23, 2008”, 10 pgs.
“U.S. Appl. No. 11/504,882, Examiner Interview Summary dated Sep. 2, 2010”, 3 pgs.
“U.S. Appl. No. 11/504,882, Final Office Action dated Dec. 21, 2010”, 7 pgs.
“U.S. Appl. No. 11/504,882, Non Final Office Action dated Jun. 19, 2014”, 11 pgs.
“U.S. Appl. No. 11/504,882, Non Final Office Action dated Jun. 23, 2010”, 8 pgs.
“U.S. Appl. No. 11/504,882, Non Final Office Action dated Nov. 13, 2013”, 13 pgs.
“U.S. Appl. No. 11/504,882, Notice of Allowance dated Dec. 1, 2014”, 9 pgs.
“U.S. Appl. No. 11/504,882, Response filed Feb. 10, 2014 to Non Final Office Action dated Nov. 13, 2013”, 11 pgs.
“U.S. Appl. No. 11/504,882, Response filed Mar. 18, 2011 to Final Office Action dated Dec. 21, 2010”, 11 pgs.
“U.S. Appl. No. 11/504,882, Response filed Sep. 17, 2014 to Non Final Office Action dated Jun. 19, 2014”, 14 pgs.
“U.S. Appl. No. 11/504,882, Response filed Sep. 23, 2010 to Non Final Office Action dated Jun. 23, 2010”, 12 pgs.
“U.S. Appl. No. 11/504,882, Supplemental Notice of Allowability dated Mar. 12, 2015”, 5 pgs.
“U.S. Appl. No. 11/541,505, Non Final Office Action dated May 19, 2009”, 7 pgs.
“U.S. Appl. No. 11/541,505, Notice of Allowance dated Sep. 18, 2009”, 8 pgs.
“U.S. Appl. No. 11/541,505, Response filed Apr. 9, 2009 to Restriction Requirement dated Mar. 9, 2009”, 1 pg.
“U.S. Appl. No. 11/541,505, Response filed Jun. 18, 09 to Non Final Office Action dated May 19, 2009”, 5 pgs.
“U.S. Appl. No. 11/541,505, Restriction Requirement dated Mar. 9, 2009”, 9 pgs.
“U.S. Appl. No. 11/541,506, Notice of Allowance dated Jun. 1, 2009”, 10 pgs.
“U.S. Appl. No. 11/541,506, Notice of Allowance dated Jun. 29, 2009”, 8 pgs.
“U.S. Appl. No. 11/541,506, Response filed Apr. 9, 2009 to Restriction Requirement dated Mar. 9, 2009”, 1 pg.
“U.S. Appl. No. 11/541,506, Restriction Requirement dated Mar. 9, 2009”, 6 pgs.
“U.S. Appl. No. 11/739,768, Examiner Interview Summary dated May 11, 2011”, 3 pgs.
“U.S. Appl. No. 11/739,768, Examiner Interview Summary dated Oct. 4, 2011”, 3 pgs.
“U.S. Appl. No. 11/739,768, Final Office Action dated Aug. 22, 2011”, 14 pgs.
“U.S. Appl. No. 11/739,768, Non Final Office Action dated Mar. 4, 2011”, 11 pgs.
“U.S. Appl. No. 11/739,768, Notice of Allowance dated Nov. 15, 2011”, 5 pgs.
“U.S. Appl. No. 11/739,768, Response filed Jun. 6, 2011 to Non Final Office Action dated Mar. 4, 2011”, 15 pgs.
“U.S. Appl. No. 11/739,768, Response filed Oct. 26, 2011 to Final Office Action dated Aug. 22, 2011”, 14 pgs.
“U.S. Appl. No. 11/740,035, Final Office Action dated Aug. 7, 2008”, 9 pgs.
“U.S. Appl. No. 11/740,035, Non Final Office Action dated Jan. 3, 2008”, 9 pgs.
“U.S. Appl. No. 11/740,035, Response filed Apr. 3, 2008 to Non Final Office Action dated Jan. 3, 2008”, 6 pgs.
“U.S. Appl. No. 11/784,821, Corrected Notice of Allowance dated Dec. 24, 2014”, 4 pgs.
“U.S. Appl. No. 11/784,821, Examiner Interview Summary dated Jun. 26, 2014”, 3 pgs.
“U.S. Appl. No. 11/784,821, Examiner Interview Summary dated Nov. 17, 2009”, 3 pgs.
“U.S. Appl. No. 11/784,821, Final Office Action dated Mar. 10, 2010”, 11 pgs.
“U.S. Appl. No. 11/784,821, Non Final Office Action dated Mar. 28, 2014”, 14 pgs.
“U.S. Appl. No. 11/784,821, Non Final Office Action dated Sep. 4, 2009”, 12 pgs.
“U.S. Appl. No. 11/784,821, Notice of Allowance dated Oct. 21, 2014”, 10 pgs.
“U.S. Appl. No. 11/784,821, Response filed Jun. 10, 2010 to Final Office Action dated Mar. 10, 2010”, 20 pgs.
“U.S. Appl. No. 11/784,821, Response filed Jun. 15, 2009 to Restriction Requirement dated May 13, 2009”, 2 pgs.
“U.S. Appl. No. 11/784,821, Response filed Jun. 26, 2014 to Non Final Office Action dated Mar. 28, 2014”, 16 pgs.
“U.S. Appl. No. 11/784,821, Response filed Nov. 23, 2009 to Non Final Office Action dated Sep. 4, 2009”, 17 pgs.
“U.S. Appl. No. 11/784,821, Restriction Requirement dated May 13, 2009”, 6 pgs.
“U.S. Appl. No. 11/869,440, Examiner Interview Summary dated Mar. 25, 2010”, 3 pgs.
“U.S. Appl. No. 11/869,440, Non Final Office Action dated Mar. 1, 2010”, 13 pgs.
“U.S. Appl. No. 11/869,440, Notice of Allowance dated Aug. 19, 2010”, 10 pgs.
“U.S. Appl. No. 11/869,440, Response filed Jun. 1, 2010 to Non Final Office Action dated Mar. 1, 2010”, 14 pgs.
“U.S. Appl. No. 11/935,681, Examiner Interview Summary dated Jul. 19, 2010”, 3 pgs.
“U.S. Appl. No. 11/935,681, Non Final Office Action dated May 24, 2010”, 12 pgs.
“U.S. Appl. No. 11/935,681, Notice of Allowance dated Nov. 8, 2010”, 10 pgs.
“U.S. Appl. No. 11/935,681, Response filed Apr. 19, 10 to Restriction Requirement dated Mar. 17, 2010”, 4 pgs.
“U.S. Appl. No. 11/935,681, Response filed Aug. 24, 2010 to Non Final Office Action dated May 24, 2010”, 13 pgs.
“U.S. Appl. No. 11/935,681, Restriction Requirement dated Mar. 17, 2010”, 6 pgs.
“U.S. Appl. No. 12/014,340, Examiner Interview Summary dated Jun. 22, 2010”, 3 pgs.
“U.S. Appl. No. 12/014,340, Non Final Office Action dated May 25, 2010”, 12 pgs.
“U.S. Appl. No. 12/014,340, Notice of Allowance dated Nov. 8, 2010”, 9 pgs.
“U.S. Appl. No. 12/014,340, Preliminary Amendment filed May 21, 2010”, 11 pgs.
“U.S. Appl. No. 12/014,340, Response filed Apr. 26, 2010 to Restriction Requirement dated Mar. 25, 2010”, 2 pgs.
“U.S. Appl. No. 12/014,340, Response filed Aug. 25, 2010 to Non Final Office Action dated May 25, 2010”, 16 pgs.
“U.S. Appl. No. 12/014,340, Restriction Requirement dated Mar. 25, 2010”, 9 pgs.
“U.S. Appl. No. 12/014,399, Examiner Interview Summary dated Jun. 23, 2010”, 3 pgs.
“U.S. Appl. No. 12/014,399, Non Final Office Action dated May 26, 2010”, 13 pgs.
“U.S. Appl. No. 12/014,399, Notice of Allowance dated Nov. 12, 2010”, 11 pgs.
“U.S. Appl. No. 12/014,399, Preliminary Amendment filed May 25, 2010”, 10 pgs.
“U.S. Appl. No. 12/014,399, Response filed May 5, 2010 to Restriction Requirement dated Apr. 6, 2010”, 2 pgs.
“U.S. Appl. No. 12/014,399, Response filed Aug. 25, 2010 to Non Final Office Action dated May 26, 2010”, 14 pgs.
“U.S. Appl. No. 12/014,399, Restriction Requirement dated Apr. 6, 2010”, 9 pgs.
“U.S. Appl. No. 12/029,861, Examiner Interview Summary dated Jan. 27, 2012”, 3 pgs.
“U.S. Appl. No. 12/029,861, Final Office Action dated Dec. 8, 2011”, 11 pgs.
“U.S. Appl. No. 12/029,861, Non Final Office Action dated Jul. 26, 2011”, 11 pgs.
“U.S. Appl. No. 12/029,861, Notice of Allowance dated Apr. 26, 2012”, 5 pgs.
“U.S. Appl. No. 12/029,861, Response filed Jan. 26, 2012 to Final Office Action dated Dec. 8, 2011”, 15 pgs.
“U.S. Appl. No. 12/029,861, Response filed May 6, 2011 to Restriction Requirement dated Apr. 7, 2011”, 10 pgs.
“U.S. Appl. No. 12/029,861, Response filed Jun. 23, 2011 to Restriction Requirement dated May 24, 2011”, 1 pgs.
“U.S. Appl. No. 12/029,861, Response filed Oct. 14, 2011 to Non Final Office Action dated Jul. 26, 2011”, 11 pgs.
“U.S. Appl. No. 12/029,861, Restriction Requirement dated Apr. 7, 2011”, 8 pgs.
“U.S. Appl. No. 12/029,861, Restriction Requirement dated May 24, 2011”, 6 pgs.
“U.S. Appl. No. 12/107,437, Examiner Interview Summary dated May 10, 2010”, 4 pgs.
“U.S. Appl. No. 12/107,437, Non Final Office Action dated Mar. 17, 2010”, 9 pgs.
“U.S. Appl. No. 12/107,437, Preliminary Amendment filed Feb. 23, 2010”, 9 pgs.
“U.S. Appl. No. 12/107,437, Response filed Jan. 29, 10 to Restriction Requirement dated Jan. 13, 2010”, 1 pgs.
“U.S. Appl. No. 12/107,437, Restriction Requirement dated Jan. 13, 2010”, 7 pgs.
“U.S. Appl. No. 12/196,398, Examiner Interview Summary dated Nov. 8, 2010”, 3 pgs.
“U.S. Appl. No. 12/196,398, Notice of Allowance dated Feb. 3, 2011”, 12 pgs.
“U.S. Appl. No. 12/196,398, Preliminary Amendment filed Nov. 10, 2008”, 3 pgs.
“U.S. Appl. No. 12/196,398, Preliminary Amendment filed Dec. 1, 2010”, 12 pgs.
“U.S. Appl. No. 12/196,398, Preliminary Amendment filed Dec. 9, 2008”, 46 pgs.
“U.S. Appl. No. 12/196,398, Response filed Oct. 29, 2010 to Restriction Requirement dated Sep. 29, 2010”, 2 pgs.
“U.S. Appl. No. 12/196,398, Restriction Requirement dated Sep. 29, 2010”, 6 pgs.
“U.S. Appl. No. 12/196,398, Supplemental Notice of Allowability dated Mar. 9, 2011”, 4 pgs.
“U.S. Appl. No. 12/196,398, Supplemental Notice of Allowability dated Apr. 15, 2011”, 4 pgs.
“U.S. Appl. No. 12/196,405, Examiner Interview Summary dated Jun. 20, 2011”, 3 pgs.
“U.S. Appl. No. 12/196,405, Non Final Office Action dated Apr. 11, 2011”, 13 pgs.
“U.S. Appl. No. 12/196,405, Notice of Allowance dated Oct. 26, 2011”, 11 pgs.
“U.S. Appl. No. 12/196,405, Preliminary Amendment filed Nov. 10, 2008”, 3 pgs.
“U.S. Appl. No. 12/196,405, Response filed Mar. 16, 2011 to Restriction Requirement dated Feb. 14, 2011”, 1 pgs.
“U.S. Appl. No. 12/196,405, Response filed Jul. 12, 2011 to Non Final Office Action dated Apr. 11, 2011”, 19 pgs.
“U.S. Appl. No. 12/196,405, Restriction Requirement dated Feb. 14, 2011”, 6 pgs.
“U.S. Appl. No. 12/196,405, Supplemental Amendment filed Oct. 3, 2011”, 12 pgs.
“U.S. Appl. No. 12/196,407, Examiner Interview Summary dated Jul. 14, 2011”, 3 pgs.
“U.S. Appl. No. 12/196,407, Non Final Office Action dated May 4, 2011”, 11 pgs.
“U.S. Appl. No. 12/196,407, Notice of Allowance dated Oct. 26, 2011”, 10 pgs.
“U.S. Appl. No. 12/196,407, Preliminary Amendment filed Nov. 10, 2008”, 3 pgs.
“U.S. Appl. No. 12/196,407, Response filed Apr. 20, 2011 to Restriction Requirement dated Mar. 22, 2011”, 12 pgs.
“U.S. Appl. No. 12/196,407, Response filed Aug. 2, 2011 to Non Final Office Action dated May 4, 2011”, 27 pgs.
“U.S. Appl. No. 12/196,407, Restriction Requirement dated Mar. 22, 2011”, 6 pgs.
“U.S. Appl. No. 12/196,407, Supplemental Response to Non Final Office Action filed Oct. 3, 2011”, 18 pgs.
“U.S. Appl. No. 12/196,410, Examiner Interview Summary dated Jul. 14, 2011”, 3 pgs.
“U.S. Appl. No. 12/196,410, Non Final Office Action dated May 9, 2011”, 9 pgs.
“U.S. Appl. No. 12/196,410, Notice of Allowance dated Oct. 13, 2011”, 8 pgs.
“U.S. Appl. No. 12/196,410, Response filed Apr. 20, 2011 to Restriction Requirement dated Mar. 22, 2011”, 13 pgs.
“U.S. Appl. No. 12/196,410, Response filed Aug. 1, 2011 to Non Final Office Action dated May 9, 2011”, 23 pgs.
“U.S. Appl. No. 12/196,410, Restriction Requirement dated Mar. 22, 2011”, 6 pgs.
“U.S. Appl. No. 12/196,410, Supplemental Amendment filed Oct. 3, 2011”, 15 pgs.
“U.S. Appl. No. 12/398,548, Examiner Interview Summary dated Jul. 12, 2011”, 3 pgs.
“U.S. Appl. No. 12/398,548, Non Final Office Action dated Apr. 12, 2011”, 7 pgs.
“U.S. Appl. No. 12/398,548, Notice of Allowance dated Oct. 18, 2011”, 7 pgs.
“U.S. Appl. No. 12/398,548, Response filed Jul. 12, 2011 to Non Final Office Action dated Apr. 12, 2011”, 15 pgs.
“U.S. Appl. No. 12/398,548, Supplemental Preliminary Amendment filed Sep. 7, 2010”, 11 pgs.
“U.S. Appl. No. 12/419,491, Examiner Interview Summary dated May 30, 2012”, 3 pgs.
“U.S. Appl. No. 12/419,491, Examiner Interview Summary dated Nov. 29, 2011”, 3 pgs.
“U.S. Appl. No. 12/419,491, Final Office Action dated Apr. 12, 2012”, 12 pgs.
“U.S. Appl. No. 12/419,491, Non Final Office Action dated Sep. 22, 2011”, 12 pgs.
“U.S. Appl. No. 12/419,491, Notice of Allowance dated Jul. 13, 2012”, 10 pgs.
“U.S. Appl. No. 12/419,491, Response filed May 30, 2012 to Final Office Action dated Apr. 12, 2012”, 12 pgs.
“U.S. Appl. No. 12/419,491, Response filed Dec. 9, 2011 to Non Final Office Action dated Sep. 22, 2011”, 17 pgs.
“U.S. Appl. No. 12/474,802, Notice of Allowance dated Aug. 31, 2011”, 13 pgs.
“U.S. Appl. No. 12/474,802, Notice of Allowance dated Oct. 26, 2011”, 4 pgs.
“U.S. Appl. No. 12/474,802, Response filed Mar. 28, 2011 to Restriction Requirement dated Feb. 24, 2011”, 12 pgs.
“U.S. Appl. No. 12/474,802, Restriction Requirement dated Feb. 24, 2011”, 6 pgs.
“U.S. Appl. No. 12/489,168, Examiner Interview Summary dated Feb. 21, 2012”, 3 pgs.
“U.S. Appl. No. 12/489,168, Non Final Office Action dated Dec. 7, 2011”, 10 pgs.
“U.S. Appl. No. 12/489,168, Notice of Allowance dated Apr. 26, 2012”, 8 pgs.
“U.S. Appl. No. 12/489,168, Notice of Allowance dated Sep. 5, 2012”, 8 pgs.
“U.S. Appl. No. 12/489,168, Preliminary Amendment filed Oct. 22, 2009”, 3 pgs.
“U.S. Appl. No. 12/489,168, Response filed Feb. 27, 2012 to Non Final Office Action dated Dec. 7, 2011”, 15 pgs.
“U.S. Appl. No. 12/489,168, Response filed Nov. 11, 2011 to Restriction Requirement dated Oct. 20, 2011”, 1 pg.
“U.S. Appl. No. 12/489,168, Restriction Requirement dated Oct. 20, 2011”, 8 pgs.
“U.S. Appl. No. 12/489,181, Examiner Interview Summary dated Feb. 13, 2012”, 3 pgs.
“U.S. Appl. No. 12/489,181, Non Final Office Action dated Jan. 3, 2012”, 9 pgs.
“U.S. Appl. No. 12/489,181, Notice of Allowance dated May 23, 2012”, 9 pgs.
“U.S. Appl. No. 12/489,181, Preliminary Amendment filed Mar. 31, 2011”, 10 pgs.
“U.S. Appl. No. 12/489,181, Preliminary Amendment filed Oct. 22, 2009”, 3 pgs.
“U.S. Appl. No. 12/489,181, Response filed Mar. 27, 2012 to Non Final Office Action dated Jan. 3, 2012”, 12 pgs.
“U.S. Appl. No. 12/489,181, Response filed Dec. 5, 2011 to Restriction Requirement dated Nov. 4, 2011”, 1 pg.
“U.S. Appl. No. 12/489,181, Restriction Requirement dated Nov. 4, 2011”, 7 pgs.
“U.S. Appl. No. 12/570,854, Examiner Interview Summary dated Apr. 16, 2012”, 3 pgs.
“U.S. Appl. No. 12/570,854, Non Final Office Action dated Feb. 10, 2012”, 8 pgs.
“U.S. Appl. No. 12/570,854, Notice of Allowance dated Jun. 29, 2012”, 10 pgs.
“U.S. Appl. No. 12/570,854, Notice of Allowance dated Sep. 19, 2012”, 6 pgs.
“U.S. Appl. No. 12/570,854, Response filed May 10, 2012 to Non Final Office Action dated Feb. 10, 2012”, 27 pgs.
“U.S. Appl. No. 12/570,854, Response filed Dec. 20, 2011 to Restriction Requirement dated Dec. 14, 2011”, 1 pg.
“U.S. Appl. No. 12/570,854, Restriction Requirement dated Dec. 14, 2011”, 6 pgs.
“U.S. Appl. No. 12/702,067, Non Final Office Action dated Mar. 5, 2013”, 8 pgs.
“U.S. Appl. No. 12/702,067, Notice of Allowance dated Oct. 7, 2013”, 11 pgs.
“U.S. Appl. No. 12/702,067, Preliminary Amendment filed Jan. 11, 2011”, 13 pgs.
“U.S. Appl. No. 12/702,067, Response filed Jun. 5, 2013 to Non Final Office Action dated Mar. 5, 2013”, 17 pgs.
“U.S. Appl. No. 12/702,067, Response filed Oct. 2, 2012 to Restriction Requirement dated Sep. 4, 2012”, 1 pg.
“U.S. Appl. No. 12/702,067, Restriction Requirement dated Sep. 4, 2012”, 9 pgs.
“U.S. Appl. No. 12/719,337, Advisory Action dated Sep. 30, 2014”, 4 pgs.
“U.S. Appl. No. 12/719,337, Examiner Interview Summary dated Apr. 4, 2014”, 4 pgs.
“U.S. Appl. No. 12/719,337, Examiner Interview Summary dated May 14, 2013”, 3 pgs.
“U.S. Appl. No. 12/719,337, Examiner Interview Summary dated Sep. 18, 2014”, 3 pgs.
“U.S. Appl. No. 12/719,337, Final Office Action dated Mar. 12, 2013”, 8 pgs.
“U.S. Appl. No. 12/719,337, Final Office Action dated Jul. 18, 2014”, 15 pgs.
“U.S. Appl. No. 12/719,337, Non Final Office Action dated Jan. 10, 2014”, 14 pgs.
“U.S. Appl. No. 12/719,337, Non Final Office Action dated Sep. 5, 2012”, 7 pgs.
“U.S. Appl. No. 12/719,337, Notice of Allowance dated Mar. 11, 2015”, 10 pgs.
“U.S. Appl. No. 12/719,337, Notice of Non-Compliant Amendment dated May 2, 2014”, 3 pgs.
“U.S. Appl. No. 12/719,337, Response filed Apr. 10, 2014 to Non Final Office Action dated Jan. 10, 2014”, 16 pgs.
“U.S. Appl. No. 12/719,337, Response filed May 25, 2012 to Restriction Requirement dated Apr. 26, 2012”, 9 pgs.
“U.S. Appl. No. 12/719,337, Response filed Jun. 5, 2013 to Final Office Action dated Mar. 12, 2013”, 16 pgs.
“U.S. Appl. No. 12/719,337, Response filed Jun. 25, 2014 to Notice of Non-Compliant Amendment dated May 2, 2014”, 10 pgs.
“U.S. Appl. No. 12/719,337, Response filed Sep. 18, 2014 to Final Office Action dated Jul. 18, 2014”, 13 pgs.
“U.S. Appl. No. 12/719,337, Response filed Nov. 28, 2012 to Non Final Office Action dated Sep. 5, 2012”, 14 pgs.
“U.S. Appl. No. 12/719,337, Restriction Requirement dated Apr. 26, 2012”, 8 pgs.
“U.S. Appl. No. 12/788,966, Examiner Interview Summary dated Jun. 1, 2012”, 3 pgs.
“U.S. Appl. No. 12/788,966, Final Office Action dated May 4, 2012”, 16 pgs.
“U.S. Appl. No. 12/788,966, Non Final Office Action dated Jan. 4, 2012”, 12 pgs.
“U.S. Appl. No. 12/788,966, Notice of Allowance dated Aug. 16, 2012”, 10 pgs.
“U.S. Appl. No. 12/788,966, Notice of Allowance dated Nov. 23, 2012”, 2 pgs.
“U.S. Appl. No. 12/788,966, Response filed Apr. 4, 2012 to Non Final Office Action dated Jan. 4, 2012”, 15 pgs.
“U.S. Appl. No. 12/788,966, Response filed Aug. 6, 2012 to Final Office Action dated May 4, 2012”, 12 pgs.
“U.S. Appl. No. 12/788,966, Response filed Dec. 16, 2011 to Restriction Requirement dated Dec. 7, 2011”, 11 pgs.
“U.S. Appl. No. 12/788,966, Restriction Requirement dated Dec. 7, 2011”, 9 pgs.
“U.S. Appl. No. 12/788,973, Advisory Action dated Jan. 23, 2013”, 3 pgs.
“U.S. Appl. No. 12/788,973, Advisory Action dated Dec. 27, 2012”, 8 pgs.
“U.S. Appl. No. 12/788,973, Final Office Action dated Sep. 18, 2012”, 16 pgs.
“U.S. Appl. No. 12/788,973, Non Final Office Action dated May 8, 2012”, 12 pgs.
“U.S. Appl. No. 12/788,973, Notice of Allowance dated Mar. 21, 2013”, 6 pgs.
“U.S. Appl. No. 12/788,973, Response filed Jan. 16, 2013 to Advisory Action dated Dec. 27, 2012”, 9 pgs.
“U.S. Appl. No. 12/788,973, Response filed Jul. 19, 2012 to Non Final Office Action dated May 8, 2012”, 21 pgs.
“U.S. Appl. No. 12/788,973, Response filed Dec. 16, 2011 to Restriction Requirement dated Dec. 6, 2011”, 11 pgs.
“U.S. Appl. No. 12/788,973, Response filed Dec. 17, 2012 to Final Office Action dated Sep. 18, 2012”, 15 pgs.
“U.S. Appl. No. 12/788,973, Restriction Requirement dated Dec. 6, 2011”, 9 pgs.
“U.S. Appl. No. 12/788,973, Supplemental Notice of Allowance dated May 24, 2013”, 2 pgs.
“U.S. Appl. No. 12/788,978, Advisory Action dated Dec. 24, 2013”, 4 pgs.
“U.S. Appl. No. 12/788,978, Applicant's Summary of Examiner Interview filed Dec. 12, 2013”, 2 pgs.
“U.S. Appl. No. 12/788,978, Corrected Notice of Allowance dated Apr. 30, 2014”, 2 pgs.
“U.S. Appl. No. 12/788,978, Examiner Interview Summary dated Jan. 28, 2014”, 3 pgs.
“U.S. Appl. No. 12/788,978, Examiner Interview Summary dated Mar. 22, 2013”, 3 pgs.
“U.S. Appl. No. 12/788,978, Examiner Interview Summary dated Sep. 11, 2012”, 3 pgs.
“U.S. Appl. No. 12/788,978, Examiner Interview Summary dated Oct. 29, 2013”, 4 pgs.
“U.S. Appl. No. 12/788,978, Examiner Interview Summary dated Dec. 16, 2013”, 3 pgs.
“U.S. Appl. No. 12/788,978, Examiner Interview Summary dated Dec. 27, 2012”, 3 pgs.
“U.S. Appl. No. 12/788,978, Final Office Action dated Aug. 20, 2013”, 17 pgs.
“U.S. Appl. No. 12/788,978, Final Office Action dated Nov. 2, 2012”, 14 pgs.
“U.S. Appl. No. 12/788,978, Non Final Office Action dated Jan. 11, 2013”, 16 pgs.
“U.S. Appl. No. 12/788,978, Non Final Office Action dated Jul. 13, 2012”, 17 pgs.
“U.S. Appl. No. 12/788,978, Notice of Allowance dated Jan. 24, 2014”, 9 pgs.
“U.S. Appl. No. 12/788,978, Notice of Non-Compliant Amendment dated Jun. 6, 2013”, 3 pgs.
“U.S. Appl. No. 12/788,978, Response filed Jan. 2, 2013 to Final Office Action dated Nov. 2, 2012”, 13 pgs.
“U.S. Appl. No. 12/788,978, Response filed Jan. 20, 2014 to Advisory Action dated Dec. 24, 2013”, 4 pgs.
“U.S. Appl. No. 12/788,978, Response filed Apr. 8, 2013 to Non Final Office Action dated Jan. 11, 2013”, 16 pgs.
“U.S. Appl. No. 12/788,978, Response filed May 21, 2012 to Restriction Requirement dated Apr. 20, 2012”, 12 pgs.
“U.S. Appl. No. 12/788,978, Response filed Jul. 3, 2013 to Notice of Non-Compliant Amendment dated Jun. 6, 2013”, 17 pgs.
“U.S. Appl. No. 12/788,978, Response filed Oct. 5, 2012 to Non Final Office Action dated Jul. 13, 2012”, 20 pgs.
“U.S. Appl. No. 12/788,978, Response filed Nov. 20, 2013 to Final Office Action dated Aug. 20, 2013”, 15 pgs.
“U.S. Appl. No. 12/788,978, Restriction Requirement dated Apr. 20, 2012”, 8 pgs.
“U.S. Appl. No. 12/828,977, Examiner Interview Summary dated Jul. 9, 2012”, 3 pgs.
“U.S. Appl. No. 12/828,977, Non Final Office Action dated May 3, 2012”, 9 pgs.
“U.S. Appl. No. 12/828,977, Notice of Allowance dated Sep. 5, 2012”, 9 pgs.
“U.S. Appl. No. 12/828,977, Preliminary Amendment filed Jul. 19, 2011”, 10 pgs.
“U.S. Appl. No. 12/828,977, Response filed Mar. 14, 2012 to Restriction Requirement dated Feb. 13, 2012”, 9 pgs.
“U.S. Appl. No. 12/828,977, Response filed Jul. 25, 2012 to Non Final Office Action dated May 3, 2012”, 11 pgs.
“U.S. Appl. No. 12/828,977, Restriction Requirement dated Feb. 13, 2012”, 7 pgs.
“U.S. Appl. No. 12/915,962, Examiner Interview Summary dated Jul. 25, 2012”, 3 pgs.
“U.S. Appl. No. 12/915,962, Non Final Office Action dated May 7, 2012”, 11 pgs.
“U.S. Appl. No. 12/915,962, Non Final Office Action dated Oct. 15, 2012”, 9 pgs.
“U.S. Appl. No. 12/915,962, Notice of Allowance dated Jun. 10, 2013”, 12 pgs.
“U.S. Appl. No. 12/915,962, Response filed Jan. 10, 2013 to Non Final Office Action dated Oct. 15, 2012”, 21 pgs.
“U.S. Appl. No. 12/915,962, Response filed Mar. 16, 2012 to Restriction Requirement dated Feb. 15, 2012”, 15 pgs.
“U.S. Appl. No. 12/915,962, Response filed Aug. 7, 2012 to Non Final Office Action dated May 7, 2012”, 26 pgs.
“U.S. Appl. No. 12/915,962, Restriction Requirement dated Feb. 15, 2012”, 8 pgs.
“U.S. Appl. No. 12/938,902, Examiner Interview Summary dated Dec. 3, 2012”, 3 pgs.
“U.S. Appl. No. 12/938,902, Non Final Office Action dated Sep. 17, 2012”, 11 pgs.
“U.S. Appl. No. 12/938,902, Notice of Allowance dated Jun. 21, 2013”, 13 pgs.
“U.S. Appl. No. 12/938,902, Notice of Allowance dated Oct. 1, 2013”, 9 pgs.
“U.S. Appl. No. 12/938,902, Response filed Aug. 6, 2012 to Restriction Requirement dated Jul. 6, 2012”, 14 pgs.
“U.S. Appl. No. 12/938,902, Response filed Dec. 10, 2012 to Non Final Office Action dated Sep. 17, 2012”, 20 pgs.
“U.S. Appl. No. 12/938,902, Restriction Requirement dated Jul. 6, 2012”, 8 pgs.
“U.S. Appl. No. 12/976,328, Examiner Interview Summary dated Feb. 13, 2012”, 3 pgs.
“U.S. Appl. No. 12/976,328, Non Final Office Action dated Dec. 15, 2011”, 13 pgs.
“U.S. Appl. No. 12/976,328, Notice of Allowance dated Apr. 30, 2012”, 9 pgs.
“U.S. Appl. No. 12/976,328, Response filed Mar. 2, 2012 to Non Final Office Action dated Dec. 15, 2011”, 15 pgs.
“U.S. Appl. No. 13/045,689, Examiner Interview Summary dated May 14, 2012”, 3 pgs.
“U.S. Appl. No. 13/045,689, Non Final Office Action dated Mar. 20, 2012”, 11 pgs.
“U.S. Appl. No. 13/045,689, Notice of Allowance dated Aug. 10, 2012”, 10 pgs.
“U.S. Appl. No. 13/045,689, Notice of Allowance dated Sep. 24, 2012”, 7 pgs.
“U.S. Appl. No. 13/045,689, Response filed Jan. 30, 12 to Restriction Requirement dated Dec. 29, 2011”, 13 pgs.
“U.S. Appl. No. 13/045,689, Response filed Jun. 8, 2012 to Non Final Office Action dated Mar. 20, 2012”, 15 pgs.
“U.S. Appl. No. 13/045,689, Restriction Requirement dated Dec. 29, 2011”, 6 pgs.
“U.S. Appl. No. 13/045,691, Examiner Interview Summary dated May 14, 2012”, 3 pgs.
“U.S. Appl. No. 13/045,691, Non Final Office Action dated Mar. 20, 2012”, 12 pgs.
“U.S. Appl. No. 13/045,691, Notice of Allowance dated Jun. 19, 2012”, 10 pgs.
“U.S. Appl. No. 13/045,691, Response filed Feb. 9, 2012 to Restriction Requirement dated Jan. 9, 2012”, 1 pg.
“U.S. Appl. No. 13/045,691, Response filed Jun. 8, 2012 to Non Final Office Action dated Mar. 20, 2012”, 17 pgs.
“U.S. Appl. No. 13/045,691, Restriction Requirement dated Jan. 9, 2012”, 6 pgs.
“U.S. Appl. No. 13/071,563, Final Office Action dated May 23, 2014”, 13 pgs.
“U.S. Appl. No. 13/071,563, Non Final Office Action dated Oct. 23, 2013”, 18 pgs.
“U.S. Appl. No. 13/071,563, Notice of Allowance dated Aug. 15, 2014”, 7 pgs.
“U.S. Appl. No. 13/071,563, Preliminary Amendment filed May 1, 2012”, 8 pgs.
“U.S. Appl. No. 13/071,563, Preliminary Amendment filed Dec. 6, 2011”, 7 pgs.
“U.S. Appl. No. 13/071,563, Response filed Jan. 21, 2014 to Non Final Office Action dated Oct. 23, 2013”, 13 pgs.
“U.S. Appl. No. 13/071,563, Response filed Jul. 23, 2014 to Final Office Action dated May 23, 2014”, 14 pgs.
“U.S. Appl. No. 13/071,563, Response filed Sep. 19, 2013 to Restriction Requirement dated Aug. 19, 2013”, 11 pgs.
“U.S. Appl. No. 13/071,563, Restriction Requirement dated Aug. 19, 2013”, 7 pgs.
“U.S. Appl. No. 13/098,897, Examiner Interview Summary dated Nov. 27, 2012”, 3 pgs.
“U.S. Appl. No. 13/098,897, Non Final Office Action dated Sep. 21, 2012”, 9 pgs.
“U.S. Appl. No. 13/098,897, Notice of Allowance dated Jun. 11, 2013”, 13 pgs.
“U.S. Appl. No. 13/098,897, Response filed Aug. 30, 2012 to Restriction Requirement dated Jul. 30, 2012”, 16 pgs.
“U.S. Appl. No. 13/098,897, Response filed Dec. 18, 2012 to Non Final Office Action dated Sep. 21, 2012”, 21 pgs.
“U.S. Appl. No. 13/098,897, Restriction Requirement dated Jul. 30, 2012”, 8 pgs.
“U.S. Appl. No. 13/098,927, Advisory Action dated Aug. 8, 2013”, 3 pgs.
“U.S. Appl. No. 13/098,927, Applicant's Summary of Examiner Interview filed Sep. 23, 2013”, 12 pgs.
“U.S. Appl. No. 13/098,927, Examiner Interview Summary dated Jun. 28, 2013”, 3 pgs.
“U.S. Appl. No. 13/098,927, Examiner Interview Summary dated Sep. 20, 2013”, 3 pgs.
“U.S. Appl. No. 13/098,927, Final Office Action dated May 22, 2013”, 10 pgs.
“U.S. Appl. No. 13/098,927, Non Final Office Action dated Sep. 24, 2012”, 12 pgs.
“U.S. Appl. No. 13/098,927, Notice of Allowance dated Jan. 8, 2014”, 5 pgs.
“U.S. Appl. No. 13/098,927, Notice of Allowance dated Sep. 26, 2013”, 14 pgs.
“U.S. Appl. No. 13/098,927, Response filed Jul. 22, 2015 to Final Office Action dated May 22, 2013”, 17 pgs.
“U.S. Appl. No. 13/098,927, Response filed Aug. 27, 2012 to Restriction Requirement dated Jul. 25, 2012”, 14 pgs.
“U.S. Appl. No. 13/098,927, Response filed Dec. 21, 2012 to Non Final Office Action dated Sep. 24, 2012”, 21 pgs.
“U.S. Appl. No. 13/098,927, Restriction Requirement dated Jul. 25, 2012”, 8 pgs.
“U.S. Appl. No. 13/102,182, Notice of Allowance dated Mar. 22, 2012”, 10 pgs.
“U.S. Appl. No. 13/109,667, Advisory Action dated Feb. 4, 2014”, 4 pgs.
“U.S. Appl. No. 13/109,667, Examiner Interview Summary dated Dec. 20, 2013”, 3 pgs.
“U.S. Appl. No. 13/109,667, Final Office Action dated Oct. 11, 2013”, 19 pgs.
“U.S. Appl. No. 13/109,667, Non Final Office Action dated May 21, 2013”, 21 pgs.
“U.S. Appl. No. 13/109,667, Notice of Allowance dated Feb. 18, 2014”, 10 pgs.
“U.S. Appl. No. 13/109,667, Response filed Jan. 13, 2014 to Final Office Action dated Oct. 11, 2013”, 20 pgs.
“U.S. Appl. No. 13/109,667, Response filed May 2, 2013 to Restriction Requirement dated Apr. 2, 2013”, 1 pg.
“U.S. Appl. No. 13/109,667, Response filed Aug. 21, 2013 to Non Final Office Action dated May 21, 2013”, 27 pgs.
“U.S. Appl. No. 13/109,667, Restriction Requirement dated Apr. 2, 2013”, 8 pgs.
“U.S. Appl. No. 13/109,667, Supplemental Notice of Allowability dated Jun. 12, 2014”, 3 pgs.
“U.S. Appl. No. 13/109,667, Supplemental Notice of Allowance dated May 28, 2014”, 2 pgs.
“U.S. Appl. No. 13/109,667, Supplemental Preliminary Amendment filed Feb. 4, 2014”, 16 pgs.
“U.S. Appl. No. 13/109,672, 312 Amendment filed Jan. 15, 2015”, 3 pgs.
“U.S. Appl. No. 13/109,672, Non Final Office Action dated May 15, 2014”, 10 pgs.
“U.S. Appl. No. 13/109,672, Notice of Allowance dated Feb. 3, 2015”, 2 pgs.
“U.S. Appl. No. 13/109,672, Notice of Allowance dated Sep. 29, 2014”, 9 pgs.
“U.S. Appl. No. 13/109,672, PTO Response to Rule 312 Communication dated Jan. 27, 2015”, 2 pgs.
“U.S. Appl. No. 13/109,672, Response filed Apr. 14, 2014 to Restriction Requirement dated Feb. 14, 2014”, 15 pgs.
“U.S. Appl. No. 13/109,672, Response filed Aug. 15, 2014 to Non Final Office Action dated May 15, 2014”, 20 pgs.
“U.S. Appl. No. 13/109,672, Response filed Nov. 4, 2013 to Restriction Requirement dated Oct. 2, 2013”, 10 pgs.
“U.S. Appl. No. 13/109,672, Restriction Requirement dated Feb. 14, 2014”, 7 pgs.
“U.S. Appl. No. 13/109,672, Restriction Requirement dated Oct. 2, 2013”, 7 pgs.
“U.S. Appl. No. 13/111,564, Corrected Notice of Allowance dated Oct. 9, 2013”, 2 pgs.
“U.S. Appl. No. 13/111,564, Examiner Interview Summary dated Jun. 18, 2013”, 3 pgs.
“U.S. Appl. No. 13/111,564, Non Final Office Action dated Mar. 18, 2013”, 8 pgs.
“U.S. Appl. No. 13/111,564, Notice of Allowance dated Jun. 28, 2013”, 12 pgs.
“U.S. Appl. No. 13/111,564, Response filed Feb. 4, 2013 to Restriction Requirement dated Jan. 3, 2013”, 20 pgs.
“U.S. Appl. No. 13/111,564, Response filed Jun. 18, 2013 to Non Final Office Action dated Mar. 18, 2013”, 25 pgs.
“U.S. Appl. No. 13/111,564, Restriction Requirement dated Jan. 3, 2013”, 5 pgs.
“U.S. Appl. No. 13/177,153, Final Office Action dated May 28, 2013”, 11 pgs.
“U.S. Appl. No. 13/177,153, Non Final Office Action dated Oct. 2, 2012”, 11 pgs.
“U.S. Appl. No. 13/177,153, Notice of Allowance dated Jan. 7, 2014”, 4 pgs.
“U.S. Appl. No. 13/177,153, Notice of Allowance dated Sep. 17, 2013”, 13 pgs.
“U.S. Appl. No. 13/177,153, Response filed Aug. 28, 2013 to Final Office Action dated May 28, 2013”, 19 pgs.
“U.S. Appl. No. 13/177,153, Response filed Sep. 4, 2012 to Restriction Requirement dated Aug. 2, 2012”, 15 pgs.
“U.S. Appl. No. 13/177,153, Response filed Dec. 20, 2012 to Non Final Office Action dated Oct. 2, 2012”, 16 pgs.
“U.S. Appl. No. 13/177,153, Restriction Requirement dated Aug. 2, 2012”, 9 pgs.
“U.S. Appl. No. 13/181,729, Examiner Interview Summary dated May 9, 2013”, 3 pgs.
“U.S. Appl. No. 13/181,729, Final Office Action dated Mar. 13, 2013”, 14 pgs.
“U.S. Appl. No. 13/181,729, Non Final Office Action dated Oct. 2, 2012”, 7 pgs.
“U.S. Appl. No. 13/181,729, Notice of Allowance dated May 23, 2013”, 9 pgs.
“U.S. Appl. No. 13/181,729, Response filed May 13, 2013 to Final Office Action dated Mar. 13, 2013”, 13 pgs.
“U.S. Appl. No. 13/181,729, Response filed Dec. 20, 2012 to Non Final Office Action dated Oct. 2, 2012”, 15 pgs.
“U.S. Appl. No. 13/269,097, Final Office Action dated Aug. 8, 2013”, 7 pgs.
“U.S. Appl. No. 13/269,097, Non Final Office Action dated Feb. 12, 2013”, 10 pgs.
“U.S. Appl. No. 13/269,097, Notice of Allowance dated Feb. 3, 2014”, 5 pgs.
“U.S. Appl. No. 13/269,097, Notice of Allowance dated Oct. 21, 2013”, 9 pgs.
“U.S. Appl. No. 13/269,097, Response filed May 13, 2013 to Non Final Office Action dated Feb. 12, 2013”, 17 pgs.
“U.S. Appl. No. 13/269,097, Response filed Oct. 8, 2013 to Final Office Action dated Aug. 8, 2013”, 12 pgs.
“U.S. Appl. No. 13/269,097, Response filed Nov. 13, 2012 to Restriction Requirement dated Oct. 17, 2012”, 1 pg.
“U.S. Appl. No. 13/269,097, Restriction Requirement dated Oct. 17, 2012”, 8 pgs.
“U.S. Appl. No. 13/278,341, Notice of Allowance dated Jun. 18, 2013”, 10 pgs.
“U.S. Appl. No. 13/278,341, Response filed Mar. 8, 2013 to Restriction Requirement dated Feb. 11, 2013”, 1 pg.
“U.S. Appl. No. 13/278,341, Restriction Requirement dated Feb. 11, 2013”, 6 pgs.
“U.S. Appl. No. 13/281,009, Corrected Notice of Allowance dated Nov. 18, 2016”, 4 pgs.
“U.S. Appl. No. 13/281,009, Corrected Notice of Allowance dated Dec. 12, 2016”, 2 pgs.
“U.S. Appl. No. 13/281,009, Examiner Interview Summary dated Nov. 18, 2016”, 2 pgs.
“U.S. Appl. No. 13/281,009, Non Final Office Action dated Jun. 2, 2015”, 9 pgs.
“U.S. Appl. No. 13/281,009, Notice of Allowance dated Feb. 24, 2016”, 9 pgs.
“U.S. Appl. No. 13/281,009, Notice of Allowance dated Jun. 23, 2016”, 9 pgs.
“U.S. Appl. No. 13/281,009, Notice of Allowance dated Oct. 29, 2015”, 8 pgs.
“U.S. Appl. No. 13/281,009, Response filed Sep. 2, 2015 to Non Final Office Action dated Jun. 2, 2015”, 13 pgs.
“U.S. Appl. No. 13/281,009, Restriction Requirement dated Feb. 11, 2015”, 6 pgs.
“U.S. Appl. No. 13/288,459, Corrected Notice of Allowance dated Aug. 3, 2016”, 4 pgs.
“U.S. Appl. No. 13/288,459, Corrected Notice of Allowance dated Sep. 9, 2016”, 4 pgs.
“U.S. Appl. No. 13/288,459, Corrected Notice of Allowance dated Sep. 23, 2016”, 4 pgs.
“U.S. Appl. No. 13/288,459, Examiner Interview Summary dated Feb. 6, 2015”, 3 pgs.
“U.S. Appl. No. 13/288,459, Examiner Interview Summary dated Jan. 11, 2016”, 1 pg.
“U.S. Appl. No. 13/288,459, Non Final Office Action dated Jun. 24, 2015”, 10 pgs.
“U.S. Appl. No. 13/288,459, Non Final Office Action dated Nov. 4, 2014”, 15 pgs.
“U.S. Appl. No. 13/288,459, Notice of Allowance dated Jan. 11, 2016”, 13 pgs.
“U.S. Appl. No. 13/288,459, Notice of Allowance dated May 10, 2016”, 7 pgs.
“U.S. Appl. No. 13/288,459, Response filed Mar. 3, 2015 to Non Final Office Action dated Nov. 4, 2014”, 16 pgs.
“U.S. Appl. No. 13/288,459, Response filed Oct. 13, 2014 to Restriction Requirement dated Aug. 11, 2014”, 15 pgs.
“U.S. Appl. No. 13/288,459, Response filed Oct. 23, 2015 to Non Final Office Action dated Jun. 24, 2015”, 14 pgs.
“U.S. Appl. No. 13/288,459, Restriction Requirement dated Aug. 11, 2014”, 9 pgs.
“U.S. Appl. No. 13/288,463, Examiner Interview Summary dated Jun. 3, 2014”, 3 pgs.
“U.S. Appl. No. 13/288,463, Non Final Office Action dated Feb. 24, 2014”, 13 pgs.
“U.S. Appl. No. 13/288,463, Notice of Allowance dated Aug. 27, 2014”, 9 pgs.
“U.S. Appl. No. 13/288,463, Response filed May 27, 2014 to Non Final Office Action dated Feb. 24, 2014”, 15 pgs.
“U.S. Appl. No. 13/288,463, Supplemental Notice of Allowability dated Dec. 8, 2014”, 5 pgs.
“U.S. Appl. No. 13/288,463, Supplemental Notice of Allowability dated Dec. 19, 2014”, 5 pgs.
“U.S. Appl. No. 13/293,825, Notice of Allowability dated Jun. 22, 2015”, 7 pgs.
“U.S. Appl. No. 13/293,825, Notice of Allowance dated May 19, 2015”, 9 pgs.
“U.S. Appl. No. 13/293,825, Response filed Apr. 15, 2015 to Restriction Requirement dated Feb. 12, 2015”, 17 pgs.
“U.S. Appl. No. 13/293,825, Restriction Requirement dated Feb. 12, 2015”, 9 pgs.
“U.S. Appl. No. 13/295,126, Non Final Office Action dated May 19, 2015”, 9 pgs.
“U.S. Appl. No. 13/295,126, Notice of Allowance dated Oct. 22, 2015”, 9 pgs.
“U.S. Appl. No. 13/295,126, Response filed Apr. 13, 2015 to Restriction Requirement dated Feb. 12, 2015”, 1 pgs.
“U.S. Appl. No. 13/295,126, Response filed Aug. 17, 2015 to Non Final Office Action dated May 19, 2015”, 21 pgs.
“U.S. Appl. No. 13/295,126, Restriction Requirement dated Feb. 12, 2015”, 9 pgs.
“U.S. Appl. No. 13/311,936, Examiner Interview Summary dated Feb. 12, 2015”, 2 pgs.
“U.S. Appl. No. 13/311,936, Non Final Office Action dated Feb. 9, 2015”, 13 pgs.
“U.S. Appl. No. 13/311,936, Non Final Office Action dated Oct. 19, 2015”, 8 pgs.
“U.S. Appl. No. 13/311,936, Notice of Allowance dated Mar. 29, 2016”, 8 pgs.
“U.S. Appl. No. 13/311,936, PTO Response to Rule 312 Communication dated May 10, 2016”, 2 pgs.
“U.S. Appl. No. 13/311,936, Response filed Jan. 18, 16 to Non Final Office Action dated Oct. 19, 2015”, 8 pgs.
“U.S. Appl. No. 13/311,936, Response filed Jun. 9, 2015 to Non Final Office Action dated Feb. 9, 2015”, 12 pgs.
“U.S. Appl. No. 13/311,936, Response filed Oct. 3, 2014 to Restriction Requirement dated Aug. 5, 2014”, 10 pgs.
“U.S. Appl. No. 13/311,936, Restriction Requirement dated Aug. 5, 2014”, 7 pgs.
“U.S. Appl. No. 13/350,985, Final Office Action dated Apr. 16, 2015”, 8 pgs.
“U.S. Appl. No. 13/350,985, Non Final Office Action dated Dec. 15, 2014”, 8 pgs.
“U.S. Appl. No. 13/350,985, Notice of Allowance dated Jul. 27, 2015”, 5 pgs.
“U.S. Appl. No. 13/350,985, Response filed Mar. 13, 15 to Non Final Office Action dated Dec. 15, 2014”, 10 pgs.
“U.S. Appl. No. 13/350,985, Response filed Jul. 9, 2015 to Final Office Action dated Apr. 16, 2015”, 8 pgs.
“U.S. Appl. No. 13/350,985, Response filed Dec. 2, 2014 to Restriction Requirement dated Oct. 2, 2014”, 9 pgs.
“U.S. Appl. No. 13/350,985, Restriction Requirement dated Oct. 2, 2014”, 6 pgs.
“U.S. Appl. No. 13/399,125, Corrected Notice of Allowance dated Aug. 28, 2014”, 2 pgs.
“U.S. Appl. No. 13/399,125, Examiner Interview Summary dated May 17, 2013”, 3 pgs.
“U.S. Appl. No. 13/399,125, Final Office Action dated Mar. 20, 2013”, 12 pgs.
“U.S. Appl. No. 13/399,125, Non Final Office Action dated Oct. 24, 2012”, 12 pgs.
“U.S. Appl. No. 13/399,125, Notice of Allowance dated May 16, 2014”, 8 pgs.
“U.S. Appl. No. 13/399,125, Response filed Jan. 10, 2013 to Non Final Office Action dated Oct. 24, 2012”, 15 pgs.
“U.S. Appl. No. 13/399,125, Response filed May 20, 2013 to Final Office Action dated Mar. 20, 2013”, 14 pgs.
“U.S. Appl. No. 13/412,105, Advisory Action dated Feb. 24, 2014”, 3 pgs.
“U.S. Appl. No. 13/412,105, Examiner Interview Summary dated Feb. 6, 2014”, 3 pgs.
“U.S. Appl. No. 13/412,105, Examiner Interview Summary dated Oct. 11, 2013”, 3 pgs.
“U.S. Appl. No. 13/412,105, Final Office Action dated Dec. 13, 2013”, 9 pgs.
“U.S. Appl. No. 13/412,105, Non Final Office Action dated Jul. 15, 2013”, 10 pgs.
“U.S. Appl. No. 13/412,105, Notice of Allowance dated Aug. 18, 2014”, 9 pgs.
“U.S. Appl. No. 13/412,105, Response filed Feb. 10, 2014 to Final Office Action dated Dec. 13, 2013”, 14 pgs.
“U.S. Appl. No. 13/412,105, Response filed Mar. 13, 2014 to Advisory Action dated Feb. 24, 2014”, 19 pgs.
“U.S. Appl. No. 13/412,105, Response filed May 6, 2013 to Restriction Requirement dated Apr. 5, 2013”, 9 pgs.
“U.S. Appl. No. 13/412,105, Response filed Oct. 14, 2013 to Non Final Office Action dated Jul. 15, 2013”, 13 pgs.
“U.S. Appl. No. 13/412,105, Restriction Requirement dated Apr. 5, 2013”, 9 pgs.
“U.S. Appl. No. 13/412,116, Corrected Notice of Allowance dated Jun. 2, 2014”, 2 pgs.
“U.S. Appl. No. 13/412,116, Examiner Interview Summary dated Dec. 13, 2013”, 3 pgs.
“U.S. Appl. No. 13/412,116, Non Final Office Action dated Sep. 11, 2013”, 9 pgs.
“U.S. Appl. No. 13/412,116, Notice of Allowance dated Feb. 19, 2014”, 9 pgs.
“U.S. Appl. No. 13/412,116, Response filed Jul. 3, 2013 to Restriction Requirement dated Jun. 19, 2013”, 1 pg.
“U.S. Appl. No. 13/412,116, Response filed Dec. 11, 2013 to Non Final Office Action dated Sep. 11, 2013”, 11 pgs.
“U.S. Appl. No. 13/412,116, Restriction Requirement dated Jun. 19, 2013”, 9 pgs.
“U.S. Appl. No. 13/412,127, Examiner Interview Summary dated Nov. 5, 2013”, 3 pgs.
“U.S. Appl. No. 13/412,127, Non Final Office Action dated Aug. 7, 2013”, 15 pgs.
“U.S. Appl. No. 13/412,127, Notice of Allowance dated Dec. 24, 2013”, 10 pgs.
“U.S. Appl. No. 13/412,127, Response filed May 23, 2013 to Restriction Requirement dated Apr. 24, 2013”, 2 pgs.
“U.S. Appl. No. 13/412,127, Response filed Nov. 5, 2013 to Non Final Office Action dated Aug. 7, 2013”, 16 pgs.
“U.S. Appl. No. 13/412,127, Restriction Requirement dated Apr. 24, 2013”, 10 pgs.
“U.S. Appl. No. 13/587,374, Final Office Action dated Nov. 6, 2013”, 9 pgs.
“U.S. Appl. No. 13/587,374, Non Final Office Action dated Jul. 17, 2013”, 8 pgs.
“U.S. Appl. No. 13/587,374, Notice of Allowance dated Feb. 28, 2014”, 5 pgs.
“U.S. Appl. No. 13/587,374, Preliminary Amendment filed Jun. 21, 2013”, 9 pgs.
“U.S. Appl. No. 13/587,374, Response filed Jan. 24, 2014 to Final Office Action dated Nov. 6, 2013”, 15 pgs.
“U.S. Appl. No. 13/587,374, Response filed Oct. 14, 2013 to Non Final Office Action dated Jul. 17, 2013”, 14 pgs.
“U.S. Appl. No. 13/609,389, 312 Amendment filed Sep. 15, 2014”, 4 pgs.
“U.S. Appl. No. 13/609,389, Examiner Interview Summary dated Feb. 4, 2014”, 4 pgs.
“U.S. Appl. No. 13/609,389, Final Office Action dated May 5, 2014”, 14 pgs.
“U.S. Appl. No. 13/609,389, Non Final Office Action dated Nov. 27, 2013”, 12 pgs.
“U.S. Appl. No. 13/609,389, Notice of Allowance dated Jul. 23, 2014”, 5 pgs.
“U.S. Appl. No. 13/609,389, PTO Response to Rule 312 Communication dated Oct. 16, 2014”, 2 pgs.
“U.S. Appl. No. 13/609,389, Response filed Feb. 27, 2014 to Non Final Office Action dated Nov. 27, 2013”, 18 pgs.
“U.S. Appl. No. 13/609,389, Response filed Jul. 10, 2014 to Final Office Action dated May 5, 2014”, 12 pgs.
“U.S. Appl. No. 13/625,413, Final Office Action dated Oct. 30, 2015”, 8 pgs.
“U.S. Appl. No. 13/625,413, Non Final Office Action dated Jun. 8, 2015”, 11 pgs.
“U.S. Appl. No. 13/625,413, Notice of Allowance dated Apr. 1, 2016”, 8 pgs.
“U.S. Appl. No. 13/625,413, Notice of Allowance dated Dec. 11, 2015”, 9 pgs.
“U.S. Appl. No. 13/625,413, Response filed May 11, 2015 to Restriction Requirement dated Mar. 10, 2015”, 1 pg.
“U.S. Appl. No. 13/625,413, Response filed Sep. 8, 2015 to Non Final Office Action dated Jun. 8, 2015”, 16 pgs.
“U.S. Appl. No. 13/625,413, Response filed Dec. 1, 2015 to Final Office Action dated Oct. 30, 2015”, 9 pgs.
“U.S. Appl. No. 13/625,413, Restriction Requirement dated Mar. 10, 2015”, 7 pgs.
“U.S. Appl. No. 13/645,964, Advisory Action dated Feb. 4, 2016”, 2 pgs.
“U.S. Appl. No. 13/645,964, Final Office Action dated Oct. 6, 2015”, 17 pgs.
“U.S. Appl. No. 13/645,964, Non Final Office Action dated Mar. 15, 2016”, 15 pgs.
“U.S. Appl. No. 13/645,964, Non Final Office Action dated Mar. 17, 2015”, 15 pgs.
“U.S. Appl. No. 13/645,964, Notice of Allowance dated Jul. 21, 2016”, 9 pgs.
“U.S. Appl. No. 13/645,964, Response filed Jun. 13, 2016 to Non Final Office Action dated Mar. 15, 2016”, 11 pgs.
“U.S. Appl. No. 13/645,964, Response filed Jul. 17, 2015 to Non Final Office Action dated Mar. 17, 2015”, 17 pgs.
“U.S. Appl. No. 13/645,964, Response filed Dec. 4, 2015 to Final Office Action dated Oct. 6, 2015”, 14 pgs.
“U.S. Appl. No. 13/656,821, Notice of Allowance dated Jun. 18, 2015”, 11 pgs.
“U.S. Appl. No. 13/656,821, Response filed May 11, 2015 to Restriction Requirement dated Mar. 10, 2015”, 1 pg.
“U.S. Appl. No. 13/656,821, Restriction Requirement dated Mar. 10, 2015”, 6 pgs.
“U.S. Appl. No. 13/720,631, Final Office Action dated Jun. 25, 2014”, 10 pgs.
“U.S. Appl. No. 13/720,631, Non Final Office Action dated Mar. 6, 2014”, 7 pgs.
“U.S. Appl. No. 13/720,631, Notice of Allowance dated Jul. 25, 2014”, 5 pgs.
“U.S. Appl. No. 13/720,631, Response filed Jun. 6, 2014 to Non Final Office Action dated Mar. 6, 2014”, 11 pgs.
“U.S. Appl. No. 13/720,631, Response filed Jul. 14, 2014 to Final Office Action dated Jun. 25, 2014”, 6 pgs.
“U.S. Appl. No. 13/720,631, Supplemental Notice of Allowance dated Sep. 8, 2014”, 2 pgs.
“U.S. Appl. No. 13/720,648, Final Office Action dated Nov. 16, 2015”, 7 pgs.
“U.S. Appl. No. 13/720,648, Non Final Office Action dated Jun. 10, 2015”, 11 pgs.
“U.S. Appl. No. 13/720,648, Notice of Allowance dated Feb. 5, 2016”, 11 pgs.
“U.S. Appl. No. 13/720,648, Response filed Jan. 13, 2016 to Final Office Action dated Nov. 16, 2015”, 9 pgs.
“U.S. Appl. No. 13/720,648, Response filed May 11, 2015 to Restriction Requirement dated Mar. 10, 2015”, 8 pgs.
“U.S. Appl. No. 13/720,648, Response filed Oct. 9, 2015 to Non Final Office Action dated Jun. 10, 2015”, 12 pgs.
“U.S. Appl. No. 13/720,648, Restriction Requirement dated Mar. 10, 2015”, 8 pgs.
“U.S. Appl. No. 13/721,970, Notice of Allowance dated Aug. 12, 2013”, 13 pgs.
“U.S. Appl. No. 13/721,970, Preliminary Amendment filed Mar. 15, 2013”, 13 pgs.
“U.S. Appl. No. 13/721,970, Response filed May 8, 2013 to Restriction Requirement dated Apr. 11, 2013”, 1 pgs.
“U.S. Appl. No. 13/721,970, Restriction Requirement dated Apr. 11, 2013”, 6 pgs.
“U.S. Appl. No. 13/751,846, Final Office Action dated Nov. 17, 2015”, 9 pgs.
“U.S. Appl. No. 13/751,846, Non Final Office Action dated Jun. 15, 2015”, 10 pgs.
“U.S. Appl. No. 13/751,846, Notice of Allowance dated Mar. 16, 2016”, 11 pgs.
“U.S. Appl. No. 13/751,846, Notice of Allowance dated Jul. 6, 2016”, 9 pgs.
“U.S. Appl. No. 13/751,846, Response filed Feb. 5, 2016 to Final Office Action dated Nov. 17, 2015”, 14 pgs.
“U.S. Appl. No. 13/751,846, Response filed May 11, 2015 to Restriction Requirement dated Mar. 10, 2015”, 15 pgs.
“U.S. Appl. No. 13/751,846, Response filed Oct. 9, 2015 to Non Final Office Action dated Jun. 15, 2015”, 20 pgs.
“U.S. Appl. No. 13/751,846, Restriction Requirement dated Mar. 10, 2015”, 7 pgs.
“U.S. Appl. No. 13/757,003, Non Final Office Action dated Jun. 25, 2015”, 8 pgs.
“U.S. Appl. No. 13/757,003, Notice of Allowance dated Feb. 8, 2016”, 10 pgs.
“U.S. Appl. No. 13/757,003, Response filed May 12, 2015 to Restriction Requirement dated Mar. 12, 2015”, 9 pgs.
“U.S. Appl. No. 13/757,003, Response filed Oct. 26, 2015 to Non Final Office Action dated Jul. 25, 2015”, 8 pgs.
“U.S. Appl. No. 13/757,003, Restriction Requirement dated Mar. 12, 2015”, 6 pgs.
“U.S. Appl. No. 13/757,019, Non Final Office Action dated Jun. 25, 2015”, 11 pgs.
“U.S. Appl. No. 13/757,019, Notice of Allowance dated Dec. 10, 2015”, 10 pgs.
“U.S. Appl. No. 13/757,019, Response filed May 11, 2015 to Restriction Requirement dated Mar. 11, 2015”, 9 pgs.
“U.S. Appl. No. 13/757,019, Response filed Oct. 26, 2015 to Non Final Office Action dated Jun. 25, 2015”, 9 pgs.
“U.S. Appl. No. 13/757,019, Restriction Requirement dated Mar. 11, 2015”, 10 pgs.
“U.S. Appl. No. 13/767,401, Non Final Office Action dated Aug. 26, 2015”, 9 pgs.
“U.S. Appl. No. 13/767,401, Notice of Allowance dated Apr. 8, 2016”, 9 pgs.
“U.S. Appl. No. 13/767,401, Notice of Allowance dated Dec. 30, 2015”, 9 pgs.
“U.S. Appl. No. 13/767,401, Response filed May 18, 2015 to Restriction Requirement dated Mar. 17, 2015”, 15 pgs.
“U.S. Appl. No. 13/767,401, Response filed Nov. 6, 2015 to Non Final Office Action dated Aug. 26, 2015”, 12 pgs.
“U.S. Appl. No. 13/767,401, Restriction Requirement dated Mar. 17, 2015”, 8 pgs.
“U.S. Appl. No. 13/790,982, Examiner Interview Summary dated Jun. 9, 2015”, 3 pgs.
“U.S. Appl. No. 13/790,982, Non Final Office Action dated Sep. 16, 2015”, 11 pgs.
“U.S. Appl. No. 13/790,982, Notice of Allowance dated Feb. 24, 2016”, 10 pgs.
“U.S. Appl. No. 13/790,982, Response filed Jun. 2, 2015 to Restriction Requirement dated Apr. 2, 2015”, 11 pgs.
“U.S. Appl. No. 13/790,982, Response filed Dec. 16, 2015 to Non Final Office Action dated Sep. 16, 2015”, 10 pgs.
“U.S. Appl. No. 13/790,982, Restriction Requirement dated Apr. 2, 2015”, 10 pgs.
“U.S. Appl. No. 13/790,997, Examiner Interview Summary dated Jun. 8, 2015”, 3 pgs.
“U.S. Appl. No. 13/790,997, Non Final Office Action dated Sep. 21, 2015”, 8 pgs.
“U.S. Appl. No. 13/790,997, Notice of Allowance dated Mar. 2, 2016”, 9 pgs.
“U.S. Appl. No. 13/790,997, Response filed Jun. 2, 2015 to Restriction Requirement dated Apr. 2, 2015”, 12 pgs.
“U.S. Appl. No. 13/790,997, Response filed Dec. 18, 2015 to Non Final Office Action dated Sep. 21, 2015”, 9 pgs.
“U.S. Appl. No. 13/790,997, Restriction Requirement dated Apr. 2, 2015”, 8 pgs.
“U.S. Appl. No. 13/791,014, Final Office Action dated Jan. 8, 2016”, 11 pgs.
“U.S. Appl. No. 13/791,014, Non Final Office Action dated Aug. 14, 2015”, 9 pgs.
“U.S. Appl. No. 13/791,014, Notice of Allowability dated Jul. 27, 2017”, 2 pgs.
“U.S. Appl. No. 13/791,014, Notice of Allowance dated Jan. 10, 2017”, 15 pgs.
“U.S. Appl. No. 13/791,014, Notice of Allowance dated Apr. 27, 2017”, 8 pgs.
“U.S. Appl. No. 13/791,014, Response filed Jun. 6, 2016 to Final Office Action dated Jan. 8, 2016”, 13 pgs.
“U.S. Appl. No. 13/791,014, Response filed Aug. 3, 2015 to Restriction Requirement dated May 1, 2015”, 9 pgs.
“U.S. Appl. No. 13/791,014, Response filed Nov. 10, 2015 to Non Final Office Action dated Aug. 14, 2015”, 13 pgs.
“U.S. Appl. No. 13/791,014, Restriction Requirement dated May 1, 2015”, 6 pgs.
“U.S. Appl. No. 13/833,567, Advisory Action dated Apr. 28, 2016”, 3 pgs.
“U.S. Appl. No. 13/833,567, Final Office Action dated Mar. 9, 2016”, 9 pgs.
“U.S. Appl. No. 13/833,567, Non Final Office Action dated May 27, 2016”, 9 pgs.
“U.S. Appl. No. 13/833,567, Non Final Office Action dated Oct. 23, 2015”, 10 pgs.
“U.S. Appl. No. 13/833,567, Notice of Allowance dated Sep. 27, 2016”, 9 pgs.
“U.S. Appl. No. 13/833,567, Response filed Jan. 22, 2016 to Non Final Office Action dated Oct. 23, 2015”, 11 pgs.
“U.S. Appl. No. 13/833,567, Response filed Apr. 20, 2016 to Final Office Action dated Mar. 9, 2016”, 10 pgs.
“U.S. Appl. No. 13/833,567, Response filed Jun. 25, 2015 to Restriction Requirement dated Apr. 3, 2015”, 10 pgs.
“U.S. Appl. No. 13/833,567, Response filed Aug. 4, 2016 to Non Final Office Action dated May 27, 2016”, 11 pgs.
“U.S. Appl. No. 13/833,567, Restriction Requirement dated Apr. 3, 2015”, 6 pgs.
“U.S. Appl. No. 13/838,755, Final Office Action dated Feb. 22, 2016”, 9 pgs.
“U.S. Appl. No. 13/838,755, Non Final Office Action dated Sep. 17, 2015”, 11 pgs.
“U.S. Appl. No. 13/838,755, Notice of Allowance dated Apr. 27, 2016”, 7 pgs.
“U.S. Appl. No. 13/838,755, Notice of Allowance dated Aug. 3, 2016”, 8 pgs.
“U.S. Appl. No. 13/838,755, Response filed Apr. 15, 2016 to Final Office Action dated Feb. 22, 2016”, 11 pgs.
“U.S. Appl. No. 13/838,755, Response filed Jun. 8, 15 to Restriction Requirement dated Apr. 6, 2015”, 1 pg.
“U.S. Appl. No. 13/838,755, Response filed Dec. 1, 2015 to Non Final Office Action dated Sep. 17, 2015”, 13 pgs.
“U.S. Appl. No. 13/838,755, Restriction Requirement dated Apr. 6, 2015”, 6 pgs.
“U.S. Appl. No. 13/889,851, Non Final Office Action dated Apr. 6, 2015”, 10 pgs.
“U.S. Appl. No. 13/889,851, Notice of Allowance dated Aug. 12, 2015”, 8 pgs.
“U.S. Appl. No. 13/889,851, Response filed Feb. 26, 2015 to Restriction Requirement dated Jan. 21, 2015”, 12 pgs.
“U.S. Appl. No. 13/889,851, Response filed Jul. 6, 2015 to Non Final Office Action dated Apr. 6, 2015”, 14 pgs.
“U.S. Appl. No. 13/889,851, Restriction Requirement dated Jan. 21, 2015”, 6 pgs.
“U.S. Appl. No. 13/889,851, Supplemental Amendment and Response filed Jul. 6, 2015 to Non Final Office Action dated Apr. 6, 2015”, 8 pgs.
“U.S. Appl. No. 13/959,145, Examiner Interview Summary dated Sep. 16, 2015”, 3 pgs.
“U.S. Appl. No. 13/959,145, Final Office Action dated Jan. 29, 2016”, 16 pgs.
“U.S. Appl. No. 13/959,145, Final Office Action dated Feb. 5, 2015”, 22 pgs.
“U.S. Appl. No. 13/959,145, Non Final Office Action dated Jul. 31, 2015”, 21 pgs.
“U.S. Appl. No. 13/959,145, Non Final Office Action dated Sep. 15, 2014”, 20 pgs.
“U.S. Appl. No. 13/959,145, Notice of Allowability dated Jun. 14, 2016”, 2 pgs.
“U.S. Appl. No. 13/959,145, Notice of Allowance dated Apr. 13, 2016”, 5 pgs.
“U.S. Appl. No. 13/959,145, Response filed Mar. 28, 2016 to Final Office Action dated Jan. 29, 2016”, 10 pgs.
“U.S. Appl. No. 13/959,145, Response filed Jul. 6, 2015 to Final Office Action dated Feb. 5, 2015”, 18 pgs.
“U.S. Appl. No. 13/959,145, Response filed Oct. 30, 2015 to Non Final Office Action dated Jul. 31, 2015”, 14 pgs.
“U.S. Appl. No. 13/959,145, Response filed Dec. 15, 2014 to Non Final Office Action dated Sep. 15, 2014”, 21 pgs.
“U.S. Appl. No. 14/055,172, Final Office Action dated Dec. 22, 2016”, 8 pgs.
“U.S. Appl. No. 14/055,172, Non Final Office Action dated Jul. 14, 2016”, 12 pgs.
“U.S. Appl. No. 14/055,172, Notice of Allowance dated Mar. 29, 2017”, 10 pgs.
“U.S. Appl. No. 14/055,172, Response filed Feb. 22, 2017 to Final Office Action dated Dec. 22, 2016”, 11 pgs.
“U.S. Appl. No. 14/055,172, Response filed May 4, 2016 to Restriction Requirement dated Mar. 4, 2016”, 8 pgs.
“U.S. Appl. No. 14/055,172, Response filed Nov. 14, 2016 to Non Final Office Action dated Jul. 14, 2016”, 19 pgs.
“U.S. Appl. No. 14/055,172, Restriction Requirement dated Mar. 4, 2016”, 6 pgs.
“U.S. Appl. No. 14/055,191, Non Final Office Action dated May 16, 2016”, 8 pgs.
“U.S. Appl. No. 14/055,191, Notice of Allowability dated Sep. 8, 2016”, 7 pgs.
“U.S. Appl. No. 14/055,191, Notice of Allowance dated Aug. 31, 2016”, 13 pgs.
“U.S. Appl. No. 14/055,191, Response filed Apr. 29, 2016 to Restriction Requirement dated Mar. 7, 2016”, 8 pgs.
“U.S. Appl. No. 14/055,191, Response filed Aug. 3, 2016 to Non Final Office Action dated May 16, 2016”, 11 pgs.
“U.S. Appl. No. 14/055,191, Restriction Requirement dated Mar. 7, 2016”, 6 pgs.
“U.S. Appl. No. 14/071,295, Non Final Office Action dated Aug. 15, 2014”, 6 pgs.
“U.S. Appl. No. 14/071,295, Notice of Allowance dated Dec. 10, 2014”, 8 pgs.
“U.S. Appl. No. 14/071,295, Response filed Nov. 17, 2014 to Non Final Office Action dated Aug. 15, 2014”, 14 pgs.
“U.S. Appl. No. 14/071,295, Supplemental Notice of Allowability dated Jan. 26, 2015”, 2 pgs.
“U.S. Appl. No. 14/094,311, Corrected Notice of Allowance dated Mar. 28, 2017”, 5 pgs.
“U.S. Appl. No. 14/094,311, Notice of Allowance dated Aug. 16, 2016”, 12 pgs.
“U.S. Appl. No. 14/094,311, Notice of Allowance dated Dec. 27, 2016”, 8 pgs.
“U.S. Appl. No. 14/094,311, Response filed Jul. 26, 2016 to Restriction Requirement dated Jun. 22, 2016”, 10 pgs.
“U.S. Appl. No. 14/094,311, Restriction Requirement dated Jun. 22, 2016”, 6 pgs.
“U.S. Appl. No. 14/095,614, Non Final Office Action dated Jan. 19, 2017”, 9 pgs.
“U.S. Appl. No. 14/095,614, Notice of Allowance dated May 8, 2017”, 8 pgs.
“U.S. Appl. No. 14/095,614, Notice of Allowance dated Nov. 6, 2017”, 9 pgs.
“U.S. Appl. No. 14/095,614, Preliminary Amendment filed Apr. 15, 2014”, 17 pgs.
“U.S. Appl. No. 14/095,614, Response filed Mar. 2, 2017 to Non Final Office Action dated Jan. 19, 2017”, 14 pgs.
“U.S. Appl. No. 14/095,614, Response filed Sep. 12, 2016 to Restriction Requirement dated Jul. 11, 2016”, 11 pgs.
“U.S. Appl. No. 14/095,614, Restriction Requirement dated Jul. 11, 2016”, 8 pgs.
“U.S. Appl. No. 14/095,639, Non Final Office Action dated Jan. 18, 2017”, 10 pgs.
“U.S. Appl. No. 14/095,639, Notice of Allowance dated Apr. 13, 2017”, 9 pgs.
“U.S. Appl. No. 14/095,639, Notice of Allowance dated Oct. 30, 2017”, 9 pgs.
“U.S. Appl. No. 14/095,639, Response filed Mar. 2, 2017 to Non Final Office Action dated Jan. 18, 2017”, 9 pgs.
“U.S. Appl. No. 14/095,639, Response filed Sep. 12, 2016 to Restriction Requirement dated Jul. 19, 2016”, 7 pgs.
“U.S. Appl. No. 14/095,639, Restriction Requirement dated Jul. 19, 2016”, 8 pgs.
“U.S. Appl. No. 14/107,350, Notice of Allowance dated Feb. 26, 2016”, 11 pgs.
“U.S. Appl. No. 14/107,350, Notice of Allowance dated Jul. 27, 2016”, 7 pgs.
“U.S. Appl. No. 14/107,350, Preliminary Amendment filed Feb. 28, 2014”, 4 pgs.
“U.S. Appl. No. 14/159,094, Examiner Interview Summary dated Nov. 29, 2016”, 1 pg.
“U.S. Appl. No. 14/159,094, Non Final Office Action dated Jun. 29, 2016”, 15 pgs.
“U.S. Appl. No. 14/159,094, Notice of Allowance dated Nov. 29, 2016”, Examiner Interview Summary dated Nov. 29, 2016 included, 11 pgs.
“U.S. Appl. No. 14/159,094, Response filed Jun. 3, 2016 to Restriction Requirement dated Apr. 20, 2016”, 9 pgs.
“U.S. Appl. No. 14/159,094, Response filed Sep. 19, 2016 to Non Final Office Action dated Jun. 29, 2016”, 13 pgs.
“U.S. Appl. No. 14/159,094, Restriction Requirement dated Apr. 20, 2016”, 6 pgs.
“U.S. Appl. No. 14/182,038, Advisory Action dated Mar. 1, 2017”, 3 pgs.
“U.S. Appl. No. 14/182,038, Final Office Action dated Dec. 19, 2016”, 8 pgs.
“U.S. Appl. No. 14/182,038, Non Final Office Action dated Jul. 19, 2016”, 10 pgs.
“U.S. Appl. No. 14/182,038, Notice of Allowance dated May 24, 2017”, 9 pgs.
“U.S. Appl. No. 14/182,038, Response filed Feb. 20, 2017 to Final Office Action dated Dec. 19, 2016”, 11 pgs.
“U.S. Appl. No. 14/182,038, Response filed Jun. 27, 2016 to Restriction Requirement dated Apr. 26, 2016”, 8 pgs.
“U.S. Appl. No. 14/182,038, Response filed Oct. 19, 2016 to Non Final Office Action dated Jul. 19, 2016”, 15 pgs.
“U.S. Appl. No. 14/182,038, Restriction Requirement dated Apr. 26, 2016”, 7 pgs.
“U.S. Appl. No. 14/182,046, Corrected Notice of Allowance dated Jan. 20, 2017”, 6 pgs.
“U.S. Appl. No. 14/182,046, Non Final Office Action dated Jul. 15, 2016”, 9 pgs.
“U.S. Appl. No. 14/182,046, Notice of Allowance dated Dec. 8, 2016”, 7 pgs.
“U.S. Appl. No. 14/182,046, Response filed Jun. 27, 2016 to Restriction Requirement dated Apr. 26, 2016”, 7 pgs.
“U.S. Appl. No. 14/182,046, Response filed Oct. 17, 2016 to Non Final Office Action dated Jul. 15, 2016”, 11 pgs.
“U.S. Appl. No. 14/182,046, Restriction Requirement dated Apr. 26, 2016”, 6 pgs.
“U.S. Appl. No. 14/211,977, Notice of Allowance dated Jul. 12, 2016”, 9 pgs.
“U.S. Appl. No. 14/211,977, Preliminary Amendment filed Mar. 2, 2016”, 7 pgs.
“U.S. Appl. No. 14/211,977, Response filed Apr. 29, 2016 to Restriction Requirement dated Mar. 11, 2016”, 8 pgs.
“U.S. Appl. No. 14/211,977, Restriction Requirement dated Mar. 11, 2016”, 6 pgs.
“U.S. Appl. No. 14/215,550, Corrected Notice of Allowance dated Jul. 27, 2017”, 2 pgs.
“U.S. Appl. No. 14/215,550, Examiner Interview Summary dated Mar. 9, 2017”, 3 pgs.
“U.S. Appl. No. 14/215,550, Final Office Action dated Feb. 1, 2017”, 11 pgs.
“U.S. Appl. No. 14/215,550, Non Final Office Action dated Jul. 19, 2016”, 12 pgs.
“U.S. Appl. No. 14/215,550, Notice of Allowance dated Jun. 21, 2017”, 8 pgs.
“U.S. Appl. No. 14/215,550, Response filed May 1, 2017 to Final Office Action dated Feb. 1, 2017”, 10 pgs.
“U.S. Appl. No. 14/215,550, Response filed Jun. 22, 2016 to Restriction Requirement dated Apr. 28, 2016”, 7 pgs.
“U.S. Appl. No. 14/215,550, Response filed Dec. 5, 2016 to Non Final Office Action dated Jul. 19, 2016”, 13 pgs.
“U.S. Appl. No. 14/215,550, Restriction Requirement dated Apr. 28, 2016”, 6 pgs.
“U.S. Appl. No. 14/275,548, Examiner Interview Summary dated May 25, 2016”, 3 pgs.
“U.S. Appl. No. 14/275,548, Non Final Office Action dated Feb. 19, 2016”, 14 pgs.
“U.S. Appl. No. 14/275,548, Notice of Allowance dated Jul. 27, 2016”, 7 pgs.
“U.S. Appl. No. 14/275,548, Response filed May 19, 2016 to Non Final Office Action dated Feb. 19, 2016”, 19 pgs.
“U.S. Appl. No. 14/324,688, Corrected Notice of Allowance dated Sep. 22, 2016”, 2 pgs.
“U.S. Appl. No. 14/324,688, Non Final Office Action dated Jan. 8, 2016”, 18 pgs.
“U.S. Appl. No. 14/324,688, Notice of Allowance dated Jun. 9, 2016”, 7 pgs.
“U.S. Appl. No. 14/324,688, Response filed Apr. 8, 2016 to Non Final Office Action dated Jan. 8, 2016”, 15 pgs.
“U.S. Appl. No. 14/456,286, Advisory Action dated Jun. 21, 2016”, 3 pgs.
“U.S. Appl. No. 14/456,286, Final Office Action dated May 27, 2016”, 15 pgs.
“U.S. Appl. No. 14/456,286, Non Final Office Action dated Oct. 17, 2016”, 17 pgs.
“U.S. Appl. No. 14/456,286, Non Final Office Action dated Dec. 30, 2015”, 16 pgs.
“U.S. Appl. No. 14/456,286, Notice of Allowance dated Feb. 15, 2017”, 9 pgs.
“U.S. Appl. No. 14/456,286, Response filed Mar. 30, 2016 to Non Final Office Action dated Dec. 30, 2015”, 15 pgs.
“U.S. Appl. No. 14/456,286, Response filed Jun. 13, 2016 to Final Office Action dated May 27, 2016”, 10 pgs.
“U.S. Appl. No. 14/456,286, Response filed Nov. 16, 2016 to Non Final Office Action dated Oct. 17, 2016”, 9 pgs.
“U.S. Appl. No. 14/456,286, Response filed Dec. 11, 2015 to Restriction Requirement dated Oct. 29, 2015”, 6 pgs.
“U.S. Appl. No. 14/456,286, Restriction Requirement dated Oct. 29, 2015”, 9 pgs.
“U.S. Appl. No. 14/492,590, Notice of Allowance dated Oct. 5, 2016”, 10 pgs.
“U.S. Appl. No. 14/492,590, Response filed Sep. 15, 2016 to Restriction Requirement dated Jul. 25, 2015”, 7 pgs.
“U.S. Appl. No. 14/492,590, Restriction Requirement dated Jul. 25, 2016”, 6 pgs.
“U.S. Appl. No. 14/492,590, Supplemental Response filed Sep. 26, 2016 to Restriction Requirement dated Jul. 25, 2016”, 10 pgs.
“U.S. Appl. No. 14/514,453, Final Office Action dated Mar. 17, 2016”, 17 pgs.
“U.S. Appl. No. 14/514,453, Non Final Office Action dated Sep. 24, 2015”, 11 pgs.
“U.S. Appl. No. 14/514,453, Response filed Dec. 16, 2015 to Non Final Office Action dated Sep. 24, 2015”, 14 pgs.
“U.S. Appl. No. 14/532,333, Response filed Apr. 7, 2016 to Restriction Requirement dated Feb. 8, 2016”, 10 pgs.
“U.S. Appl. No. 14/532,333, Restriction Requirement dated Feb. 8, 2016”, 6 pgs.
“U.S. Appl. No. 14/589,101, Advisory Action dated Feb. 21, 2017”, 5 pgs.
“U.S. Appl. No. 14/589,101, Advisory Action dated May 22, 2018”, 3 pgs.
“U.S. Appl. No. 14/589,101, Examiner Interview Summary dated Jan. 30, 2017”, 3 pgs.
“U.S. Appl. No. 14/589,101, Final Office Action dated Feb. 22, 2018”, 15 pgs.
“U.S. Appl. No. 14/589,101, Final Office Action dated Oct. 2, 2015”, 10 pgs.
“U.S. Appl. No. 14/589,101, Final Office Action dated Nov. 16, 2016”, 12 pgs.
“U.S. Appl. No. 14/589,101, Non Final Office Action dated Feb. 12, 2015”, 10 pgs.
“U.S. Appl. No. 14/589,101, Non Final Office Action dated May 5, 2016”, 14 pgs.
“U.S. Appl. No. 14/589,101, Non Final Office Action dated Sep. 14, 2017”, 13 pgs.
“U.S. Appl. No. 14/589,101, Response filed Jan. 23, 2017 to Final Office Action dated Nov. 16, 2016”, 9 pgs.
“U.S. Appl. No. 14/589,101, Response filed Apr. 10, 2018 to Final Office Action dated Feb. 22, 2018”, 10 pgs.
“U.S. Appl. No. 14/589,101, Response filed Jun. 12, 2015 to Non Final Office Action dated Feb. 12, 2015”, 11 pgs.
“U.S. Appl. No. 14/589,101, Response filed Nov. 13, 2017 to Non Final Office Action dated Sep. 14, 2017”, 10 pgs.
“U.S. Appl. No. 14/589,101, Response filed Dec. 29, 2015 to Final Office Action dated Oct. 2, 2015”, 15 pgs.
“U.S. Appl. No. 14/589,191, Response filed Aug. 5, 2016 to Non Final Office Action dated May 5, 2016”, 16 pgs.
“U.S. Appl. No. 14/594,285, Final Office Action dated May 22, 2017”, 12 pgs.
“U.S. Appl. No. 14/594,285, Non Final Office Action dated Jan. 11, 2017”, 15 pgs.
“U.S. Appl. No. 14/594,285, Notice of Allowance dated Jun. 27, 2017”, 10 pgs.
“U.S. Appl. No. 14/594,285, Response filed Apr. 11, 2017 to Non Final Office Action dated Jan. 11, 2017”, 12 pgs.
“U.S. Appl. No. 14/594,285, Response filed Jun. 14, 2017 to Final Office Action dated May 22, 2017”, 9 pgs.
“U.S. Appl. No. 14/594,285, Response filed Dec. 14, 2016 to Restriction Requirement dated Nov. 7, 2016”, 8 pgs.
“U.S. Appl. No. 14/594,285, Restriction Requirement dated Nov. 7, 2016”, 6 pgs.
“U.S. Appl. No. 14/599,909, Non Final Office Action dated Jul. 27, 2017”, 18 pgs.
“U.S. Appl. No. 14/599,909, Notice of Allowance dated Feb. 13, 2018”, 9 pgs.
“U.S. Appl. No. 14/599,909, Response filed Sep. 21, 2017 to Non Final Office Action dated Jul. 27, 2017”, 10 pgs.
“U.S. Appl. No. 14/635,055, Non Final Office Action dated Aug. 28, 2017”, 8 pgs.
“U.S. Appl. No. 14/635,055, Notice of Allowance dated Feb. 28, 2018”, 11 pgs.
“U.S. Appl. No. 14/635,055, Response filed Jun. 27, 2017 to Restriction Requirement dated Apr. 27, 2017”, 11 pgs.
“U.S. Appl. No. 14/635,055, Response filed Nov. 28, 2017 to Non Final Office Action dated Aug. 28, 2017”, 13 pgs.
“U.S. Appl. No. 14/635,055, Restriction Requirement dated Apr. 27, 2017”, 7 pgs.
“U.S. Appl. No. 14/697,140, Advisory Action dated Aug. 11, 2017”, 3 pgs.
“U.S. Appl. No. 14/697,140, Final Office Action dated Jun. 30, 2017”, 13 pgs.
“U.S. Appl. No. 14/697,140, Final Office Action dated Sep. 23, 2016”, 10 pgs.
“U.S. Appl. No. 14/697,140, Non Final Office Action dated Jan. 10, 2017”, 12 pgs.
“U.S. Appl. No. 14/697,140, Non Final Office Action dated Apr. 8, 2016”, 8 pgs.
“U.S. Appl. No. 14/697,140, Notice of Allowance dated Sep. 5, 2017”, 7 pgs.
“U.S. Appl. No. 14/697,140, Response filed Mar. 1, 2017 to Non Final Office Action dated Jan. 10, 2017”, 11 pgs.
“U.S. Appl. No. 14/697,140, Response filed Jun. 13, 2016 to Non Final Office Action dated Apr. 8, 2016”, 10 pgs.
“U.S. Appl. No. 14/697,140, Response filed Jul. 27, 2017 to Final Office Action dated Jun. 30, 2017”, 10 pgs.
“U.S. Appl. No. 14/697,140, Response filed Nov. 16, 2016 to Final Office Action dated Sep. 23, 2016”, 13 pgs.
“U.S. Appl. No. 14/794,309, Final Office Action dated Mar. 20, 2017”, 18 pgs.
“U.S. Appl. No. 14/794,309, Non Final Office Action dated Jun. 20, 2017”, 16 pgs.
“U.S. Appl. No. 14/794,309, Non Final Office Action dated Nov. 22, 2016”, 13 pgs.
“U.S. Appl. No. 14/794,309, Notice of Allowance dated Sep. 18, 2017”, 5 pgs.
“U.S. Appl. No. 14/794,309, Preliminary Amendment filed Sep. 22, 2015”, 6 pgs.
“U.S. Appl. No. 14/794,309, Response filed Feb. 22, 2017 to Non Final Office Action dated Nov. 22, 2016”, 12 pgs.
“U.S. Appl. No. 14/794,309, Response filed May 22, 2017 to Final Office Action dated Mar. 20, 2017”, 13 pgs.
“U.S. Appl. No. 14/794,309, Response filed Aug. 17, 2017 to Non Final Office Action dated Jun. 20, 2017”, 12 pgs.
“U.S. Appl. No. 14/794,309, Supplemental Preliminary Amendment filed Mar. 3, 2016”, 8 pgs.
“U.S. Appl. No. 14/854,308, Notice of Allowance dated Mar. 16, 2018”, 11 pgs.
“U.S. Appl. No. 14/854,308, Response filed Dec. 20, 2017 to Restriction Requirement dated Oct. 20, 2017”, 8 pgs.
“U.S. Appl. No. 14/854,308, Restriction Requirement dated Oct. 20, 2017”, 8 pgs.
“U.S. Appl. No. 14/854,308, Supplemental Preliminary Amendment Filed Aug. 31, 2017”, 3 pgs.
“U.S. Appl. No. 14/876,167, Final Office Action dated Jul. 31, 2018”, 8 pgs.
“U.S. Appl. No. 14/876,167, Non Final Office Action dated Mar. 13, 2018”, 8 pgs.
“U.S. Appl. No. 14/876,167, Notice of Allowance dated Dec. 10, 2018”, 8 pgs.
“U.S. Appl. No. 14/876,167, Preliminary Amendment filed Oct. 27, 2015”, 8 pgs.
“U.S. Appl. No. 14/876,167, Response filed Jan. 9, 2018 to Restriction Requirement dated Nov. 22, 2017”, 6 pgs.
“U.S. Appl. No. 14/876,167, Response filed Jun. 6, 2018 to Non Final Office Action dated Mar. 13, 2018”, 9 pgs.
“U.S. Appl. No. 14/876,167, Response filed Sep. 28, 2018 to Final Office Action dated Jul. 31, 2018”, 10 pgs.
“U.S. Appl. No. 14/876,167, Restriction Requirement dated Nov. 22, 2017”, 9 pgs.
“U.S. Appl. No. 14/936,831, Advisory Action dated Jan. 29, 2019”, 3 pgs.
“U.S. Appl. No. 14/936,831, Final Office Action dated Nov. 20, 2018”, 8 pgs.
“U.S. Appl. No. 14/936,831, Non Final Office Action dated May 16, 2018”, 11 pgs.
“U.S. Appl. No. 14/936,831, Notice of Non-Compliant Amendment dated Mar. 14, 2018”, 2 pgs.
“U.S. Appl. No. 14/936,831, Preliminary Amendment filed Nov. 11, 2015”, 6 pgs.
“U.S. Appl. No. 14/936,831, Response filed Jan. 10, 2018 to Restriction Requirement dated Nov. 22, 2017”, 6 pgs.
“U.S. Appl. No. 14/936,831, Response filed Jan. 21, 2019 to Final Office Action dated Nov. 20, 2018”, 9 pgs.
“U.S. Appl. No. 14/936,831, Response filed Mar. 26, 2018 to Notice of Non-Compliant Amendment dated Mar. 14, 2018”, 6 pgs.
“U.S. Appl. No. 14/936,831, Response filed Aug. 16, 2018 to Non Final Office Action dated May 16, 2018”, 9 pgs.
“U.S. Appl. No. 14/936,831, Restriction Requirement dated Nov. 22, 2017”, 8 pgs.
“U.S. Appl. No. 14/956,724, Examiner Interview Summary dated Jun. 20, 2017”, 3 pgs.
“U.S. Appl. No. 14/956,724, Non Final Office Action dated Mar. 31, 2017”, 17 pgs.
“U.S. Appl. No. 14/956,724, Notice of Allowance dated Aug. 23, 2017”, 9 pgs.
“U.S. Appl. No. 14/956,724, Preliminary Amendment filed Dec. 7, 2015”, 8 pgs.
“U.S. Appl. No. 14/956,724, Response filed Jun. 16, 2017 to Non Final Office Action dated Mar. 31, 2017”, 12 pgs.
“U.S. Appl. No. 14/956,724, Supplemental Preliminary Amendment filed Feb. 11, 2016”, 7 pgs.
“U.S. Appl. No. 14/956,724, Supplemental Preliminary Amendment filed Oct. 3, 2016”, 8 pgs.
“U.S. Appl. No. 14/983,108, Final Office Action dated Aug. 30, 2018”, 9 pgs.
“U.S. Appl. No. 14/983,108, Non Final Office Action dated Apr. 10, 2018”, 7 pgs.
“U.S. Appl. No. 14/983,108, Non Final Office Action dated Nov. 5, 2018”, 8 pgs.
“U.S. Appl. No. 14/983,108, Notice of Allowance dated Mar. 8, 2019”, 8 pgs.
“U.S. Appl. No. 14/983,108, Preliminary Amendment filed Dec. 30, 2015”, 7 pgs.
“U.S. Appl. No. 14/983,108, Response filed Jan. 24, 2018 to Restriction Requirement dated Dec. 4, 2017”, 6 pgs.
“U.S. Appl. No. 14/983,108, Response filed Feb. 4, 2019 to Non Final Office Action dated Nov. 5, 2018”, 8 pgs.
“U.S. Appl. No. 14/983,108, Response filed Jun. 13, 2018 to Non Final Office Action dated Apr. 10, 2018”, 10 pgs.
“U.S. Appl. No. 14/983,108, Response filed Oct. 22, 2018 to Final Office Action dated Aug. 30, 2018”, 9 pgs.
“U.S. Appl. No. 14/983,108, Restriction Requirement dated Dec. 4, 2017”, 7 pgs.
“U.S. Appl. No. 14/983,747, Non Final Office Action dated Apr. 9, 2018”, 13 pgs.
“U.S. Appl. No. 14/983,747, Notice of Allowance dated Sep. 24, 2018”, 14 pgs.
“U.S. Appl. No. 14/983,747, Preliminary Amendment filed Jan. 4, 2016”, 5 pgs.
“U.S. Appl. No. 14/983,747, Response filed Jan. 24, 2018 to Restriction Requirement dated Dec. 20, 2017”, 5 pgs.
“U.S. Appl. No. 14/983,747, Response filed Jun. 13, 2018 to Non Final Office Action dated Apr. 9, 2018”, 9 pgs.
“U.S. Appl. No. 14/983,747, Restriction Requirement dated Dec. 20, 2017”, 7 pgs.
“U.S. Appl. No. 14/983,747, Supplemental Response to Restriction Requirement filed Jan. 24, 2018”, 5 pgs.
“U.S. Appl. No. 15/060,007, Final Office Action dated Jan. 3, 2019”, 9 pgs.
“U.S. Appl. No. 15/060,007, Non Final Office Action dated Nov. 9, 2018”, 17 pgs.
“U.S. Appl. No. 15/060,007, Notice of Allowance dated Mar. 6, 2019”, 5 pgs.
“U.S. Appl. No. 15/060,007, Preliminary Amendment filed Mar. 9, 2016”, 9 pgs.
“U.S. Appl. No. 15/060,007, Response filed Feb. 15, 2019 to Final Office Action dated Jan. 3, 2019”, 9 pgs.
“U.S. Appl. No. 15/060,007, Response filed Nov. 26, 2018 to Non Final Office Action dated Nov. 9, 2018”, 10 pgs.
“U.S. Appl. No. 15/061,352, Corrected Notice of Allowance dated Feb. 12, 2018”, 2 pgs.
“U.S. Appl. No. 15/061,352, Non Final Office Action dated Nov. 17, 2017”, 6 pgs.
“U.S. Appl. No. 15/061,352, Notice of Allowance dated Jan. 19, 2018”, 10 pgs.
“U.S. Appl. No. 15/061,352, Preliminary Amendment filed Mar. 7, 2016”, 8 pgs.
“U.S. Appl. No. 15/061,352, Response filed Dec. 12, 2017 to Non Final Office Action dated Nov. 17, 2017”, 9 pgs.
“U.S. Appl. No. 15/074,553, Corrected Notice of Allowance dated Feb. 12, 2018”, 2 pgs.
“U.S. Appl. No. 15/074,553, Non Final Office Action dated Nov. 17, 2017”, 6 pgs.
“U.S. Appl. No. 15/074,553, Notice of Allowance dated Jan. 19, 2018”, 10 pgs.
“U.S. Appl. No. 15/074,553, Preliminary Amendment filed Mar. 21, 2016”, 8 pgs.
“U.S. Appl. No. 15/074,553, Response filed Dec. 12, 2017 to Non Final Office Action dated Nov. 17, 2017”, 8 pgs.
“U.S. Appl. No. 15/131,663, Non Final Office Action dated Oct. 2, 2018”, 7 pgs.
“U.S. Appl. No. 15/131,663, Notice of Allowance dated Mar. 19, 2019”, 8 pgs.
“U.S. Appl. No. 15/131,663, Preliminary Amendment filed Dec. 21, 2016”, 6 pgs.
“U.S. Appl. No. 15/131,663, Response Filed Jan. 2, 2019 to Non-Final Office Action dated Oct. 2, 2018”, 9 pgs.
“U.S. Appl. No. 15/131,663, Response filed Jul. 13, 2018 to Restriction Requirement dated May 18, 2018”, 8 pgs.
“U.S. Appl. No. 15/131,663, Restriction Requirement dated May 18, 2018”, 7 pgs.
“U.S. Appl. No. 15/166,480, Notice of Allowance dated Sep. 20, 2018”, 12 pgs.
“U.S. Appl. No. 15/166,480, Response filed Jul. 18, 2018 to Restriction Requirement dated May 21, 2018”, 6 pgs.
“U.S. Appl. No. 15/166,480, Restriction Requirement dated May 21, 2018”, 6 pgs.
“U.S. Appl. No. 15/166,480, Supplemental Preliminary Amendment filed Jul. 18, 2017”, 7 pgs.
“U.S. Appl. No. 15/200,546, Non Final Office Action dated Oct. 15, 2018”, 10 pgs.
“U.S. Appl. No. 15/200,546, Notice of Allowance dated Mar. 19, 2019”, 7 pgs.
“U.S. Appl. No. 15/200,546, Preliminary Amendment filed Dec. 21, 2016”, 6 pgs.
“U.S. Appl. No. 15/200,546, Response Filed Jan. 15, 2019 to Non-Final Office Action dated Oct. 15, 2018”, 10 pgs.
“U.S. Appl. No. 15/200,546, Response Filed Sep. 17, 2018 to Restriction Requirement dated Jul. 16, 2018”, 8 pgs.
“U.S. Appl. No. 15/200,546, Restriction Requirement dated Jul. 16, 2018”, 6 pgs.
“U.S. Appl. No. 15/278,777, Non Final Office Action dated Feb. 28, 2018”, 14 pgs.
“U.S. Appl. No. 15/278,777, Notice of Allowance dated Jul. 16, 2018”, 8 pgs.
“U.S. Appl. No. 15/278,777, Preliminary Amendment filed Oct. 3, 2016”, 7 pgs.
“U.S. Appl. No. 15/278,777, Response filed May 29, 2018 to Non Final Office action dated Feb. 28, 2018”, 11 pgs.
“U.S. Appl. No. 15/288,183, Non Final Office Action dated Dec. 10, 2018”, 13 pgs.
“U.S. Appl. No. 15/288,183, Preliminary Amendment filed Oct. 31, 2016”, 7 pgs.
“U.S. Appl. No. 15/288,183, Response filed Feb. 27, 2019 to Non Final Office Action dated Dec. 10, 2018”, 11 pgs.
“U.S. Appl. No. 15/288,183, Response filed Oct. 25, 2018 to Restriction Requirement dated Sep. 12, 2018”, 7 pgs.
“U.S. Appl. No. 15/288,183, Restriction Requirement dated Sep. 12, 2018”, 6 pgs.
“U.S. Appl. No. 15/288,183, Supplemental Preliminary Amendment filed Jul. 27, 2017”, 7 pgs.
“U.S. Appl. No. 15/294,994, Examiner Interview Summary dated Feb. 26, 2019”, 3 pgs.
“U.S. Appl. No. 15/294,994, Final Office Action dated Jan. 25, 2019”, 13 pgs.
“U.S. Appl. No. 15/294,994, Non Final Office Action dated Aug. 9, 2018”, 9 pgs.
“U.S. Appl. No. 15/294,994, Preliminary Amendment filed Jan. 25, 2017”, 8 pgs.
“U.S. Appl. No. 15/294,994, Response filed Feb. 27, 2019 to Final Office Action dated Jan. 25, 2019”, 9 pgs.
“U.S. Appl. No. 15/294,994, Response filed Oct. 25, 2018 to Non Final Office Action dated Aug. 9, 2018”, 10 pgs.
“U.S. Appl. No. 15/294,994, Supplemental Preliminary Amendment filed May 31, 2017”, 6 pgs.
“U.S. Appl. No. 15/297,844, Notice of Allowance dated Aug. 30, 2018”, 10 pgs.
“U.S. Appl. No. 15/297,844, Preliminary Amendment filed Oct. 20, 2016”, 7 pgs.
“U.S. Appl. No. 15/297,844, Supplemental Preliminary Amendment filed Jan. 25, 2018”, 6 pgs.
“U.S. Appl. No. 15/332,590, Notice of Allowance dated Dec. 5, 2018”, 13 pgs.
“U.S. Appl. No. 15/332,590, Preliminary Amendment filed Nov. 22, 2016”, 5 pgs.
“U.S. Appl. No. 15/361,917, Non Final Office Action dated Apr. 19, 2019”, 11 pgs.
“U.S. Appl. No. 15/361,917, Preliminary Amendment filed Nov. 30, 2016”, 6 pgs.
“U.S. Appl. No. 15/361,917, Response filed Feb. 14, 2019 to Restriction Requirement dated Jan. 3, 2019”, 6 pgs.
“U.S. Appl. No. 15/361,917, Restriction Requirement dated Jan. 3, 2019”, 6 pgs.
“U.S. Appl. No. 15/401,768, Preliminary Amendment filed Mar. 23, 2017”, 6 pgs.
“U.S. Appl. No. 15/401,768, Restriction Requirement dated Mar. 15, 2019”, 6 pgs.
“U.S. Appl. No. 15/401,768, Supplemental Preliminary Amendment filed Jun. 22, 2017”, 7 pgs.
“U.S. Appl. No. 15/412,676, Preliminary Amendment filed Jul. 3, 2017”, 7 pgs.
“U.S. Appl. No. 15/412,676, Restriction Requirement dated Mar. 15, 2019”, 6 pgs.
“U.S. Appl. No. 15/455,895, Preliminary Amendment filed Mar. 13, 2017”, 6 pgs.
“U.S. Appl. No. 15/461,675, Preliminary Amendment filed Jun. 24, 2017”, 6 pgs.
“U.S. Appl. No. 15/461,675, Restriction Requirement dated Mar. 26, 2019”, 6 pgs.
“U.S. Appl. No. 15/461,675, Supplemental Preliminary Amendment filed Jun. 28, 2018”, 7 pgs.
“U.S. Appl. No. 15/622,718, Preliminary Amendment filed Jun. 15, 2017”, 7 pgs.
“U.S. Appl. No. 15/626,384, Preliminary Amendment filed Aug. 10, 2018”, 11 pgs.
“U.S. Appl. No. 15/654,386, Preliminary Amendment filed Aug. 30, 2017”, 11 pgs.
“U.S. Appl. No. 15/659,689, Non Final Office Action dated Oct. 31, 2018”, 13 pgs.
“U.S. Appl. No. 15/659,689, Preliminary Amendment filed Jul. 26, 2017”, 7 pgs.
“U.S. Appl. No. 15/662,572, Preliminary Amendment filed Jul. 31, 2017”, 7 pgs.
“U.S. Appl. No. 15/664,572, Preliminary Amendment filed Aug. 3, 2017”, 7 pgs.
“U.S. Appl. No. 15/682,187, Preliminary Amendment filed Sep. 7, 2017”, 6 pgs.
“U.S. Appl. No. 15/703,727, Preliminary Amendment filed Sep. 14, 2017”, 7 pgs.
“U.S. Appl. No. 15/715,731, Preliminary Amendment Filed Sep. 26, 2017”, 9 pgs.
“U.S. Appl. No. 15/715,731, Supplemental Preliminary Amendment filed Dec. 29, 2017”, 8 pgs.
“U.S. Appl. No. 15/720,997, Preliminary Amendment filed Oct. 2, 2017”, 6 pgs.
“U.S. Appl. No. 15/722,002, Preliminary Amendment filed Jun. 29, 2018”, 5 pgs.
“U.S. Appl. No. 15/793,216, Preliminary Amendment filed Oct. 26, 2017”, 8 pgs.
“U.S. Appl. No. 15/865,938, Preliminary Amendment filed Jan. 10, 2018”, 7 pgs.
“U.S. Appl. No. 15/866,089, Preliminary Amendment filed Jan. 10, 2018”, 10 pgs.
“U.S. Appl. No. 15/886,712, Preliminary Amendment filed Feb. 2, 2018”, 8 pgs.
“U.S. Appl. No. 15/891,049, Preliminary Amendment filed Feb. 8, 2018”, 6 pgs.
“U.S. Appl. No. 15/903,261, Preliminary Amendment filed Feb. 28, 2018”, 6 pgs.
“U.S. Appl. No. 15/917,143, Preliminary Amendment filed Mar. 14, 2018”, 7 pgs.
“U.S. Appl. No. 15/941,481, Preliminary Amendment filed Mar. 30, 2018”, 7 pgs.
“U.S. Appl. No. 15/945,425, Preliminary Amendment filed Apr. 5, 2018”, 8 pgs.
“U.S. Appl. No. 15/945,425, Supplemental Preliminary Amendment filed May 10, 2018”, 6 pgs.
“U.S. Appl. No. 15/956,444, Preliminary Amendment filed Apr. 19, 2018”, 7 pgs.
“U.S. Appl. No. 15/972,646, Preliminary Amendment filed May 9, 2018”, 6 pgs.
“U.S. Appl. No. 16/160,559, Preliminary Amendment filed Oct. 17, 2018”, 6 pgs.
“U.S. Appl. No. 16/251,342, Preliminary Amendment filed Jan. 21, 2019”, 6 pgs.
“U.S. Appl. No. 16/255,300, Preliminary Amendment filed Jan. 24, 2019”, 6 pgs.
“U.S. Appl. No. 16/380,742, Preliminary Amendment filed Apr. 12, 2019”, 6 pgs.
“Arthroscopic Meniscal Repair using the Meniscal Cinch™”, Surgical Technique brochure. Arthrex®, 6 sheets, (2008), 6 sheets.
“Australian Application Serial No. 2014236885, First Examination Report dated Dec. 11, 2017”, 2 pgs.
“Australian Application Serial No. 2014236885, Response filed Feb. 14, 2018 to First Examination Report dated Dec. 11, 2017”, 6 pgs.
“Bio-Intrafix Tibial Soft Tissue Fastener, Building on the Legacy of IntraFix”, DePuy Mitek brochure, (Feb. 2007), 6 pgs.
“Bio-Intrafix (TCP/PLA) & Intrafix, Tibial Soft Tissue Fasteners”, DePuy Mitek, ((date unknown)), 6 pgs.
“Biomechanical Evaluation of the Biomet Sports Medicine JurggerKnot™ Soft Anchor in Porcine Bone”, Study completed Jan. 2010. Biomet Sports Medicine Research and Develo ment, Warsaw, Indiana, (Jan. 2010), 2 pgs.
“Canadian Application Serial No. 2906596, Office Action dated Feb. 26, 2018”, 3 pgs.
“Chinese Application Serial No. 201480027708.4, Office Action dated Feb. 14, 2017”, (W/English Translation), 18 pgs.
“Chinese Application Serial No. 201480027708.4, Office Action dated May 26, 2016”, W/English Translation, 15 pgs.
“Chinese Application Serial No. 201480027708.4, Office Action dated Aug. 18, 2017”, (W/English Translation), 8 pgs.
“Chinese Application Serial No. 201480027708.4, Response filed May 2, 2017 to Office Action dated Feb. 14, 2017”, (W/ English Translation), 17 pgs.
“Chinese Application Serial No. 201480027708.4, Response filed Oct. 10, 2016 to Office Action dated May 26, 2016”, (W/ English Translation of Claims), 14 pgs.
“Chinese Application Serial No. 201480027708.4, Response filed Oct. 31, 2017 to Office Action dated Aug. 18, 2017”, (W/ English Claims), 7 pgs.
“Declaration of John White regarding PSCD and Customized Device and Exhibits 1-5”.
“Do your next distal tendon repair with . . . The Lubbers Technique”, Teno Fix® brochure, Ortheon® Medical, (2003), 2 pgs.
“European Application No. 16168202.6, Extended European Search Report dated Aug. 16, 2017”, 11 pgs.
“European Application No. 16168202.6, Response filed Nov. 3, 2017 to Extended European Search Report dated Aug. 16, 2017”, 9 pgs.
“European Application Serial No. 10727548.9, Examination Notification Art. 94(3) dated Sep. 18, 2014”, 6 pgs.
“European Application Serial No. 10727548.9, Office Action dated Jan. 11, 2016”, 6 pgs.
“European Application Serial No. 10727548.9, Office Action dated Jan. 19, 2012”, 2 pgs.
“European Application Serial No. 10727548.9, Response filed Mar. 19, 2015 to Examination Notification Art. 94(3) dated Sep. 18, 2014”, 23 pgs.
“European Application Serial No. 11707316.3, Examination Notification Art. 94(3) dated Feb. 4, 2014”, 3 pgs.
“European Application Serial No. 11707316.3, Examination Notification Art. 94(3) dated Dec. 17, 2014”, 5 pgs.
“European Application Serial No. 11707316.3, Office Action dated Nov. 10, 2015”, 6 pgs.
“European Application Serial No. 11707316.3, Response filed Jun. 5, 14 to Examination Notification Art. 94(3) dated Feb. 4, 2014”, 7 pgs.
“European Application Serial No. 11707316.3, Response filed Jun. 29, 2015 to Examination Notification Art. 94(3) dated Dec. 17, 2014”, 25 pgs.
“European Application Serial No. 12721676.0, Communication pursuant to Article 94(3) EPC dated Sep. 30, 2015”, 4 pgs.
“European Application Serial No. 12721676.0, Office Action dated Jan. 3, 2014”, 2 pgs.
“European Application Serial No. 12721676.0, Preliminary Amendment filed Nov. 19, 2013”, 9 pgs.
“European Application Serial No. 12721676.0, Response filed Apr. 11, 2016 to Communication pursuant to Article 94(3) EPC dated Sep. 30, 2015”, 38 pgs.
“European Application Serial No. 12721676.0, Response filed Jul. 10, 2014 to Office Action dated Jan. 3, 2014”, 2 pgs.
“European Application Serial No. 12791902.5, Examination Notification Art. 94(3) dated Aug. 14, 2015”, 4 pgs.
“European Application Serial No. 12791902.5, Office Action dated Jul. 15, 2014”, 2 pgs.
“European Application Serial No. 12791902.5, Response filed Feb. 23, 2016 to Examination Notification Art. 94(3) dated Aug. 14, 2015”, 12 pgs.
“European Application Serial No. 12806211.4, Examination Notification Art. 94(3) dated Aug. 13, 2015”, 5 pgs.
“European Application Serial No. 12806211.4, Office Action dated Jul. 18, 2014”, 2 pgs.
“European Application Serial No. 12806211.4, Response filed Feb. 23, 16 to Communication Pursuant to Article 94(3) EPC dated Aug. 13, 2015”, 11 pgs.
“European Application Serial No. 13818131.8, Office Action dated Jul. 28, 2015”, 2 pgs.
“European Application Serial No. 13818131.8, Response filed Feb. 8, 2016 to Office Action dated Jul. 28, 2015”, 14 pgs.
“European Application Serial No. 14716173.1, Office Action dated Nov. 5, 2015”, 2 pgs.
“European Application Serial No. 14716173.1, Response filed May 16, 2016 to Communication pursuant to Rules 161(1) and 162 EPC dated Nov. 5, 2015”, 10 pgs.
“European Application Serial No. 14716173.1, Response filed Sep. 25, 2017 to Office Action dated Mar. 14, 2017”, 12pgs.
“European Application Serial No. 16168202.6, Communication Pursuant to Article 94(3) EPC dated Apr. 25, 2018”, 5 pgs.
“European Application Serial No. 16168202.6, Communication pursuant to Article 94(3) EPC dated Dec. 11, 2018”, 6 pgs.
“European Application Serial No. 16168202.6, Partial European Search Report dated May 9, 2017”, 12 pgs.
“European Application Serial No. 16168202.6, Response filed Sep. 5, 2018 to Communication Pursuant to Article 94(3) EPC dated Apr. 25, 2018”, 13 pgs.
“European Application Serial No. 17169003.5, Extended European Search Report dated May 11, 2018”, 8 pgs.
“European Application Serial No. 17169003.5, Response Filed Dec. 19, 2018 to Extended European Search Report dated May 11, 2018”, 22 pgs.
“European Application Serial No. 12806211.4, Communication Pursuant to Article 94(3) EPC dated Jun. 23, 2016”, 4 pgs.
“EZ Loc Femoral Fixation Device”, copyright 2005 Arthrotek, Inc, (2005), 8 pgs.
“International Application Serial No. PCT/US2009/039580, International Preliminary Report on Patentability dated Nov. 4, 2010”, 9 pgs.
“International Application Serial No. PCT/US2009/039580, International Search Report dated Jul. 30, 2009”, 4 pgs.
“International Application Serial No. PCT/US2009/039580, Written Opinion dated Jul. 30, 2009”, 7 pgs.
“International Application Serial No. PCT/US2010/036602, International Preliminary Report on Patentability dated Dec. 8, 2011”, 9 pgs.
“International Application Serial No. PCT/US2010/036602, International Search Report dated Nov. 8, 2010”, 6 pgs.
“International Application Serial No. PCT/US2010/036602, Written Opinion dated Nov. 8, 2010”, 7 pgs.
“International Application Serial No. PCT/US2011/026349, International Preliminary Report on Patentability dated Sep. 20, 2012”, 11 pgs.
“International Application Serial No. PCT/US2011/026349, International Search Report dated Jul. 28, 2011”, 6 pgs.
“International Application Serial No. PCT/US2011/026349, Invitation to Pay Additional Fees dated Jun. 9, 2011”, 5 pgs.
“International Application Serial No. PCT/US2011/026349, Written Opinion dated Jul. 28, 2011”, 9 pgs.
“International Application Serial No. PCT/US2011/038188, International Preliminary Report on Patentability dated Dec. 6, 2012”, 14 pgs.
“International Application Serial No. PCT/US2011/038188, International Search Report dated Oct. 14, 2011”, 6 pgs.
“International Application Serial No. PCT/US2011/038188, Invitation to Pay Additional Fees dated Aug. 5, 2011”, 5 pgs.
“International Application Serial No. PCT/US2011/038188, Written Opinion dated Oct. 14, 2011”, 12 pgs.
“International Application Serial No. PCT/US2012/030294, International Preliminary Report on Patentability dated Oct. 10, 2013”, 9 pgs.
“International Application Serial No. PCT/US2012/030294, International Search Report dated May 23, 2012”, 6 pgs.
“International Application Serial No. PCT/US2012/030294, Written Opinion dated May 23, 2012”, 7 pgs.
“International Application Serial No. PCT/US2012/037703, International Preliminary Report on Patentability dated Nov. 28, 2013”, 10 pgs.
“International Application Serial No. PCT/US2012/037703, International Search Report dated Sep. 21, 2012”, 6 pgs.
“International Application Serial No. PCT/US2012/037703, Invitation to Pay Additional Fees dated Jul. 19, 2012”, 7 pgs.
“International Application Serial No. PCT/US2012/037703, Written Opinion dated Sep. 21, 2012”, 8 pgs.
“International Application Serial No. PCT/US2012/062738, International Preliminary Report on Patentability dated May 15, 2014”, 9 pgs.
“International Application Serial No. PCT/US2012/062738, International Search Report dated Mar. 6, 2013”, 6 pgs.
“International Application Serial No. PCT/US2012/062738, Written Opinion dated Mar. 6, 2013”, 7 pgs.
“International Application Serial No. PCT/US2012/064832, International Preliminary Report on Patentability dated May 30, 2014”, 9 pgs.
“International Application Serial No. PCT/US2012/064832, International Search Report dated Feb. 6, 2013”, 3 pgs.
“International Application Serial No. PCT/US2012/064832, Written Opinion dated Feb. 6, 2013”, 7 pgs.
“International Application Serial No. PCT/US2013/058921, International Preliminary Report on Patentability dated Mar. 26, 2015”, 9 pgs.
“International Application Serial No. PCT/US2013/058921, International Search Report dated Oct. 21, 2013”, 5 pgs.
“International Application Serial No. PCT/US2013/058921, Written Opinion dated Oct. 21, 2013”, 6 pgs.
“International Application Serial No. PCT/US2013/075989, International Preliminary Report on Patentability dated Jul. 2, 2015”, 10 pgs.
“International Application Serial No. PCT/US2013/075989, International Search Report dated Mar. 6, 2014”, 4 pgs.
“International Application Serial No. PCT/US2013/075989, Written Opinion dated Mar. 6, 2014”, 7 pgs.
“International Application Serial No. PCT/US2014/026413, International Preliminary Report on Patentability dated Sep. 24, 2015”, 10 pgs.
“International Application Serial No. PCT/US2014/026413, International Search Report dated Jun. 6, 2014”, 5 pgs.
“International Application Serial No. PCT/US2014/026413, Written Opinion dated Jun. 6, 2014”, 8 pgs.
“JuggerKnot™ Soft Anchor Midfoot Repair”, brochure. Biomet Sports Medicine, (Jul. 2011), 12 pgs.
“JuggerKnot™ Soft Anchor. It's Small. It's strong. And it's all suture . . . ”, Ordering Information brochure. Biomet Sports Medicine, (Jun. 2011), 2 pgs.
“JuggerKnot™ Soft Anchor. Labral Repair”, brochure. Biomet Sports Medicine, (Apr. 2011), 12 pgs.
“JuggerKnot™ Soft Anchor: Arthroscopic and Mini-Open Rotator Cuff Repair Using JuggerKnot™ Soft Anchor—2.9mm with ALLthread™ Knotless Anchor Surgical Technique”, brochure, Biomet® Sports Medicine, (2013), 16 pgs.
“Make your next tendon repair an open-and-shut case. The Teno Fix® Tendon Repair System”, Teno Fix® brochure, Ortheon® Medical, (2003), 2 pgs.
“Mallory-Head Modular Calcar Revision System”, Biomet Orthopedics, Inc., (2006), 20 pgs.
“Next Generation in Knee Ligament Reconstruction & Repair Technology”, Suture Tensioner w/Tensiometer, Arthrex®, Inc. catalog, (2009).
“PANALOK Anchor with PDS II and ETHIBOND Suture”, Mitek Products ETHICON, (1997), 2 pgs.
“Rapid Sternal Closure”, KLS Martin L.P., [Online] retrieved from the internet.
“Rotator Cuff Fixation”, Acufex Fastenator System: Shoulder Arthroscopy, H-2-H-22.
“SE Graft Tensioning System Surgical Technique”, Linvatec Corporation copyright 2003, (2004), 12 pgs.
“SportMesh™ Soft Tissue Reinforcment, Made from . . . Artelon® optimal tissue repair”, Biomet® Sports Medicine, Inc., (2007), 8 pgs.
“Sternal Cable System”, Pioneer®, [Online] retrieved from the internet.
“The AutoCuff System”, Opus Medical, [Online], Retrieved from the Internet: <www.opusmedical.com>, (2003), 4 pgs.
“Toggleloc™ Femoral Fixation Device”, Arthrotek, (Mar. 31, 2006), 8 pgs.
“TriTis™ Tibial Fixation System and Implant”, brochure. Scandius Biomedical, (2006).
Albritton, Mark J, et al., “Toggleloc Fixation Device with Ziploop Technology: Biceps Tendon Reattachment”, Biomet Sports Medicine, a Biomet Company Brochure 2099, (2011), 1-12.
Alford, J Winslow, et al., “Cartilage Restoration, Part 1. Basic Science, Historical Perspective, Patient Evaluation, and Treatment Options”, The American Journal of Sports Medicine, 33(2), (2005), 295-306.
Andrews, James R, “Toggleloc™ Fixation Device with Ziploop™ Technology: ACL Reconstruction Bone-Tendon-Bone”, Biomet Sports Medicine, a Biomet Company Brochure, (2013), 1-20.
Anitua, Eduardo, et al., “Autologous platelets as a source of proteins for healing and tissue regeneration”, Thromb Haemost, vol. 91, (2004), 4-15.
Arthrotek, “A Biomet Company; Sure fire Hybrid Meniscal Device”, Fall AANA, (2004), 37 pgs.
Barber, Alan F, “Uses and Abuses of Sutures and Anchors”, Shoulder Scope, San Diego Shoulder Arthroscopy Library, (Jul. 1999), 6 pgs.
Barber, Alan F, “Using Sutures and Anchors”, San Diego Shoulder Arthroscopy Course, 17th Annual Meetina, (Jun. 14, 2000), 9 pgs.
Charlton, Timothy, “Ziptight™ Fixation System Featuring Zip Loop™ Technology. Ankle Syndesmosis. Surgical Protocol”, Biomet Sports® Medicine brochure, (Jun. 15, 2011), 8 pgs.
Edwards, Andrew, et al., “The Attachments of the Fiber Bundles of the Posterior Cruciate ligament: An Anatomic Study”, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 23, No. 3, (Mar. 2008), 284-290.
Flavia, Namie Azato, “Traction endurance biomechanical study of metallic suture anchors at different insertion angles”, Acta Ortop. Bras., vol. 11, No. 1, Sao Paulo, (Jan./Mar. 2003), pp. 25-31.
Floryan, K, et al., “Home Study Program: Intraoperative use of Autologous Platelet-Rich and Platelet-Poor Plasma for Orthopedic Surgery Patients”, AORN Journal: Home Study Program, 80(4), (Oct. 2004), 667-678.
Fromm, Stuart M.D. E, “”, Rapidloc, Meniscal Repair System, Mitek Products, Ethicon, (2001), 6 pgs.
Haynesworth, S E, et al., “Mitogenic Stimulation of Human Mesenchymal Stem Cells by Platelet Releasate Suggests a Mechanism for Enhancement of Bone Repair by Platelet Concentrate”, 48th Annual Meeting of the Orthopaedic Research Society Poster No. 0462, (2002), 1 pg.
Hecker, AT, et al., “Pull-out strength of suture anchors for rotator cuff and Bankart lesion repairs”, The American Journal of Sports Medicine 21(6), (1993), 874-879.
Hunt, Patrick, et al., “Development of a Perforated Biodegradable Interference Screw; Arthroscopy:”, The Journal of Arthroscopic and Related Surgery, vol. 21, No. 3;, (Mar. 2005), 258-265.
Lawhorn, M D, et al., “MaxFire™ Meniscal Repair Device with Zip Loop™ Technology”, Biomet Sports Medicine, (Feb. 29, 2008), 12 pgs.
Majors, MD, Roy Alan, “Meniscal repairs: proven techniques and current trends”, Lippincott Williams & Wilkins, Inc.;, (2002), 30-36.
Miller, Mark D, et al., “Pitfalls Associated with FasT-Fix Meniscal Repair”, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 18 No. 8 :, (Oct. 2002), 939-943.
Mithoefer, Kai MD, et al., “The Microfracture Technique for the Treatment of Articular Cartilage Lesions in the Knee. A Prospective Cohort Study”, The Journal of Bone and Joint Surgery 87(9), (Sep. 2005), 1911-1920.
Nixon, A J, “Platelet Enriched Plasma Provides an Intensely Anabolic Vehicle for Sustained Chondrocyte Function After Implantation”, 52nd Annual Meeting of the Orthopedic Research Society: Paper No. 1416, (2005), 2 pgs.
Roseberg, MD, Thomas D, “ACL Reconstruction with Acufex Director Drill Guide and Endobutton CL Fixation System”, Smith & Nephew: Knee Series, Technique Guide, (2005), 12 pgs.
Saxena, Pankaj, et al., “Use of Double Wires in Sternal Closure, A Useful Technique”, Texas Heart® Institute. Journal List> Tex Heart Inst J > v.33(4), (2006).
Smith, et al., “Endoscopic Meniscal Repair Using the T-Fix”, (1996), 16 pgs.
Smith, et al., “Fast-Fix”, Meniscal Repair System;, (2001), 3 pgs.
Steadman, et al., “Microfracture: Surgical Technique and Rehalibitation to Treat Chondral Defects”, Clinical Orthopaedics and Related Research 391, (2001), S362-S369.
Thomas, Roseberg D, “Technique for ACL Reconstruction with Acufex Director Drill Guide and Endobutton CL”, Smith & Nephew, Technique Guide, (1999), 18 pgs.
Weiler, A, et al., “Biodegradierbare Interferenzschrauben in der Kreuzbandchirurgie”, OPJOURNAL 14, (1998), 278-284.
Zeitani, Jacob M.D, “A New Sternal Reinforcement Device to Prevent and Treat Sternal Dehiscence”, CTSNet, [Online], Retrieved from the Internet: <URL: http://www.ctsnet.org/print/article/new-sternal-reinforcement-device-prevent-and-treat-sternal-dehiscence>, (Jun. 30, 2008), 6 pgs.
Related Publications (1)
Number Date Country
20190254652 A1 Aug 2019 US
Divisions (1)
Number Date Country
Parent 12489168 Jun 2009 US
Child 13751846 US
Continuations (3)
Number Date Country
Parent 15941481 Mar 2018 US
Child 16400199 US
Parent 14983747 Dec 2015 US
Child 15941481 US
Parent 13751846 Jan 2013 US
Child 14983747 US
Continuation in Parts (12)
Number Date Country
Parent 12474802 May 2009 US
Child 12489168 US
Parent 12196410 Aug 2008 US
Child 12474802 US
Parent 12196407 Aug 2008 US
Child 12196410 US
Parent 12196405 Aug 2008 US
Child 12196407 US
Parent 12014340 Jan 2008 US
Child 12196405 US
Parent 12014399 Jan 2008 US
Child 12014340 US
Parent 11935681 Nov 2007 US
Child 12014399 US
Parent 11869440 Oct 2007 US
Child 11935681 US
Parent 11541505 Sep 2006 US
Child 11869440 US
Parent 11541506 Sep 2006 US
Child 11541505 US
Parent 11347662 Feb 2006 US
Child 11541506 US
Parent 11347661 Feb 2006 US
Child 11347662 US